≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Dermatitis due to substances taken internally

EFO MESH Endpoint Browser PheWeb

L12_INTERNALSUBSTANCEDERM

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — L27
  • Hospital discharge: ICD-9 — 693
  • Hospital discharge: excluded ICD-10 — L27.2
  • Cause of death: ICD-10 — L27
  • Cause of death: ICD-9 — 693
  • Cause of death: excluded ICD-10 — L27.2

2 out of 7 registries used, show all original rules.

2403

4. Check minimum number of events

None

2403

5. Include endpoints

None

2403

6. Filter based on genotype QC (FinnGen only)

2338

Control definitions (FinnGen only)

Control exclude
L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF12
Parent code in ICD-10
L20-L30
Name in latin
Dermatitis e substantiis devoratis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 2338 1493 845
Unadjusted period prevalence (%) 0.48 0.53 0.39
Median age at first event (years) 53.66 50.77 58.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2403
Matched controls
24030
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L27.1
ICD-10 Finland
Localized skin eruption due to drugs and medicaments
282.7
307.7
458
20
XQ802
NOMESCO Finland
Epicutan test
31.2
307.7
242
86
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
9.8
307.7
563
724
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
1316.5
307.7
1610
37
XQ800
NOMESCO Finland
Prick test
8.0
275.6
413
607
L30.9
ICD-10 Finland
Dermatitis, unspecified
4.9
256.3
737
2000
L20.0
ICD-10 Finland
Besnier prurigo
+∞
252.7
238
*
H02AB06
ATC
prednisolone; systemic
4.1
235.8
1586
7779
E0000UV, ,
ATC
3.4
189.7
1297
6156
XQ820
NOMESCO Finland
Exposure to medicinal substance
42.6
176.4
106
26
D07AC01
ATC
betamethasone; topical
3.3
176.1
1098
4877
D07AB08
ATC
desonide; topical
5.1
175.5
421
963
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.4
169.0
370
781
R06AE07
ATC
cetirizine; oral
3.0
151.4
1382
7445
6930B
ICD-9 Finland
Dermatitis due to substances taken internally, Due to drugs and medicines[EXANTHEMA EX USU PHARMACIS]
+∞
144.2
137
*
XQ899
NOMESCO Finland
Other assessment of skin
39.4
130.6
80
21
D07AA02
ATC
hydrocortisone; topical
3.7
128.8
487
1547
L50.0
ICD-10 Finland
Allergic urticaria
7.7
124.8
181
251
J01FF01
ATC
clindamycin; systemic
2.8
121.5
860
3936
T78.4
ICD-10 Finland
Allergy, unspecified
5.7
118.9
234
444
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
+∞
115.6
110
*
XQ801
NOMESCO Finland
Intracutantest
25.5
112.7
79
32
E000001, ,
ATC
3.1
111.0
602
2368
D07AB02
ATC
hydrocortisone butyrate; topical
2.7
110.8
839
3943
TQW80
NOMESCO Finland
Local dermatologic skincare
10.8
100.5
110
106
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
7.7
98.1
141
193
C01CA24
ATC
epinephrine; parenteral
4.3
96.6
271
690
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
96.3
1308
7947
D07BA04
ATC
hydrocortisone and antiseptics; topical
3.6
93.9
344
1057
R50.9
ICD-10 Finland
Fever, unspecified
2.9
90.8
536
2185
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
53.1
90.8
52
10
L27.2
ICD-10 Finland
Dermatitis due to ingested food
911.7
90.4
88
*
501
Kela drug reimbursment
Cow's milk and / or soy protein allergy in young children
16.0
84.8
73
47
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
8.2
83.9
113
143
D07AC13
ATC
mometasone; topical
2.5
83.1
739
3667
L50.9
ICD-10 Finland
Urticaria, unspecified
4.9
80.3
184
397
6939X
ICD-9 Finland
Dermatitis due to substances taken internally, Due to unspecified substance taken internally
+∞
78.6
75
*
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
3.0
76.1
379
1397
E000002, ,
ATC
3.3
75.8
318
1059
D07AD01
ATC
clobetasol; topical
2.8
74.6
449
1833
D02AX
ATC
Other emollients and protectives
6.7
72.6
117
181
L20
ICD-10 Finland
Atopic dermatitis
+∞
71.2
68
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
70.5
360
1342
6931A
ICD-9 Finland
Dermatitis due to substances taken internally, Due to food
+∞
70.1
67
*
L27.9
ICD-10 Finland
Dermatitis due to unspecified substance taken internally
+∞
65.9
63
*
J01MA12
ATC
levofloxacin; systemic
2.5
64.9
520
2426
L30.3
ICD-10 Finland
Infective dermatitis
8.2
64.6
87
110
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
+∞
63.8
61
*
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.2
60.5
169
426
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
59.1
422
1859
E000006, ,
ATC
3.7
58.0
199
580
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
57.0
884
5342
L04AX03
ATC
methotrexate; systemic
2.8
55.7
311
1210
A46
ICD-10 Finland
Erysipelas
2.5
55.0
394
1734
R06AX27
ATC
desloratadine; oral
2.0
54.4
780
4565
E000003, ,
ATC
4.5
53.7
134
309
L04AX01
ATC
azathioprine; systemic
4.0
53.1
157
412
J01MA02
ATC
ciprofloxacin; systemic
2.0
53.0
960
6087
H02AB04
ATC
methylprednisolone; systemic
2.5
51.9
394
1779
ZX108
NOMESCO Finland
Inhalation
11.5
51.0
53
47
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
50.8
742
4351
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
+∞
50.2
48
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.7
49.1
161
454
H02AB07
ATC
prednisone; oral
2.4
46.7
368
1684
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
46.7
323
1393
A02BC02
ATC
pantoprazole; systemic
1.9
46.1
1639
12705
N05BB01
ATC
hydroxyzine; systemic
3.3
46.0
188
611
R06AE09
ATC
levocetirizine; oral
2.3
45.7
392
1860
N02AX02
ATC
tramadol; systemic, rectal
1.9
45.4
1024
6878
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.5
45.0
331
1467
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
44.8
658
3840
J01DB01
ATC
cefalexin; oral
2.2
43.9
2003
16754
D11AH01
ATC
tacrolimus; topical
95.9
42.9
47
5
P01BA02
ATC
hydroxychloroquine; oral
2.7
42.4
244
959
XQ848
NOMESCO Finland
Dermatological photography
5.0
42.1
92
190
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.0
41.7
543
3026
D07XC01
ATC
betamethasone; topical
2.5
41.2
287
1238
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.3
41.2
163
519
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
39.8
494
2701
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
39.0
588
3439
N02AA05
ATC
oxycodone; systemic
2.1
38.8
456
2442
L04AD01
ATC
ciclosporin; systemic
5.5
38.7
75
139
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
38.3
561
3245
J01MA14
ATC
moxifloxacin; systemic
2.6
37.9
243
1006
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.2
37.7
104
259
J01DA01
ATC
[U] cefalexin
1.8
37.6
1462
11287
C03CA01
ATC
furosemide; systemic
1.9
37.6
687
4267
N03AX16
ATC
[U] pregabalin
1.9
37.6
554
3209
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.5
37.6
254
1079
L30.8
ICD-10 Finland
Other specified dermatitis
5.4
37.6
75
143
R03BA02
ATC
budesonide; inhalant
2.0
37.0
466
2554
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
36.1
490
2756
D07BC01
ATC
betamethasone and antiseptics; topical
2.4
35.9
266
1178
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.3
35.8
141
447
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
6.9
35.7
55
81
D02AE01
ATC
carbamide; topical
3.0
34.8
158
545
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.6
34.6
119
346
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.7
34.3
111
310
D07CC01
ATC
betamethasone and antibiotics; topical
2.3
34.2
291
1367
N03AG01
ATC
valproic acid; systemic, rectal
2.8
34.2
181
680
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
10.7
34.0
37
35
L50.8
ICD-10 Finland
Other urticaria
5.0
33.9
73
149
JN4AD
NOMESCO Finland
Body CT examination
2.3
33.4
295
1407
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
33.4
330
1648
L04AA06
ATC
mycophenolic acid; systemic
5.0
33.3
73
151
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.6
33.2
197
784
J01FA06
ATC
roxithromycin; oral
1.7
32.9
925
6456
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
11.1
32.9
35
32
ZX120
NOMESCO Finland
Intravenous
2.4
32.9
255
1151
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
32.7
560
3388
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
32.6
650
4116
R03AC02
ATC
salbutamol; inhalant
1.7
32.0
1319
10148
R03DC03
ATC
montelukast; oral
2.0
31.7
424
2362
A04AA01
ATC
ondansetron; systemic, rectal
2.4
31.4
231
1017
6930A
ICD-9 Finland
Dermatitis due to substances taken internally, Due to drugs and medicines[ECZEMA EX USU PHARMACIS]
+∞
31.3
30
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.9
31.2
153
551
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
316.9
30.9
31
*
J01AA02
ATC
doxycycline; systemic
1.7
30.4
1775
14866
D11AH02
ATC
pimecrolimus; topical
+∞
30.3
29
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.1
30.2
83
206
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.0
30.0
87
225
A92
ICPC
Allergy/allergic reaction NOS
3.4
29.8
112
345
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
29.6
977
7056
D09AB01
ATC
zinc bandage without supplements; topical
6.4
29.1
48
76
D05BB02
ATC
acitretin; oral
4.7
29.0
68
149
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
28.9
201
862
J02AC01
ATC
fluconazole; systemic
1.6
28.9
923
6602
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
28.9
891
6317
L30.0
ICD-10 Finland
Nummular dermatitis
4.0
28.8
82
209
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
28.7
539
3335
N03AX12
ATC
[U] gabapentin; oral
2.0
28.7
380
2104
S88
ICPC
Dermatitis contact/allergic
4.3
28.7
74
175
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.5
28.4
188
788
S01GX01
ATC
cromoglicic acid; ophthalmic
1.8
28.1
487
2940
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
28.1
483
2909
R06.0
ICD-10 Finland
Dyspnoea
1.7
28.0
636
4153
R01AD08
ATC
fluticasone; nasal
1.7
28.0
673
4463
H02AB02
ATC
dexamethasone; systemic
2.1
28.0
297
1519
M04AA01
ATC
allopurinol; systemic
2.1
28.0
294
1498
J05AB01
ATC
aciclovir; systemic
1.8
27.8
530
3292
UJF32
NOMESCO Finland
Coloscopy
1.7
27.7
581
3707
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
27.2
247
1188
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
27.2
265
1311
R06AX13
ATC
loratadine; oral
1.9
27.2
367
2044
L26
ICD-10 Finland
Exfoliative dermatitis
+∞
27.1
26
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
27.1
390
2219
R01AD09
ATC
mometasone; nasal
1.6
27.1
1062
7952
P01AB01
ATC
metronidazole; oral, rectal
1.6
27.1
926
6709
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
26.5
417
2439
J05AB11
ATC
valaciclovir; oral
1.9
26.2
356
1985
L20.8
ICD-10 Finland
Other atopic dermatitis
+∞
26.1
25
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
26.0
345
1907
WZC30
NOMESCO Finland
Teaching
1.9
26.0
392
2261
M79.6
ICD-10 Finland
Pain in limb
1.6
25.9
1021
7629
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.4
25.9
180
772
XG410
NOMESCO Finland
Flow-volume spirometry
3.1
25.5
110
368
N03AF01
ATC
carbamazepine; oral, rectal
2.8
25.5
136
512
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
25.3
313
1690
D11AX14
ATC
[U] tacrolimus
+∞
25.0
24
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.0
24.9
54
111
JN4BD
NOMESCO Finland
Extensive body CT
2.2
24.8
237
1163
R60.0
ICD-10 Finland
Localized oedema
2.0
24.7
296
1579
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
24.6
162
677
H02AB09
ATC
hydrocortisone; systemic
3.6
24.6
82
234
R06AX22
ATC
ebastine; oral
1.8
24.5
395
2323
R03BA05
ATC
fluticasone; inhalant
1.8
24.5
437
2652
J01XX08
ATC
linezolid; systemic
8.0
24.3
33
42
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.4
24.2
167
713
N02BE01
ATC
paracetamol; systemic, rectal
1.9
24.1
2093
18765
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
+∞
24.0
23
*
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
23.9
459
2843
N05CF01
ATC
zopiclone; oral
1.6
23.6
708
4932
R03AC03
ATC
terbutaline; inhalant
1.9
23.5
325
1819
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.6
23.5
77
217
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
23.5
470
2945
J01FA10
ATC
azithromycin; systemic
1.5
23.5
1363
11022
AA1AD
NOMESCO Finland
CT of head and brain
1.6
23.4
640
4357
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
7.3
23.3
34
47
J01FA09
ATC
clarithromycin; systemic
1.6
23.2
712
4982
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.6
23.1
78
224
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
23.1
256
1326
L01BA01
ATC
methotrexate; systemic
3.0
23.1
106
368
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
3.9
23.1
68
178
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.1
23.0
63
156
A03
ICPC
Fever
1.7
22.9
458
2867
A02BC05
ATC
esomeprazole; systemic
1.6
22.8
897
6642
N03AF02
ATC
oxcarbazepine; oral
3.1
22.8
98
328
XW000
NOMESCO Finland
Bone marrow biopsy
2.8
22.5
114
418
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
45.5
22.4
27
6
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
22.3
240
1230
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
22.3
234
1189
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.0
22.2
64
165
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
22.0
314
1774
N03AX09
ATC
lamotrigine; oral
2.5
22.0
140
576
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.4
21.9
156
676
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.2
21.7
88
284
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.1
21.7
91
300
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.5
21.7
142
592
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
21.6
316
1798
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
21.6
875
6504
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
21.5
220
1107
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
21.4
960
7289
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
21.3
177
819
J01DA09
ATC
[U] cefadroxil
1.6
21.0
588
4009
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
20.9
282
1562
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
60.6
20.9
24
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
20.9
702
4997
A07EC01
ATC
sulfasalazine; oral, rectal
2.1
20.7
197
963
J46
ICD-10 Finland
Status asthmaticus
3.2
20.5
81
258
M54.5
ICD-10 Finland
Low back pain
1.5
20.4
840
6248
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
20.3
222
1143
SPAT1263
SPAT
Sampling
1.5
20.3
956
7313
J01FA01
ATC
erythromycin; systemic
1.8
20.3
330
1940
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
20.2
968
7429
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
20.1
165
760
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
20.0
959
7357
N03AX14
ATC
levetiracetam; systemic
3.1
19.9
84
278
L27.8
ICD-10 Finland
Dermatitis due to other substances taken internally
+∞
19.8
19
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.3
19.8
51
121
E000007, ,
ATC
2.7
19.7
109
418
R02
ICPC
Shortness of breath/dyspnoea
1.8
19.7
317
1856
R51.80
ICD-10 Finland
Headache
1.7
19.7
391
2433
L04AA01
ATC
[U] ciclosporin
4.8
19.7
44
93
S29
ICPC
Skin symptom/complaint other
1.7
19.5
458
2980
WW500
NOMESCO Finland
Blood transfusion
2.6
19.4
111
433
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.1
19.4
190
939
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
19.2
252
1382
L51.9
ICD-10 Finland
Erythema multiforme, unspecified
16.9
19.2
30
18
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.3
19.0
72
223
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.7
19.0
101
380
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.0
19.0
84
286
B01AB05
ATC
enoxaparin; parenteral
1.5
18.9
673
4832
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.8
18.6
56
149
A02BC03
ATC
lansoprazole; oral
1.6
18.6
604
4246
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.7
18.6
59
163
S76
ICPC
Skin infection other
2.4
18.5
132
573
TGC00
NOMESCO Finland
Bronchial lavation
3.4
18.4
67
203
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
18.3
220
1171
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
18.3
562
3899
S18
ICPC
Laceration/cut
1.5
18.2
1027
8093
N06AX21
ATC
duloxetine; oral
1.8
18.0
277
1599
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
17.9
173
851
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
17.9
403
2591
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.7
17.8
98
375
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
17.8
1202
9791
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
37.0
17.6
22
6
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
17.6
146
676
A07AA02
ATC
nystatin; oral
2.3
17.6
135
605
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
7.8
17.4
24
31
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.3
17.3
132
589
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.3
17.2
128
565
SPAT1260
SPAT
Consultation of another employee
1.7
17.2
381
2435
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.8
17.1
278
1630
S97
ICPC
Chronic ulcer skin
2.2
17.1
140
645
SPAT1153
SPAT
Removal of sutures
1.5
17.0
651
4731
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
16.7
161
790
L03AA02
ATC
filgrastim; parenteral
2.9
16.7
80
285
M13.9
ICD-10 Finland
Arthritis, unspecified
2.1
16.6
174
881
M79.1
ICD-10 Finland
Myalgia
1.7
16.6
356
2254
N05BA01
ATC
diazepam; systemic, rectal
1.8
16.6
286
1705
R01AD12
ATC
fluticasone furoate; nasal
1.5
16.6
708
5256
SPAT1301
SPAT
No procedures
1.5
16.5
679
5004
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.5
16.4
106
439
ZX112
NOMESCO Finland
Subcutaneous
3.3
16.4
61
187
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
16.4
201
1076
J45.8
ICD-10 Finland
Mixed asthma
2.9
16.4
77
271
L51.0
ICD-10 Finland
Nonbullous erythema multiforme
23.2
16.4
23
10
Z51.5
ICD-10 Finland
Palliative care
2.0
16.4
190
998
ZXD05
NOMESCO Finland
Urgent procedure
1.5
16.4
657
4812
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.0
16.4
71
239
N05BA04
ATC
oxazepam; oral
1.5
16.4
592
4244
N02BF02
ATC
pregabalin; oral
2.1
16.3
161
798
C07AB07
ATC
bisoprolol; oral
1.4
16.3
985
7814
L04AA13
ATC
[U] leflunomide
3.1
16.3
67
219
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
16.2
552
3905
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
3.3
16.2
60
184
S87
ICPC
Dermatitis/atopic eczema
3.6
16.1
53
150
J45
ICD-10 Finland
Asthma
1.9
16.1
232
1310
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.8
16.1
48
127
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
16.1
307
1884
SPAT1255
SPAT
Intravenous administration of medicine
2.1
16.1
153
748
L50
ICD-10 Finland
Urticaria
3.3
16.0
59
180
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
15.9
647
4747
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
4.4
15.9
40
93
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
14.6
15.8
26
18
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
15.8
347
2212
127
Kela drug reimbursment
Transplant complication
3.9
15.7
46
120
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.9
15.7
74
261
E930A
ICD-9 Finland
Antibiotics[PENISILLIINIT]
33.6
15.7
20
6
L04AX04
ATC
lenalidomide; oral
5.9
15.7
28
48
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.4
15.7
108
461
L29.9
ICD-10 Finland
Pruritus, unspecified
3.3
15.6
58
178
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
15.6
129
597
L30
ICD-10 Finland
Other dermatitis
3.2
15.5
61
194
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
15.4
307
1907
SPAT1229
SPAT
Assessment of need for aid
2.0
15.4
164
837
WW200
NOMESCO Finland
Immunization
2.9
15.3
72
254
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
4.1
15.2
42
105
M25.5
ICD-10 Finland
Pain in joint
1.5
15.2
726
5491
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
15.1
599
4368
A04AA02
ATC
granisetron; systemic, transdermal
2.1
15.1
151
753
L40.5
ICD-10 Finland
Arthropathic psoriasis
3.6
15.1
49
138
N03AX18
ATC
lacosamide; systemic
5.0
15.0
32
65
L04AB04
ATC
adalimumab; parenteral
3.0
14.9
66
225
T78.3
ICD-10 Finland
Angioneurotic oedema
4.2
14.9
39
94
R53
ICD-10 Finland
Malaise and fatigue
1.5
14.8
575
4170
R60.9
ICD-10 Finland
Oedema, unspecified
2.2
14.8
128
603
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.5
14.7
51
150
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.1
14.6
61
201
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
14.6
140
687
D05AX52
ATC
calcipotriol, combinations; topical
2.4
14.6
105
458
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.2
14.5
56
176
J20
ICD-10 Finland
Acute bronchitis
1.8
14.5
236
1382
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.6
14.5
82
319
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.3
14.5
105
459
X57
ICD-10 Finland
Unspecified privation
3.1
14.5
60
197
Z88.1
ICD-10 Finland
Personal history of allergy to other antibiotic agents
150.9
14.5
15
*
A41.9
ICD-10 Finland
Sepsis, unspecified
2.6
14.5
85
337
A02BC01
ATC
omeprazole; systemic
1.5
14.4
574
4183
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
3.6
14.3
47
133
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.5
14.3
681
5138
L17
ICPC
Foot/toe symptom/complaint
1.5
14.2
673
5069
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
14.2
402
2719
R11
ICD-10 Finland
Nausea and vomiting
1.8
14.2
220
1269
R96
ICPC
Asthma
1.8
14.2
220
1270
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
14.2
187
1026
395
Kela drug reimbursment
Dupilumab
42.7
14.1
17
*
SPAT1254
SPAT
Administration of medicine
1.6
14.1
341
2224
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
14.0
138
683
D07XB05
ATC
dexamethasone; topical
3.1
13.9
57
186
J01EA01
ATC
trimethoprim; systemic
1.5
13.9
569
4165
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.9
13.9
190
1056
L71.9
ICD-10 Finland
Rosacea, unspecified
2.9
13.8
66
235
A07EA06
ATC
budesonide; oral, local oral
2.5
13.8
90
375
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
13.8
858
6786
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
13.7
146
744
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
13.7
225
1321
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
13.7
101
445
S06
ICPC
Rash localized
2.1
13.6
130
636
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
4.3
13.6
35
83
WX002
NOMESCO Finland
Sedation and analgesia
1.6
13.5
390
2649
L16
ICPC
Ankle symptom/complaint
1.7
13.4
283
1782
UKC02
NOMESCO Finland
Cystoscopy
1.6
13.3
295
1879
R42
ICD-10 Finland
Dizziness and giddiness
1.5
13.3
486
3472
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.0
13.3
138
697
D07AC14
ATC
methylprednisolone aceponate; topical
2.4
13.3
89
376
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
10.5
13.2
25
24
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
13.2
222
1313
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
13.2
1163
9728
E000004, ,
ATC
3.7
13.0
41
113
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.1
13.0
123
600
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
13.0
205
1189
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
3.8
13.0
39
104
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
5.2
13.0
26
50
D11AH05
ATC
dupilumab; topical
28.5
13.0
17
6
SPAT1325
SPAT
Vaccination
1.4
13.0
701
5396
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
12.9
260
1615
UDC00
NOMESCO Finland
Ear microscopy
1.9
12.9
166
903
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
12.9
350
2343
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
11.6
12.8
23
20
A10AB05
ATC
insulin aspart; parenteral
1.9
12.7
169
930
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.5
12.7
82
341
L03AA13
ATC
pegfilgrastim; parenteral
2.2
12.6
105
488
D11AX15
ATC
[U] pimecrolimus
+∞
12.5
12
*
R03AC12
ATC
salmeterol; inhalant
2.3
12.5
94
418
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.5
12.5
76
307
153
Kela drug reimbursment
Lenalidomid
5.3
12.5
25
48
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.8
12.5
211
1250
G47.3
ICD-10 Finland
Sleep apnoea
1.5
12.4
439
3110
R01AD58
ATC
fluticasone, combinations; nasal
1.5
12.4
548
4058
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
12.4
587
4405
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
12.4
589
4425
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
3.2
12.3
47
147
D07AB01
ATC
clobetasone; topical
2.7
12.3
67
256
B35.3
ICD-10 Finland
Tinea pedis
2.2
12.3
101
466
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.1
12.3
33
81
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
12.3
223
1347
L28.0
ICD-10 Finland
Lichen simplex chronicus
14.4
12.3
20
14
K30
ICD-10 Finland
Functional dyspepsia
1.7
12.3
247
1535
N02BF01
ATC
gabapentin; oral
1.7
12.2
225
1364
K59.1
ICD-10 Finland
Functional diarrhoea
2.0
12.2
133
684
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.6
12.2
68
263
N05BA09
ATC
clobazam; oral
5.1
12.2
25
49
S21
ICPC
Skin texture symptom/complaint
1.6
12.2
314
2074
A10AC01
ATC
insulin (human); parenteral
1.9
12.2
163
899
R03AK08
ATC
formoterol and beclometasone; inhalant
2.2
12.1
101
469
L40.9
ICD-10 Finland
Psoriasis, unspecified
3.6
12.1
40
114
N06AX16
ATC
venlafaxine; oral
1.6
12.1
309
2037
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
12.0
256
1613
A02BA02
ATC
ranitidine; systemic
1.5
12.0
374
2578
XX3DW
NOMESCO Finland
Time consuming IT work
1.7
12.0
223
1355
D69.0
ICD-10 Finland
Allergic purpura
5.3
12.0
24
46
M03BX02
ATC
tizanidine; oral
1.4
12.0
1307
11237
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
5.0
11.9
25
50
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
11.9
90
401
212
Kela drug reimbursment
Gout
3.3
11.9
44
135
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
11.9
290
1890
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
11.8
218
1324
N06AX11
ATC
mirtazapine; oral
1.4
11.8
719
5635
L50.1
ICD-10 Finland
Idiopathic urticaria
4.9
11.7
25
51
L50.3
ICD-10 Finland
Dermatographic urticaria
3.4
11.7
41
122
C91.4
ICD-10 Finland
Hairy-cell leukaemia
30.2
11.6
15
5
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.1
11.6
48
158
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.8
11.6
169
958
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
11.6
309
2058
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.1
11.6
47
153
L51.1
ICD-10 Finland
Bullous erythema multiforme
23.0
11.6
16
7
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
3.8
11.5
34
90
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
11.5
225
1388
6929X
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]
+∞
11.5
11
*
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
11.5
379
2646
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.4
11.4
74
308
L24.0
ICD-10 Finland
Irritant contact dermatitis due to detergents
120.6
11.4
12
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.6
11.4
64
249
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
11.4
89
403
H03AA01
ATC
levothyroxine sodium; systemic
1.5
11.4
485
3562
L40.8
ICD-10 Finland
Other psoriasis
5.4
11.3
22
41
D01AC02
ATC
miconazole; topical
1.9
11.3
146
796
J01FA15
ATC
telithromycin; oral
1.7
11.3
201
1208
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
35.2
11.3
14
*
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
4.9
11.2
24
49
M01AE02
ATC
naproxen; oral, rectal
1.3
11.2
1246
10696
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
11.2
190
1126
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
11.1
100
479
134
Kela drug reimbursment
General erythroderma
12.8
11.1
19
15
A06AD11
ATC
lactulose; oral
1.6
11.1
292
1937
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
3.6
11.1
35
97
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
8.1
11.1
24
30
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
11.1
520
3886
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.3
11.1
79
344
WX892
NOMESCO Finland
Monitored bed care
1.8
11.1
156
875
C10AC01
ATC
colestyramine; oral
2.6
11.1
62
241
XCK00
NOMESCO Finland
Perimetry
2.0
11.1
119
610
N18.8
ICD-10 Finland
Other chronic renal failure
3.0
11.0
49
168
C08CA01
ATC
amlodipine; oral
1.4
11.0
733
5811
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.8
11.0
53
190
L88
ICPC
Rheumatoid/seropositive arthritis
2.2
11.0
94
441
SPAT1312
SPAT
General health counselling
1.4
11.0
686
5381
D06AX01
ATC
fusidic acid; topical
1.7
11.0
196
1177
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
11.0
438
3172
ZXE00
NOMESCO Finland
One hour or less
1.4
11.0
817
6592
J01CE08
ATC
benzathine benzylpenicillin; parenteral
4.5
11.0
26
58
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
43.5
10.9
13
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.0
10.9
48
164
L01BB02
ATC
mercaptopurine; oral
3.5
10.9
36
103
A04
ICPC
Weakness/tiredness general
1.5
10.8
363
2539
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
10.8
186
1106
R03BA01
ATC
beclometasone; inhalant
1.6
10.8
278
1834
S02
ICPC
Pruritus
2.3
10.8
80
354
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
10.8
151
845
Z3231
NOMESCO Finland
Registered nurse
1.4
10.8
552
4187
L28
ICPC
Limited function/disability (L)
1.5
10.8
378
2670
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
10.7
239
1524
A03FA02
ATC
cisapride; oral, rectal
1.8
10.7
152
855
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.9
10.6
49
172
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
10.6
276
1828
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.2
10.6
89
416
L93.0
ICD-10 Finland
Discoid lupus erythematosus
8.5
10.5
22
26
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
10.5
1186
10166
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
10.5
152
860
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.0
10.5
46
157
N03AE01
ATC
clonazepam; systemic
2.0
10.5
115
594
Z51.6
ICD-10 Finland
Desensitization to allergens
3.5
10.4
35
101
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.9
10.4
125
665
M05BX04
ATC
denosumab; parenteral
1.9
10.4
131
708
Z00.0
ICD-10 Finland
General medical examination
1.5
10.4
410
2960
TK800
NOMESCO Finland
Hemodialysis
3.0
10.4
44
147
H01
ICPC
Ear pain/earache
1.6
10.4
267
1762
B03XA02
ATC
darbepoetin alfa; parenteral
2.8
10.3
50
180
A11CC03
ATC
alfacalcidol; systemic
2.7
10.3
53
197
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.2
10.3
82
374
A01AB09
ATC
miconazole; local oral
1.7
10.3
176
1045
ZY010
NOMESCO Finland
Hospital outpatient
1.9
10.3
122
647
Z71.8
ICD-10 Finland
Other specified counselling
1.4
10.3
751
6031
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.9
10.3
125
669
R74
ICPC
Upper respiratory infection acute
1.4
10.3
754
6060
L04AB01
ATC
etanercept; parenteral
3.0
10.2
43
143
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.5
10.2
63
257
L01
ICPC
Neck symptom/complaint
1.5
10.2
362
2561
183
Kela drug reimbursment
Lamotrigin and topiramate
4.1
10.2
27
66
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
3.3
10.1
38
118
J31.0
ICD-10 Finland
Chronic rhinitis
1.7
10.0
181
1091
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
10.0
192
1176
H66.9
ICD-10 Finland
Otitis media, unspecified
1.8
10.0
163
954
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.8
10.0
30
80
S06.0
ICD-10 Finland
Concussion
1.6
10.0
234
1509
137
Kela drug reimbursment
Uraemia requiring dialysis
4.6
10.0
23
50
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
10.0
269
1793
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.3
10.0
36
109
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
10.0
88
419
M01AH05
ATC
etoricoxib; oral
1.3
10.0
1292
11257
R03AC13
ATC
formoterol; inhalant
2.0
10.0
101
507
Z94.0
ICD-10 Finland
Kidney transplant status
3.9
9.9
29
76
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
4.2
9.9
26
63
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
9.9
157
913
Z01.2
ICD-10 Finland
Dental examination
1.3
9.9
1034
8742
S01
ICPC
Pain/tenderness of skin
2.0
9.9
103
523
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
4.3
9.8
25
59
D05AX02
ATC
calcipotriol; topical
2.3
9.8
70
305
L40.1
ICD-10 Finland
Generalized pustular psoriasis
26.1
9.8
13
5
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
2.5
9.8
58
232
B01AB10
ATC
tinzaparin; parenteral
1.6
9.8
223
1429
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
9.8
1611
14502
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.7
9.8
22
47
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
9.8
649
5128
J30.3
ICD-10 Finland
Other allergic rhinitis
2.2
9.7
79
364
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
9.7
258
1714
X58
ICD-10 Finland
Exposure to other specified factors
1.5
9.7
315
2187
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
9.7
133
740
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.0
9.6
104
534
B07.9
ICD-10 Finland
Verruca simplex
2.2
9.6
82
385
UDM02
NOMESCO Finland
Sinoscopy
2.7
9.6
51
193
C90.0
ICD-10 Finland
Multiple myeloma
3.5
9.6
32
92
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
9.6
830
6818
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.1
9.6
89
432
J32.4
ICD-10 Finland
Chronic pansinusitis
3.1
9.6
38
122
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.9
9.6
112
591
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
9.6
172
1036
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.9
9.6
43
149
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
9.6
253
1680
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
9.5
268
1803
D05AX03
ATC
calcitriol; topical
3.6
9.5
30
83
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.5
9.5
301
2077
L04AC05
ATC
ustekinumab; parenteral
7.2
9.5
22
31
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.7
9.5
165
986
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.1
9.5
85
408
R55
ICD-10 Finland
Syncope and collapse
1.6
9.5
216
1385
C07AA05
ATC
propranolol; systemic
1.4
9.4
421
3108
N06AA09
ATC
amitriptyline; systemic
1.7
9.4
178
1087
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.3
9.4
73
330
E930W
ICD-9 Finland
Antibiotics[MUUT MÄÄRITELLYT ANTIBIOOTIT]
100.4
9.4
10
*
T78.0
ICD-10 Finland
Anaphylactic shock due to adverse food reaction
17.6
9.4
14
8
M01AH02
ATC
rofecoxib; oral
1.6
9.4
235
1541
R07.3
ICD-10 Finland
Other chest pain
1.6
9.3
214
1373
ZXA10
NOMESCO Finland
Bilateral
1.5
9.3
362
2603
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
4.4
9.3
23
53
N30.0
ICD-10 Finland
Acute cystitis
1.5
9.3
375
2716
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
2.7
9.3
49
185
A28
ICPC
Limited function/disability NOS
1.5
9.3
343
2443
R52.9
ICD-10 Finland
Pain, unspecified
1.6
9.2
212
1361
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.7
9.2
28
76
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.2
9.1
72
328
K07
ICPC
Swollen ankles/oedema
2.0
9.1
97
496
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
9.1
704
5682
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.7
9.1
172
1051
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.1
9.1
87
428
XQ845
NOMESCO Finland
Dermatoscopy
3.0
9.1
40
137
C08CA13
ATC
lercanidipine; oral
1.5
9.1
268
1823
V03AE01
ATC
polystyrene sulfonate; oral
3.5
9.1
30
86
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
8.3
9.1
19
23
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
15.6
9.0
14
9
K02.1
ICD-10 Finland
Caries of dentine
1.3
9.0
1303
11454
SPAT1310
SPAT
Counselling related to known health issue
1.3
9.0
650
5191
N18.0
ICD-10 Finland
End-stage renal disease
4.1
9.0
24
59
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.2
8.9
76
357
L04AD02
ATC
tacrolimus; systemic
3.5
8.9
30
87
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
8.9
412
3059
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.7
8.9
46
172
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
24.1
8.9
12
5
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
8.9
370
2695
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.9
8.9
116
636
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.0
8.9
94
480
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
3.9
8.9
25
64
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.8
8.9
42
150
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.7
8.8
20
43
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
8.8
392
2890
L30.4
ICD-10 Finland
Erythema intertrigo
3.5
8.8
29
83
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.2
8.8
34
108
S11
ICPC
Skin infection post-traumatic
3.2
8.8
33
103
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.2
8.8
33
103
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.3
8.7
62
270
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.6
8.7
50
197
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
8.7
203
1307
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.6
8.7
47
180
C09CA06
ATC
candesartan; oral
1.4
8.7
475
3628
XQ832
NOMESCO Finland
Other provocation test
50.2
8.7
10
*
L23.1
ICD-10 Finland
Allergic contact dermatitis due to adhesives
50.2
8.7
10
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.3
8.7
22
52
R01AD01
ATC
beclometasone; nasal
1.5
8.7
292
2042
A07AA09
ATC
vancomycin; oral
3.1
8.6
34
109
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
8.6
296
2077
Z2446
NOMESCO Finland
Social worker
1.7
8.6
142
836
J02AC02
ATC
itraconazole; systemic
1.5
8.6
322
2299
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
8.6
63
279
M07.3
ICD-10 Finland
Other psoriatic arthropathies
3.6
8.6
27
75
WZA10
NOMESCO Finland
Extensive medical or dental certificate
3.1
8.6
35
115
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
8.5
67
305
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.0
8.5
37
126
A12AA04
ATC
calcium carbonate; oral
3.2
8.5
33
105
N03AB02
ATC
phenytoin; systemic
3.4
8.5
29
85
J04AB02
ATC
rifampicin; systemic
3.3
8.5
31
95
H60.1
ICD-10 Finland
Cellulitis of external ear
3.3
8.5
31
95
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.7
8.5
141
832
OAB50, ,
SPAT
1.7
8.5
163
1001
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
20.1
8.5
12
6
K07.60
ICD-10 Finland
Snapping jaw
1.8
8.5
118
661
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
8.4
151
909
M05BA04
ATC
alendronic acid; oral
1.7
8.4
171
1064
D06BX01
ATC
metronidazole; topical
1.6
8.4
203
1318
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
8.4
313
2230
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.2
8.4
70
326
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
2.8
8.4
40
143
XQ830
NOMESCO Finland
Exposure to foodstuff
90.4
8.4
9
*
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
8.4
61
269
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.7
8.4
42
155
K50.1
ICD-10 Finland
Crohn disease of large intestine
3.4
8.4
29
86
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
4.7
8.3
19
41
L13
ICPC
Hip symptom/complaint
1.4
8.3
380
2812
J01XC01
ATC
fusidic acid; systemic
3.3
8.3
30
91
M18.9
ICD-10 Finland
Arthrosis of first carpometacarpal joint, unspecified
3.3
8.3
30
91
6929B
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]
+∞
8.3
8
*
R01AC01
ATC
cromoglicic acid; nasal
2.1
8.3
78
381
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
4.0
8.3
23
58
H25.8
ICD-10 Finland
Other senile cataract
1.6
8.3
198
1282
A07EC02
ATC
mesalazine; oral, rectal
1.9
8.3
107
584
N06AB04
ATC
citalopram; systemic
1.4
8.3
396
2953
M79.7
ICD-10 Finland
Fibromyalgia
2.1
8.3
76
368
K65.0
ICD-10 Finland
Acute peritonitis
3.6
8.3
26
72
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
1.9
8.3
96
507
WX882
NOMESCO Finland
High dependency care
2.2
8.3
64
290
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.0
8.2
36
123
B34.9
ICD-10 Finland
Viral infection, unspecified
2.1
8.2
71
336
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.3
8.2
63
284
EMB10
NOMESCO Finland
Tonsillectomy
1.8
8.2
127
734
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.6
8.2
44
168
L08
ICPC
Shoulder symptom/complaint
1.4
8.2
456
3490
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
8.2
630
5068
R06.2
ICD-10 Finland
Wheezing
1.9
8.2
97
516
B02.9
ICD-10 Finland
Zoster without complication
1.7
8.2
134
788
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.0
8.2
34
113
N06AB10
ATC
escitalopram; oral
1.4
8.2
432
3280
L04AC07
ATC
tocilizumab; parenteral
7.5
8.2
18
24
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.4
8.1
339
2468
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.0
8.1
87
447
ZXH09, ,
SPAT
2.4
8.1
53
223
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.8
8.1
126
730
E931A
ICD-9 Finland
Other anti-infectives[SULFONAMIDIT]
33.5
8.1
10
*
S01AD03
ATC
aciclovir; ophthalmic
2.2
8.1
68
319
R03BA08
ATC
ciclesonide; inhalant
1.6
8.1
166
1038
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
8.0
433
3296
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
8.9
8.0
16
18
B01AC04
ATC
clopidogrel; oral
1.5
8.0
283
1996
R05
ICD-10 Finland
Cough
1.4
8.0
442
3377
L21.0
ICD-10 Finland
Seborrhoea capitis
6.3
8.0
20
32
S70
ICPC
Herpes zoster
2.3
8.0
56
243
S91
ICPC
Psoriasis
3.9
8.0
23
60
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
8.0
83
422
L29.8
ICD-10 Finland
Other pruritus
3.5
8.0
26
74
UJK02
NOMESCO Finland
ERCP
2.4
8.0
54
231
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.0
8.0
86
443
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.6
8.0
185
1192
R06AX26
ATC
fexofenadine; oral
1.7
7.9
128
749
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.0
7.9
88
458
R31
ICD-10 Finland
Unspecified haematuria
1.6
7.9
181
1162
WQ000
NOMESCO Finland
Hyposensibilisation
4.4
7.9
19
43
H05AA02
ATC
teriparatide; parenteral
6.6
7.9
19
29
S01GX02
ATC
levocabastine; ophthalmic
1.8
7.9
113
639
K12.00
ICD-10 Finland
Recurrent oral aphthae
2.8
7.9
37
132
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.2
7.9
67
316
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
7.9
206
1365
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.6
7.8
25
70
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.7
7.8
135
805
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.8
7.8
104
574
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.5
7.8
257
1787
130
Kela drug reimbursment
Malignant tumour
1.6
7.8
160
999
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.8
7.8
108
604
R03BB07
ATC
umeclidinium bromide; inhalant
4.1
7.8
21
52
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
4.1
7.8
21
52
W19
ICD-10 Finland
Unspecified fall
1.6
7.8
195
1278
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
10.8
7.8
14
13
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.2
7.8
63
291
K50.8
ICD-10 Finland
Other Crohn disease
2.8
7.8
37
133
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
7.8
197
1296
QDB10, ,
SPAT
2.3
7.7
54
234
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
7.7
140
846
D11
ICPC
Diarrhoea
1.5
7.7
259
1808
L04AK01
ATC
leflunomide; oral
4.2
7.7
20
48
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.1
7.7
74
365
WIX00
NOMESCO Finland
Allergy cleanup guidance
45.1
7.7
9
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
7.7
224
1518
J01DC02
ATC
cefuroxime; systemic
1.8
7.7
110
621
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
7.7
210
1404
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
4.3
7.7
19
44
318
Kela drug reimbursment
Teriparatide
5.9
7.7
20
34
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.1
7.7
67
319
J01DA06
ATC
[U] cefuroxime
1.5
7.7
273
1929
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
7.7
65
306
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.8
7.6
37
134
TAB00
NOMESCO Finland
Lumbar puncture
1.9
7.6
88
464
J33.8
ICD-10 Finland
Other polyp of sinus
2.6
7.6
41
157
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.3
7.6
56
249
T78.1
ICD-10 Finland
Other adverse food reactions, not elsewhere classified
25.1
7.6
10
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
7.6
477
3720
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
7.6
261
1833
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.6
7.6
158
992
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.5
846
7144
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.8
7.5
35
124
L04AB06
ATC
golimumab; parenteral
3.8
7.5
22
58
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.9
7.5
92
495
M10
ICD-10 Finland
Gout
2.0
7.5
76
383
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.9
7.5
95
517
R00.2
ICD-10 Finland
Palpitations
1.6
7.5
166
1058
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.0
7.5
31
103
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.3
7.4
56
251
A01AB04
ATC
amphotericin B; local oral
1.9
7.4
87
461
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
3.9
7.4
21
54
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.1
7.4
68
330
D06BB03
ATC
aciclovir; topical
1.9
7.4
86
455
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
7.4
134
811
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.8
7.4
111
637
R21
ICPC
Throat symptom/complaint
1.3
7.4
477
3733
A06AC51
ATC
ispaghula, combinations; oral
1.9
7.4
90
484
IHZ05, ,
SPAT
1.8
7.3
104
586
C03DA01
ATC
spironolactone; oral
1.5
7.3
221
1509
M01CB01
ATC
sodium aurothiomalate; parenteral
2.9
7.3
33
115
R01AD11
ATC
triamcinolone; nasal
1.6
7.3
161
1024
WVA20
NOMESCO Finland
Medicine administration
2.2
7.3
60
279
L27
ICD-10 Finland
Dermatitis due to substances taken internally
+∞
7.3
7
*
69299
ICD-8 Finland
Other eczema and dermatitis, Due to other and unspecified cause
+∞
7.3
7
*
6938X
ICD-9 Finland
Dermatitis due to substances taken internally, Due to other specified substances taken internally
+∞
7.3
7
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
3.1
7.3
29
94
G40
ICD-10 Finland
Epilepsy
3.5
7.3
24
69
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
7.2
503
3978
R06.4
ICD-10 Finland
Hyperventilation
2.8
7.2
35
127
J01CF05
ATC
flucloxacillin; systemic
1.7
7.2
137
839
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
15.8
7.2
11
7
ZSN00
NOMESCO Finland
Procedure related to previous procedure classified in chapter N
5.8
7.2
19
33
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
2.6
7.2
40
156
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
7.2
244
1708
V03AE02
ATC
sevelamer; oral
7.3
7.2
16
22
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
30.1
7.1
9
*
J01CA04
ATC
amoxicillin; systemic
1.3
7.1
1852
17277
R75
ICPC
Sinusitis acute/chronic
1.8
7.1
107
614
WZA90
NOMESCO Finland
Other medical or dental certificate
1.3
7.1
486
3833
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
7.1
331
2457
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
7.1
153
969
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
7.1
453
3538
WVA30, ,
SPAT
1.7
7.1
123
736
W10
ICD-10 Finland
Fall on and from stairs and steps
1.8
7.1
106
608
SPAT1262
SPAT
Handing over of treatment supplies
1.4
7.1
311
2285
J04BA02
ATC
dapsone; oral
6.0
7.1
18
30
JN6AD
NOMESCO Finland
CT of torso and neck
2.7
7.1
37
140
L03
ICPC
Low back symptom/complaint
1.3
7.1
612
4990
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.1
7.0
61
290
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.6
7.0
39
152
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
7.0
189
1260
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.5
7.0
43
176
ZXA05
NOMESCO Finland
Left side
1.3
7.0
449
3507
SPAT1240
SPAT
Therapeutic discussion
1.5
7.0
219
1508
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
2.2
7.0
54
245
H57.1
ICD-10 Finland
Ocular pain
1.9
7.0
86
464
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.3
7.0
51
226
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.7
7.0
129
785
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.4
7.0
24
71
N30.2
ICD-10 Finland
Other chronic cystitis
3.4
7.0
24
71
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.0
7.0
30
102
Z49.2
ICD-10 Finland
Other dialysis
4.4
7.0
17
39
G43.9
ICD-10 Finland
Migraine, unspecified
1.7
7.0
136
840
49300
ICD-8 Finland
Asthma, bronchiale
2.5
6.9
43
177
N05AH04
ATC
quetiapine; oral
1.4
6.9
361
2731
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.7
6.9
36
136
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
2.2
6.9
53
240
L14
ICPC
Leg/thigh symptom/complaint
1.6
6.9
162
1047
S80.0
ICD-10 Finland
Contusion of knee
1.6
6.9
163
1055
WW300
NOMESCO Finland
Transfer of autologic stem cells
7.5
6.9
15
20
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
3.1
6.9
28
92
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
3.1
6.9
28
92
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
6.9
150
952
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.2
6.9
58
273
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
6.9
1585
14522
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
2.8
6.8
32
114
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.6
6.8
145
914
G44.2
ICD-10 Finland
Tension-type headache
1.4
6.8
275
1988
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
6.8
177
1170
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
3.4
6.8
24
72
WZC00, ,
SPAT
1.4
6.8
305
2247
S89.9
ICD-10 Finland
Unspecified injury of lower leg
2.0
6.8
74
383
R20.2
ICD-10 Finland
Paraesthesia of skin
1.6
6.8
137
853
J47
ICD-10 Finland
Bronchiectasis
2.6
6.8
38
149
L20
ICPC
Joint symptom/complaint NOS
1.9
6.8
79
419
M35.1
ICD-10 Finland
Other overlap syndromes
6.1
6.8
17
28
L51.19
ICD-10 Finland
Other bullous erythema multiforme
40.2
6.8
8
*
B05DA
ATC
Isotonic solutions
4.3
6.7
17
40
N77.1*A60.0
ICD-10 Finland
Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection
4.3
6.7
17
40
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
4.3
6.7
17
40
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.0
6.7
67
336
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.2
6.7
26
83
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
2.8
6.7
33
121
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
3.2
6.7
25
78
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.7
6.7
116
694
R4110, ,
SPAT
1.4
6.7
263
1894
C05AA08
ATC
fluocortolone; rectal, topical
1.5
6.7
235
1657
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.8
6.7
99
567
J94.8
ICD-10 Finland
Other specified pleural conditions
2.8
6.6
32
116
S28
ICPC
Limited function/disability (S)
3.7
6.6
20
54
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
2.9
6.6
30
105
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
4.0
6.6
18
45
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.7
6.6
107
628
7080A
ICD-9 Finland
Urticaria, Allergic urticaria
7.8
6.6
14
18
SPAT1216
SPAT
Assessment of functional ability
1.4
6.6
283
2070
M02AA10
ATC
ketoprofen; topical
1.4
6.6
291
2139
A01
ICPC
Pain general/multiple sites
1.5
6.6
205
1410
B86
ICD-10 Finland
Scabies
2.1
6.6
58
278
P25
ICPC
Phase of life problem adult
1.8
6.6
93
525
P03
ICPC
Feeling depressed
1.5
6.6
225
1578
I45.9
ICD-10 Finland
Conduction disorder, unspecified
3.5
6.6
22
64
R4180
NOMESCO Finland
Podiatric therapy
3.0
6.5
28
95
J01CF02
ATC
cloxacillin; systemic
2.4
6.5
42
176
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
3.8
6.5
19
50
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
6.5
126
776
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.8
6.5
98
563
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.4
6.5
41
170
R4110
NOMESCO Finland
Physiotherapy
1.3
6.5
537
4345
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
6.5
93
527
ULC02
NOMESCO Finland
Hysteroscopy
1.8
6.5
95
542
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
2.3
6.5
47
208
H60.8
ICD-10 Finland
Other otitis externa
2.1
6.5
61
300
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
6.5
317
2373
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.6
6.4
148
952
H53.4
ICD-10 Finland
Visual field defects
2.4
6.4
40
165
UJF92
NOMESCO Finland
Capsular endoscopy
2.3
6.4
45
196
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
70.0
6.4
7
*
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.1
6.4
57
274
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.3
6.4
44
190
R52.2
ICD-10 Finland
Other chronic pain
1.9
6.4
77
413
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.0
6.4
64
322
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.6
6.4
34
130
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.8
6.4
94
537
R01AD05
ATC
budesonide; nasal
1.6
6.4
137
867
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
6.4
559
4557
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
6.4
115
696
A08
ICPC
Swelling
1.7
6.4
107
635
L29
ICD-10 Finland
Pruritus
2.9
6.4
29
102
ZX100
NOMESCO Finland
Oral
2.9
6.4
29
102
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
4.1
6.4
17
42
R09
ICPC
Sinus symptom/complaint
1.5
6.3
174
1166
R06AX11
ATC
astemizole; oral
2.1
6.3
57
276
ZY010, ,
SPAT
2.6
6.3
34
131
128
Kela drug reimbursment
Cancers of female genital organs
2.4
6.3
41
173
D72.1
ICD-10 Finland
Eosinophilia
6.0
6.3
16
27
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
3.5
6.3
21
61
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.4
6.3
39
161
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.7
6.3
31
114
J35.0
ICD-10 Finland
Chronic tonsillitis
1.7
6.3
109
653
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.0
6.3
60
297
R68.2
ICD-10 Finland
Dry mouth, unspecified
3.9
6.3
18
47
L29.0
ICD-10 Finland
Pruritus ani
3.9
6.3
18
47
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
6.3
108
646
L12
ICPC
Hand/finger symptom/complaint
1.4
6.3
357
2737
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.3
6.3
43
186
69282
ICD-8 Finland
Other eczema and dermatitis, E microbis
+∞
6.3
6
*
6918C
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]
+∞
6.3
6
*
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
6.2
420
3300
C09CA03
ATC
valsartan; oral
1.5
6.2
162
1072
J37.0
ICD-10 Finland
Chronic laryngitis
2.0
6.2
63
318
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.2
6.2
48
218
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.4
6.2
42
180
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.8
6.2
82
453
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.4
6.2
41
174
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.4
6.2
39
162
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.0
6.2
62
312
M05BA07
ATC
risedronic acid; oral
2.1
6.2
57
278
L43.8
ICD-10 Finland
Other lichen planus
2.6
6.2
35
138
J01AA04
ATC
lymecycline; systemic
1.4
6.2
253
1834
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.9
6.2
71
375
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.5
6.2
20
57
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.8
6.2
29
104
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.2
6.1
49
226
R05
ICPC
Cough
1.3
6.1
517
4190
R03BC01
ATC
cromoglicic acid; inhalant
2.6
6.1
33
127
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
2.2
6.1
48
220
H16.0
ICD-10 Finland
Corneal ulcer
1.7
6.1
96
560
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.0
6.1
64
328
1XC02, ,
NOMESCO Finland
3.8
6.1
18
48
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
4.1
6.1
16
39
J01DA08
ATC
[U] cefaclor
1.4
6.1
251
1823
120
Kela drug reimbursment
Hypogammaglobulinaemia
12.5
6.1
10
8
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
12.5
6.1
10
8
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
6.1
1481
13552
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
2.8
6.1
29
105
SPAT1097
SPAT
Recording of ECG
1.4
6.0
251
1825
R60.1
ICD-10 Finland
Generalized oedema
3.6
6.0
19
53
1CX01, ,
NOMESCO Finland
10.0
6.0
11
11
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
2.5
6.0
36
146

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
1.3e+00
2.2e+00
3.6e+00
8.3e+00
4.5e+00
3.2e+00
1.7e+00
cases:14.26%
controls:4.50%
cases:13.66%
controls:1.79%
cases:8.94%
controls:0.26%
cases:46.64%
controls:0.02%
cases:22.68%
controls:0.34%
cases:30.43%
controls:1.74%
cases:22.20%
controls:5.17%
314
983
1888
20871
301
391
1903
21475
197
56
2007
21810
1028
5
1176
21861
499
74
1701
21740
643
371
1470
20900
403
966
1412
17732
Dermatitis, unspecified
L30.9 [45572271]
1.5e+00
2.8e+00
4.6e+00
1.0e+50
4.5e+00
2.6e+00
1.6e+00
cases:4.22%
controls:0.99%
cases:5.13%
controls:0.32%
cases:4.54%
controls:0.05%
cases:2.04%
controls:0.00%
cases:2.45%
controls:0.03%
cases:4.83%
controls:0.38%
cases:7.99%
controls:1.76%
93
216
2109
21638
113
69
2091
21797
100
10
2104
21856
45
0
2159
21866
54
6
2146
21808
102
80
2011
21191
145
330
1670
18368
prednisolone; oral, parenteral
H02AB06 [21602734]
1.0e+00
1.7e+00
2.8e+00
4.8e+00
3.5e+00
1.7e+00
1.2e+00
cases:21.07%
controls:8.68%
cases:18.56%
controls:3.91%
cases:9.85%
controls:0.67%
cases:6.26%
controls:0.05%
cases:16.23%
controls:0.61%
cases:17.98%
controls:3.84%
cases:25.90%
controls:9.58%
464
1897
1738
19957
409
856
1795
21010
217
147
1987
21719
138
12
2066
21854
357
133
1843
21681
380
816
1733
20455
470
1791
1345
16907
prednisolone
A07EA01 [21600653]
1.0e+00
1.7e+00
2.8e+00
4.8e+00
3.5e+00
1.7e+00
1.2e+00
cases:21.07%
controls:8.74%
cases:18.60%
controls:3.93%
cases:9.85%
controls:0.68%
cases:6.26%
controls:0.05%
cases:16.23%
controls:0.61%
cases:18.03%
controls:3.87%
cases:25.95%
controls:9.65%
464
1910
1738
19944
410
860
1794
21006
217
149
1987
21717
138
12
2066
21854
357
133
1843
21681
381
823
1732
20448
471
1805
1344
16893
Emergency Room Visit
ER [9203]
6.0e-01
1.3e+00
2.8e+00
7.2e+00
1.9e+00
1.1e+00
8.0e-01
cases:44.23%
controls:30.22%
cases:29.54%
controls:9.98%
cases:17.65%
controls:1.29%
cases:31.99%
controls:0.04%
cases:7.86%
controls:1.22%
cases:24.28%
controls:9.53%
cases:44.63%
controls:26.67%
974
6605
1228
15249
651
2183
1553
19683
389
281
1815
21585
705
8
1499
21858
173
266
2027
21548
513
2027
1600
19244
810
4987
1005
13711
desonide
D07AB08 [21602112]
1.3e+00
2.0e+00
3.5e+00
1.0e+50
4.9e+00
2.5e+00
1.5e+00
cases:3.59%
controls:0.99%
cases:2.50%
controls:0.36%
cases:1.77%
controls:0.05%
cases:1.41%
controls:0.00%
cases:3.55%
controls:0.03%
cases:3.74%
controls:0.31%
cases:4.74%
controls:1.12%
79
217
2123
21637
55
79
2149
21787
39
12
2165
21854
31
0
2173
21866
78
6
2122
21808
79
67
2034
21204
86
209
1729
18489
Multiple myeloma
C90.0 [45600562]
1.9e+00
2.4e+00
3.2e+00
—
3.4e+00
2.4e+00
2.1e+00
cases:0.50%
controls:0.07%
cases:0.82%
controls:0.08%
cases:1.13%
controls:0.05%
—
—
cases:1.18%
controls:0.04%
cases:0.99%
controls:0.09%
cases:0.83%
controls:0.11%
11
16
2191
21838
18
17
2186
21849
25
10
2179
21856
—
26
9
2174
21805
21
19
2092
21252
15
20
1800
18678
epinephrine
S01EA01 [21603673]
1.4e+00
2.0e+00
3.4e+00
1.0e+50
3.5e+00
2.3e+00
1.9e+00
cases:2.72%
controls:0.69%
cases:2.09%
controls:0.27%
cases:0.68%
controls:0.02%
cases:0.23%
controls:0.00%
cases:1.05%
controls:0.03%
cases:2.46%
controls:0.26%
cases:4.68%
controls:0.71%
60
151
2142
21703
46
60
2158
21806
15
5
2189
21861
5
0
2199
21866
23
7
2177
21807
52
55
2061
21216
85
133
1730
18565
epinephrine; parenteral
C01CA24 [21600303]
1.4e+00
2.0e+00
3.4e+00
1.0e+50
3.5e+00
2.3e+00
1.9e+00
cases:2.72%
controls:0.69%
cases:2.09%
controls:0.27%
cases:0.68%
controls:0.02%
cases:0.23%
controls:0.00%
cases:1.05%
controls:0.03%
cases:2.46%
controls:0.26%
cases:4.68%
controls:0.71%
60
151
2142
21703
46
60
2158
21806
15
5
2189
21861
5
0
2199
21866
23
7
2177
21807
52
55
2061
21216
85
133
1730
18565
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.7e+00
1.8e+00
3.5e+00
—
3.4e+00
2.4e+00
1.7e+00
cases:1.14%
controls:0.22%
cases:1.13%
controls:0.19%
cases:0.77%
controls:0.02%
—
—
cases:1.32%
controls:0.05%
cases:1.61%
controls:0.15%
cases:1.93%
controls:0.37%
25
47
2177
21807
25
42
2179
21824
17
5
2187
21861
—
29
10
2171
21804
34
31
2079
21240
35
70
1780
18628
Psoriasis vulgaris
L40.0 [45543370]
1.4e+00
1.7e+00
3.6e+00
1.0e+50
3.2e+00
2.5e+00
1.8e+00
cases:1.32%
controls:0.34%
cases:1.23%
controls:0.22%
cases:0.82%
controls:0.02%
cases:0.64%
controls:0.00%
cases:0.91%
controls:0.04%
cases:1.99%
controls:0.17%
cases:2.53%
controls:0.41%
29
74
2173
21780
27
48
2177
21818
18
5
2186
21861
14
0
2190
21866
20
8
2180
21806
42
37
2071
21234
46
77
1769
18621
Chronic lymphocytic leukaemia of B-cell type
C91.1 [45600564]
1.6e+00
1.8e+00
2.9e+00
1.0e+50
3.1e+00
2.3e+00
2.3e+00
cases:0.64%
controls:0.12%
cases:0.54%
controls:0.09%
cases:0.50%
controls:0.03%
cases:0.32%
controls:0.00%
cases:0.50%
controls:0.02%
cases:0.71%
controls:0.08%
cases:0.77%
controls:0.08%
14
27
2188
21827
12
20
2192
21846
11
6
2193
21860
7
0
2197
21866
11
5
2189
21809
15
16
2098
21255
14
15
1801
18683
Internal Medicine
11 [38004456]
5.5e-01
1.1e+00
2.5e+00
6.1e+00
1.8e+00
1.0e+00
7.6e-01
cases:28.88%
controls:18.95%
cases:20.69%
controls:7.71%
cases:12.21%
controls:1.16%
cases:19.06%
controls:0.05%
cases:8.50%
controls:1.45%
cases:18.93%
controls:7.61%
cases:32.73%
controls:18.61%
636
4142
1566
17712
456
1685
1748
20181
269
254
1935
21612
420
12
1784
21854
187
316
2013
21498
400
1619
1713
19652
594
3479
1221
15219
Basophils [#/volume] in Blood
26444-0 [3006315]
6.4e-01
1.2e+00
2.2e+00
5.1e+00
2.4e+00
1.4e+00
8.9e-01
cases:15.49%
controls:8.81%
cases:15.74%
controls:5.43%
cases:8.89%
controls:1.07%
cases:4.17%
controls:0.03%
cases:10.73%
controls:1.04%
cases:18.50%
controls:5.40%
cases:26.45%
controls:12.84%
341
1926
1861
19928
347
1188
1857
20678
196
235
2008
21631
92
6
2112
21860
236
227
1964
21587
391
1148
1722
20123
480
2400
1335
16298
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
5.9e-01
1.2e+00
2.2e+00
5.2e+00
2.4e+00
1.4e+00
8.4e-01
cases:14.26%
controls:8.47%
cases:15.02%
controls:5.12%
cases:7.85%
controls:0.98%
cases:3.86%
controls:0.02%
cases:9.82%
controls:0.95%
cases:17.37%
controls:5.09%
cases:23.75%
controls:11.85%
314
1850
1888
20004
331
1119
1873
20747
173
214
2031
21652
85
5
2119
21861
216
208
1984
21606
367
1083
1746
20188
431
2215
1384
16483
Differential panel, method unspecified - Blood
69738-3 [42870588]
6.9e-01
1.3e+00
2.1e+00
4.5e+00
2.6e+00
1.5e+00
1.1e+00
cases:10.76%
controls:5.71%
cases:11.48%
controls:3.47%
cases:5.94%
controls:0.76%
cases:3.27%
controls:0.04%
cases:8.41%
controls:0.71%
cases:13.49%
controls:3.48%
cases:20.06%
controls:7.77%
237
1248
1965
20606
253
758
1951
21108
131
166
2073
21700
72
8
2132
21858
185
155
2015
21659
285
740
1828
20531
364
1453
1451
17245
Inpatient Hospital
21 [8717]
4.4e-01
1.0e+00
2.5e+00
6.1e+00
1.9e+00
1.1e+00
6.3e-01
cases:40.10%
controls:30.11%
cases:23.91%
controls:10.22%
cases:13.48%
controls:1.28%
cases:21.42%
controls:0.06%
cases:8.41%
controls:1.32%
cases:22.62%
controls:9.14%
cases:37.08%
controls:23.90%
883
6580
1319
15274
527
2235
1677
19631
297
279
1907
21587
472
13
1732
21853
185
287
2015
21527
478
1944
1635
19327
673
4468
1142
14230
pegfilgrastim; parenteral
L03AA13 [21603856]
1.3e+00
2.3e+00
3.5e+00
—
2.8e+00
2.5e+00
1.2e+00
cases:0.91%
controls:0.24%
cases:1.18%
controls:0.12%
cases:0.91%
controls:0.03%
—
—
cases:0.59%
controls:0.04%
cases:1.37%
controls:0.11%
cases:0.77%
controls:0.23%
20
52
2182
21802
26
26
2178
21840
20
6
2184
21860
—
13
8
2187
21806
29
24
2084
21247
14
43
1801
18655
Eosinophils [#/volume] in Blood
26449-9 [3013115]
6.2e-01
1.2e+00
2.2e+00
5.0e+00
2.4e+00
1.4e+00
8.9e-01
cases:15.89%
controls:9.22%
cases:16.20%
controls:5.64%
cases:9.26%
controls:1.10%
cases:4.40%
controls:0.03%
cases:10.82%
controls:1.06%
cases:18.69%
controls:5.51%
cases:27.11%
controls:13.25%
350
2016
1852
19838
357
1233
1847
20633
204
240
2000
21626
97
7
2107
21859
238
232
1962
21582
395
1171
1718
20100
492
2477
1323
16221
Monocytes [#/volume] in Blood
26484-6 [3001604]
6.4e-01
1.2e+00
2.2e+00
4.9e+00
2.4e+00
1.4e+00
9.0e-01
cases:15.44%
controls:8.78%
cases:15.79%
controls:5.43%
cases:8.94%
controls:1.07%
cases:4.22%
controls:0.03%
cases:10.73%
controls:1.04%
cases:18.41%
controls:5.37%
cases:26.50%
controls:12.78%
340
1919
1862
19935
348
1187
1856
20679
197
235
2007
21631
93
7
2111
21859
236
227
1964
21587
389
1142
1724
20129
481
2390
1334
16308
Monocytes/Leukocytes in Blood
26485-3 [3019069]
6.2e-01
1.2e+00
2.2e+00
4.8e+00
2.5e+00
1.4e+00
8.9e-01
cases:14.58%
controls:8.38%
cases:15.11%
controls:5.09%
cases:8.17%
controls:1.02%
cases:4.36%
controls:0.04%
cases:10.50%
controls:0.95%
cases:17.51%
controls:5.05%
cases:24.46%
controls:11.74%
321
1831
1881
20023
333
1112
1871
20754
180
224
2024
21642
96
8
2108
21858
231
208
1969
21606
370
1074
1743
20197
444
2195
1371
16503
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
6.2e-01
1.2e+00
2.1e+00
4.8e+00
2.5e+00
1.4e+00
8.9e-01
cases:14.53%
controls:8.36%
cases:15.06%
controls:5.07%
cases:8.08%
controls:1.02%
cases:4.31%
controls:0.04%
cases:10.36%
controls:0.96%
cases:17.27%
controls:5.06%
cases:24.41%
controls:11.76%
320
1827
1882
20027
332
1108
1872
20758
178
223
2026
21643
95
8
2109
21858
228
209
1972
21605
365
1077
1748
20194
443
2198
1372
16500
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
6.0e-01
1.2e+00
2.2e+00
4.9e+00
2.4e+00
1.4e+00
8.7e-01
cases:15.67%
controls:9.27%
cases:16.02%
controls:5.66%
cases:9.03%
controls:1.07%
cases:4.17%
controls:0.03%
cases:10.86%
controls:1.10%
cases:18.60%
controls:5.55%
cases:26.61%
controls:13.20%
345
2025
1857
19829
353
1237
1851
20629
199
235
2005
21631
92
7
2112
21859
239
239
1961
21575
393
1181
1720
20090
483
2469
1332
16229
Basophils/Leukocytes in Blood
30180-4 [3022096]
6.0e-01
1.2e+00
2.2e+00
4.8e+00
2.5e+00
1.4e+00
8.7e-01
cases:14.26%
controls:8.34%
cases:14.93%
controls:5.07%
cases:8.21%
controls:1.01%
cases:4.26%
controls:0.04%
cases:10.36%
controls:0.96%
cases:17.27%
controls:5.04%
cases:24.24%
controls:11.79%
314
1823
1888
20031
329
1109
1875
20757
181
221
2023
21645
94
8
2110
21858
228
210
1972
21604
365
1072
1748
20199
440
2205
1375
16493
Infectious Disease
44 [38004484]
1.1e+00
2.1e+00
3.0e+00
1.0e+50
3.5e+00
2.3e+00
1.4e+00
cases:3.81%
controls:1.28%
cases:3.99%
controls:0.49%
cases:2.09%
controls:0.11%
cases:2.45%
controls:0.00%
cases:2.41%
controls:0.07%
cases:4.97%
controls:0.53%
cases:5.73%
controls:1.41%
84
280
2118
21574
88
108
2116
21758
46
24
2158
21842
54
0
2150
21866
53
16
2147
21798
105
113
2008
21158
104
264
1711
18434
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
5.9e-01
1.2e+00
2.2e+00
4.8e+00
2.5e+00
1.3e+00
8.4e-01
cases:14.67%
controls:8.68%
cases:15.11%
controls:5.26%
cases:8.35%
controls:1.02%
cases:4.40%
controls:0.04%
cases:10.68%
controls:1.01%
cases:17.46%
controls:5.22%
cases:24.35%
controls:12.15%
323
1896
1879
19958
333
1150
1871
20716
184
224
2020
21642
97
8
2107
21858
235
220
1965
21594
369
1111
1744
20160
442
2272
1373
16426
Emergency Medicine
93 [38004510]
4.3e-01
1.0e+00
2.4e+00
6.2e+00
1.8e+00
9.3e-01
5.4e-01
cases:16.49%
controls:11.36%
cases:14.88%
controls:5.91%
cases:8.08%
controls:0.78%
cases:14.29%
controls:0.03%
cases:4.05%
controls:0.72%
cases:15.00%
controls:6.52%
cases:29.20%
controls:19.40%
363
2482
1839
19372
328
1293
1876
20573
178
171
2026
21695
315
7
1889
21859
89
157
2111
21657
317
1387
1796
19884
530
3627
1285
15071
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
5.1e-01
1.2e+00
2.4e+00
4.5e+00
2.5e+00
1.3e+00
8.1e-01
cases:13.49%
controls:8.53%
cases:14.75%
controls:4.75%
cases:9.62%
controls:0.94%
cases:3.04%
controls:0.04%
cases:9.27%
controls:0.86%
cases:15.81%
controls:4.74%
cases:24.24%
controls:12.48%
297
1865
1905
19989
325
1038
1879
20828
212
205
1992
21661
67
8
2137
21858
204
188
1996
21626
334
1008
1779
20263
440
2333
1375
16365
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
5.6e-01
1.2e+00
2.1e+00
4.8e+00
2.3e+00
1.4e+00
9.0e-01
cases:17.17%
controls:10.54%
cases:18.97%
controls:6.86%
cases:12.16%
controls:1.66%
cases:6.40%
controls:0.05%
cases:13.55%
controls:1.53%
cases:21.77%
controls:6.69%
cases:29.92%
controls:14.77%
378
2303
1824
19551
418
1499
1786
20367
268
363
1936
21503
141
12
2063
21854
298
333
1902
21481
460
1422
1653
19849
543
2762
1272
15936
triamcinolone and antiseptics
D07BB03 [21602150]
1.2e+00
1.8e+00
3.2e+00
1.0e+50
3.6e+00
2.1e+00
1.2e+00
cases:4.31%
controls:1.29%
cases:2.72%
controls:0.45%
cases:0.91%
controls:0.04%
cases:0.77%
controls:0.00%
cases:1.55%
controls:0.04%
cases:2.79%
controls:0.35%
cases:4.68%
controls:1.51%
95
283
2107
21571
60
98
2144
21768
20
8
2184
21858
17
0
2187
21866
34
9
2166
21805
59
75
2054
21196
85
282
1730
18416
Inpatient Visit
IP [9201]
3.3e-01
1.1e+00
2.2e+00
5.8e+00
1.9e+00
1.1e+00
6.1e-01
cases:10.45%
controls:7.72%
cases:8.44%
controls:2.84%
cases:3.27%
controls:0.37%
cases:6.99%
controls:0.02%
cases:2.45%
controls:0.37%
cases:8.00%
controls:2.68%
cases:13.72%
controls:7.96%
230
1688
1972
20166
186
622
2018
21244
72
81
2132
21785
154
5
2050
21861
54
80
2146
21734
169
570
1944
20701
249
1489
1566
17209
chlorhexidine, combinations
D08AC52 [21602208]
1.2e+00
1.8e+00
3.2e+00
1.0e+50
3.6e+00
2.1e+00
1.2e+00
cases:4.13%
controls:1.23%
cases:2.72%
controls:0.44%
cases:0.91%
controls:0.04%
cases:0.77%
controls:0.00%
cases:1.50%
controls:0.04%
cases:2.65%
controls:0.34%
cases:4.68%
controls:1.48%
91
269
2111
21585
60
96
2144
21770
20
8
2184
21858
17
0
2187
21866
33
9
2167
21805
56
73
2057
21198
85
277
1730
18421
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
1.2e+00
1.8e+00
3.2e+00
1.0e+50
3.6e+00
2.1e+00
1.2e+00
cases:4.13%
controls:1.23%
cases:2.72%
controls:0.44%
cases:0.91%
controls:0.04%
cases:0.77%
controls:0.00%
cases:1.50%
controls:0.04%
cases:2.65%
controls:0.34%
cases:4.68%
controls:1.48%
91
269
2111
21585
60
96
2144
21770
20
8
2184
21858
17
0
2187
21866
33
9
2167
21805
56
73
2057
21198
85
277
1730
18421
chlorhexidine
S03AA04 [21605193]
1.2e+00
1.8e+00
3.2e+00
1.0e+50
3.6e+00
2.1e+00
1.2e+00
cases:4.13%
controls:1.23%
cases:2.72%
controls:0.44%
cases:0.91%
controls:0.04%
cases:0.77%
controls:0.00%
cases:1.50%
controls:0.04%
cases:2.65%
controls:0.34%
cases:4.68%
controls:1.48%
91
269
2111
21585
60
96
2144
21770
20
8
2184
21858
17
0
2187
21866
33
9
2167
21805
56
73
2057
21198
85
277
1730
18421
chlorhexidine
D09AA12 [21602275]
1.2e+00
1.8e+00
3.2e+00
1.0e+50
3.6e+00
2.1e+00
1.2e+00
cases:4.13%
controls:1.23%
cases:2.72%
controls:0.44%
cases:0.91%
controls:0.04%
cases:0.77%
controls:0.00%
cases:1.50%
controls:0.04%
cases:2.65%
controls:0.34%
cases:4.68%
controls:1.48%
91
269
2111
21585
60
96
2144
21770
20
8
2184
21858
17
0
2187
21866
33
9
2167
21805
56
73
2057
21198
85
277
1730
18421
chlorhexidine
S02AA09 [21605155]
1.2e+00
1.8e+00
3.2e+00
1.0e+50
3.6e+00
2.1e+00
1.2e+00
cases:4.13%
controls:1.23%
cases:2.72%
controls:0.44%
cases:0.91%
controls:0.04%
cases:0.77%
controls:0.00%
cases:1.50%
controls:0.04%
cases:2.65%
controls:0.34%
cases:4.68%
controls:1.48%
91
269
2111
21585
60
96
2144
21770
20
8
2184
21858
17
0
2187
21866
33
9
2167
21805
56
73
2057
21198
85
277
1730
18421
hydrocortisone and antiseptics
D07BA04 [21602146]
1.2e+00
1.8e+00
3.2e+00
1.0e+50
3.6e+00
2.1e+00
1.2e+00
cases:4.13%
controls:1.24%
cases:2.72%
controls:0.45%
cases:0.91%
controls:0.04%
cases:0.77%
controls:0.00%
cases:1.50%
controls:0.04%
cases:2.65%
controls:0.34%
cases:4.68%
controls:1.48%
91
270
2111
21584
60
98
2144
21768
20
8
2184
21858
17
0
2187
21866
33
9
2167
21805
56
73
2057
21198
85
277
1730
18421
hydrocortisone
D07XA01 [21602180]
1.2e+00
1.8e+00
3.2e+00
1.0e+50
3.6e+00
2.1e+00
1.2e+00
cases:4.13%
controls:1.24%
cases:2.72%
controls:0.45%
cases:0.91%
controls:0.04%
cases:0.77%
controls:0.00%
cases:1.50%
controls:0.04%
cases:2.65%
controls:0.34%
cases:4.68%
controls:1.48%
91
270
2111
21584
60
98
2144
21768
20
8
2184
21858
17
0
2187
21866
33
9
2167
21805
56
73
2057
21198
85
277
1730
18421
Fever, unspecified
R50.9 [45582716]
1.1e+00
1.6e+00
4.0e+00
1.0e+50
3.2e+00
2.0e+00
1.1e+00
cases:3.81%
controls:1.32%
cases:2.45%
controls:0.51%
cases:2.45%
controls:0.05%
cases:1.91%
controls:0.00%
cases:1.18%
controls:0.05%
cases:2.89%
controls:0.39%
cases:4.74%
controls:1.59%
84
289
2118
21565
54
111
2150
21755
54
10
2150
21856
42
0
2162
21866
26
11
2174
21803
61
82
2052
21189
86
297
1729
18401
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
9.6e-01
2.2e+00
4.1e+00
—
2.6e+00
2.0e+00
1.1e+00
cases:1.14%
controls:0.44%
cases:1.63%
controls:0.19%
cases:2.27%
controls:0.04%
—
—
cases:0.59%
controls:0.05%
cases:1.42%
controls:0.19%
cases:1.65%
controls:0.55%
25
96
2177
21758
36
42
2168
21824
50
8
2154
21858
—
13
10
2187
21804
30
41
2083
21230
30
102
1785
18596
Bacterial infection, unspecified
A49.9 [45590816]
9.5e-01
1.8e+00
4.1e+00
—
3.0e+00
2.1e+00
1.1e+00
cases:2.04%
controls:0.80%
cases:1.77%
controls:0.29%
cases:1.32%
controls:0.02%
—
—
cases:0.82%
controls:0.04%
cases:2.37%
controls:0.31%
cases:3.36%
controls:1.20%
45
175
2157
21679
39
63
2165
21803
29
5
2175
21861
—
18
9
2182
21805
50
66
2063
21205
61
224
1754
18474
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
1.4e+00
2.2e+00
3.0e+00
—
3.0e+00
2.1e+00
1.2e+00
cases:0.91%
controls:0.22%
cases:1.32%
controls:0.15%
cases:1.04%
controls:0.05%
—
—
cases:1.00%
controls:0.05%
cases:1.66%
controls:0.20%
cases:0.94%
controls:0.27%
20
48
2182
21806
29
33
2175
21833
23
12
2181
21854
—
22
11
2178
21803
35
43
2078
21228
17
51
1798
18647
hydrocortisone
S02BA01 [21605166]
1.1e+00
1.8e+00
3.4e+00
1.0e+50
3.6e+00
1.7e+00
1.1e+00
cases:11.85%
controls:4.30%
cases:7.94%
controls:1.46%
cases:4.54%
controls:0.16%
cases:2.72%
controls:0.00%
cases:4.73%
controls:0.14%
cases:7.00%
controls:1.35%
cases:12.89%
controls:4.69%
261
940
1941
20914
175
319
2029
21547
100
34
2104
21832
60
0
2144
21866
104
30
2096
21784
148
288
1965
20983
234
877
1581
17821
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
1.0e+00
2.2e+00
3.2e+00
—
2.6e+00
2.3e+00
1.3e+00
cases:1.18%
controls:0.43%
cases:1.77%
controls:0.20%
cases:1.00%
controls:0.04%
—
—
cases:0.32%
controls:0.02%
cases:1.61%
controls:0.16%
cases:1.21%
controls:0.34%
26
95
2176
21759
39
43
2165
21823
22
9
2182
21857
—
7
5
2193
21809
34
35
2079
21236
22
63
1793
18635
hydrocortisone aceponate
D07AC16 [21602135]
1.1e+00
1.7e+00
3.3e+00
1.0e+50
3.7e+00
1.7e+00
1.1e+00
cases:13.35%
controls:5.04%
cases:8.76%
controls:1.72%
cases:4.90%
controls:0.18%
cases:3.09%
controls:0.00%
cases:5.50%
controls:0.14%
cases:7.76%
controls:1.58%
cases:14.88%
controls:5.41%
294
1102
1908
20752
193
377
2011
21489
108
40
2096
21826
68
0
2136
21866
121
31
2079
21783
164
337
1949
20934
270
1012
1545
17686
hydrocortisone
D07AA02 [21602102]
1.1e+00
1.7e+00
3.3e+00
1.0e+50
3.7e+00
1.7e+00
1.1e+00
cases:13.35%
controls:5.04%
cases:8.76%
controls:1.72%
cases:4.90%
controls:0.18%
cases:3.09%
controls:0.00%
cases:5.50%
controls:0.14%
cases:7.76%
controls:1.58%
cases:14.88%
controls:5.41%
294
1102
1908
20752
193
377
2011
21489
108
40
2096
21826
68
0
2136
21866
121
31
2079
21783
164
337
1949
20934
270
1012
1545
17686
hydrocortisone butyrate
D07AB02 [21602106]
1.1e+00
1.7e+00
3.3e+00
1.0e+50
3.7e+00
1.7e+00
1.1e+00
cases:13.35%
controls:5.04%
cases:8.76%
controls:1.72%
cases:4.90%
controls:0.18%
cases:3.09%
controls:0.00%
cases:5.50%
controls:0.14%
cases:7.76%
controls:1.58%
cases:14.88%
controls:5.41%
294
1102
1908
20752
193
377
2011
21489
108
40
2096
21826
68
0
2136
21866
121
31
2079
21783
164
337
1949
20934
270
1012
1545
17686
hydrocortisone buteprate
D07AB11 [21602115]
1.1e+00
1.7e+00
3.3e+00
1.0e+50
3.7e+00
1.7e+00
1.1e+00
cases:13.35%
controls:5.04%
cases:8.76%
controls:1.72%
cases:4.90%
controls:0.18%
cases:3.09%
controls:0.00%
cases:5.50%
controls:0.14%
cases:7.76%
controls:1.58%
cases:14.88%
controls:5.41%
294
1102
1908
20752
193
377
2011
21489
108
40
2096
21826
68
0
2136
21866
121
31
2079
21783
164
337
1949
20934
270
1012
1545
17686
betamethasone
C05AA05 [21601610]
1.1e+00
1.5e+00
3.1e+00
—
3.9e+00
1.7e+00
1.2e+00
cases:11.63%
controls:4.33%
cases:7.17%
controls:1.71%
cases:4.26%
controls:0.20%
—
—
cases:7.05%
controls:0.15%
cases:8.76%
controls:1.65%
cases:15.10%
controls:4.88%
256
946
1946
20908
158
374
2046
21492
94
43
2110
21823
—
155
33
2045
21781
185
351
1928
20920
274
912
1541
17786
betamethasone
D07AC01 [21602120]
1.1e+00
1.5e+00
3.1e+00
—
3.9e+00
1.7e+00
1.2e+00
cases:11.63%
controls:4.33%
cases:7.17%
controls:1.71%
cases:4.26%
controls:0.20%
—
—
cases:7.05%
controls:0.15%
cases:8.76%
controls:1.65%
cases:15.10%
controls:4.88%
256
946
1946
20908
158
374
2046
21492
94
43
2110
21823
—
155
33
2045
21781
185
351
1928
20920
274
912
1541
17786
betamethasone
S02BA07 [21605169]
1.1e+00
1.5e+00
3.1e+00
—
3.9e+00
1.7e+00
1.2e+00
cases:11.63%
controls:4.33%
cases:7.17%
controls:1.71%
cases:4.26%
controls:0.20%
—
—
cases:7.05%
controls:0.15%
cases:8.76%
controls:1.65%
cases:15.10%
controls:4.88%
256
946
1946
20908
158
374
2046
21492
94
43
2110
21823
—
155
33
2045
21781
185
351
1928
20920
274
912
1541
17786
betamethasone
A07EA04 [21600656]
1.1e+00
1.5e+00
3.1e+00
—
3.9e+00
1.7e+00
1.2e+00
cases:11.63%
controls:4.33%
cases:7.17%
controls:1.71%
cases:4.26%
controls:0.20%
—
—
cases:7.05%
controls:0.15%
cases:8.76%
controls:1.65%
cases:15.10%
controls:4.88%
256
946
1946
20908
158
374
2046
21492
94
43
2110
21823
—
155
33
2045
21781
185
351
1928
20920
274
912
1541
17786
hydrocortisone
A07EA02 [21600654]
1.1e+00
1.7e+00
3.3e+00
1.0e+50
3.7e+00
1.6e+00
1.1e+00
cases:13.53%
controls:5.14%
cases:8.80%
controls:1.74%
cases:4.90%
controls:0.18%
cases:3.09%
controls:0.00%
cases:5.50%
controls:0.15%
cases:7.76%
controls:1.59%
cases:15.04%
controls:5.44%
298
1124
1904
20730
194
380
2010
21486
108
40
2096
21826
68
0
2136
21866
121
32
2079
21782
164
339
1949
20932
273
1018
1542
17680
hydrocortisone
C05AA01 [21601608]
1.1e+00
1.7e+00
3.3e+00
1.0e+50
3.7e+00
1.6e+00
1.1e+00
cases:13.53%
controls:5.14%
cases:8.80%
controls:1.74%
cases:4.90%
controls:0.18%
cases:3.09%
controls:0.00%
cases:5.50%
controls:0.15%
cases:7.76%
controls:1.59%
cases:15.04%
controls:5.44%
298
1124
1904
20730
194
380
2010
21486
108
40
2096
21826
68
0
2136
21866
121
32
2079
21782
164
339
1949
20932
273
1018
1542
17680
Body CT examination
JN4AD [2001310897]
1.0e+00
2.1e+00
3.0e+00
—
3.1e+00
2.1e+00
1.3e+00
cases:1.45%
controls:0.52%
cases:2.72%
controls:0.34%
cases:0.95%
controls:0.05%
—
—
cases:0.77%
controls:0.04%
cases:3.22%
controls:0.41%
cases:3.91%
controls:1.11%
32
114
2170
21740
60
74
2144
21792
21
11
2183
21855
—
17
8
2183
21806
68
87
2045
21184
71
207
1744
18491
Cystostatic therapy of methastized malignancy
WD105 [2001310678]
1.2e+00
2.3e+00
3.1e+00
—
2.5e+00
2.1e+00
1.3e+00
cases:0.64%
controls:0.18%
cases:0.95%
controls:0.10%
cases:0.73%
controls:0.03%
—
—
cases:0.50%
controls:0.04%
cases:1.37%
controls:0.16%
cases:0.99%
controls:0.28%
14
40
2188
21814
21
22
2183
21844
16
7
2188
21859
—
11
9
2189
21805
29
35
2084
21236
18
53
1797
18645
General Practice
1 [38004446]
4.2e-01
8.1e-01
2.1e+00
6.0e+00
1.6e+00
9.2e-01
5.8e-01
cases:16.67%
controls:11.66%
cases:9.89%
controls:4.66%
cases:5.08%
controls:0.64%
cases:8.62%
controls:0.02%
cases:3.45%
controls:0.69%
cases:11.17%
controls:4.77%
cases:22.15%
controls:13.70%
367
2549
1835
19305
218
1020
1986
20846
112
141
2092
21725
190
5
2014
21861
76
151
2124
21663
236
1015
1877
20256
402
2561
1413
16137
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
9.8e-01
2.0e+00
3.0e+00
—
3.6e+00
1.7e+00
1.3e+00
cases:2.18%
controls:0.83%
cases:2.59%
controls:0.38%
cases:0.95%
controls:0.05%
—
—
cases:1.45%
controls:0.04%
cases:1.66%
controls:0.31%
cases:3.80%
controls:1.02%
48
181
2154
21673
57
82
2147
21784
21
11
2183
21855
—
32
9
2168
21805
35
67
2078
21204
69
191
1746
18507
Hypersensitivity skin testing
268377001 [4147813]
1.9e+00
3.4e+00
—
—
—
4.8e+00
2.4e+00
cases:2.77%
controls:0.44%
cases:2.31%
controls:0.08%
—
—
—
—
—
—
cases:8.05%
controls:0.08%
cases:4.13%
controls:0.38%
61
97
2141
21757
51
17
2153
21849
—
—
—
170
16
1943
21255
75
71
1740
18627
clindamycin; oral, parenteral
J01FF01 [21602985]
7.9e-01
1.6e+00
3.9e+00
1.0e+50
3.2e+00
1.6e+00
1.4e+00
cases:6.49%
controls:3.04%
cases:3.58%
controls:0.77%
cases:3.77%
controls:0.08%
cases:0.82%
controls:0.00%
cases:1.77%
controls:0.07%
cases:3.50%
controls:0.75%
cases:9.48%
controls:2.60%
143
665
2059
21189
79
168
2125
21698
83
17
2121
21849
18
0
2186
21866
39
16
2161
21798
74
159
2039
21112
172
486
1643
18212
Simple antiboidy therapy of methastized malignancy
WD405 [2001310688]
1.4e+00
2.5e+00
2.9e+00
—
3.2e+00
2.4e+00
1.1e+00
cases:0.45%
controls:0.11%
cases:0.91%
controls:0.08%
cases:0.50%
controls:0.03%
—
—
cases:0.55%
controls:0.02%
cases:1.04%
controls:0.09%
cases:0.66%
controls:0.22%
10
24
2192
21830
20
17
2184
21849
11
6
2193
21860
—
12
5
2188
21809
22
20
2091
21251
12
41
1803
18657
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
9.1e-01
1.9e+00
2.8e+00
—
3.2e+00
2.0e+00
1.4e+00
cases:2.77%
controls:1.13%
cases:3.45%
controls:0.52%
cases:1.32%
controls:0.08%
—
—
cases:1.73%
controls:0.07%
cases:3.50%
controls:0.48%
cases:5.62%
controls:1.39%
61
247
2141
21607
76
114
2128
21752
29
17
2175
21849
—
38
15
2162
21799
74
102
2039
21169
102
260
1713
18438
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
1.2e+00
1.8e+00
3.0e+00
—
2.8e+00
1.9e+00
1.3e+00
cases:1.82%
controls:0.56%
cases:2.04%
controls:0.34%
cases:1.13%
controls:0.05%
—
—
cases:0.82%
controls:0.05%
cases:2.22%
controls:0.33%
cases:2.70%
controls:0.73%
40
122
2162
21732
45
75
2159
21791
25
12
2179
21854
—
18
11
2182
21803
47
71
2066
21200
49
136
1766
18562
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
4.1e-01
9.7e-01
2.2e+00
4.4e+00
2.3e+00
1.1e+00
7.3e-01
cases:22.52%
controls:16.12%
cases:22.41%
controls:9.85%
cases:13.93%
controls:1.82%
cases:4.76%
controls:0.06%
cases:14.18%
controls:1.66%
cases:25.32%
controls:9.78%
cases:37.13%
controls:22.10%
496
3522
1706
18332
494
2154
1710
19712
307
397
1897
21469
105
14
2099
21852
312
363
1888
21451
535
2081
1578
19190
674
4132
1141
14566
Other psoriatic arthropathies
M07.3*L40.5 [2000503010]
1.4e+00
1.8e+00
2.0e+00
—
2.6e+00
2.4e+00
1.9e+00
cases:0.86%
controls:0.22%
cases:0.77%
controls:0.13%
cases:0.27%
controls:0.04%
—
—
cases:0.32%
controls:0.02%
cases:1.04%
controls:0.10%
cases:1.38%
controls:0.21%
19
48
2183
21806
17
29
2187
21837
6
8
2198
21858
—
7
5
2193
21809
22
21
2091
21250
25
40
1790
18658
Medical Oncology
90 [38004507]
3.2e-01
1.2e+00
2.3e+00
4.0e+00
2.2e+00
1.5e+00
8.9e-01
cases:4.63%
controls:3.41%
cases:7.53%
controls:2.38%
cases:6.81%
controls:0.75%
cases:3.13%
controls:0.06%
cases:6.55%
controls:0.77%
cases:9.28%
controls:2.33%
cases:9.04%
controls:3.94%
102
745
2100
21109
166
521
2038
21345
150
165
2054
21701
69
13
2135
21853
144
167
2056
21647
196
496
1917
20775
164
736
1651
17962
Erysipelas
A46 [45561706]
1.1e+00
2.0e+00
3.7e+00
—
2.6e+00
1.5e+00
1.1e+00
cases:3.50%
controls:1.20%
cases:2.90%
controls:0.39%
cases:2.59%
controls:0.07%
—
—
cases:0.73%
controls:0.06%
cases:1.99%
controls:0.45%
cases:5.12%
controls:1.74%
77
263
2125
21591
64
86
2140
21780
57
15
2147
21851
—
16
12
2184
21802
42
96
2071
21175
93
325
1722
18373
Outpatient Hospital
22 [8756]
4.6e-01
1.0e+00
2.0e+00
5.0e+00
1.7e+00
1.1e+00
6.6e-01
cases:32.33%
controls:23.24%
cases:16.92%
controls:6.81%
cases:5.72%
controls:0.82%
cases:5.04%
controls:0.04%
cases:3.82%
controls:0.75%
cases:15.19%
controls:5.51%
cases:27.88%
controls:16.60%
712
5078
1490
16776
373
1490
1831
20376
126
179
2078
21687
111
8
2093
21858
84
163
2116
21651
321
1171
1792
20100
506
3104
1309
15594
hydroxyzine; oral, parenteral
N05BB01 [21604590]
1.0e+00
1.6e+00
3.2e+00
—
3.3e+00
1.5e+00
1.2e+00
cases:4.04%
controls:1.50%
cases:2.99%
controls:0.59%
cases:2.45%
controls:0.11%
—
—
cases:2.68%
controls:0.11%
cases:2.89%
controls:0.66%
cases:5.40%
controls:1.63%
89
328
2113
21526
66
130
2138
21736
54
23
2150
21843
—
59
23
2141
21791
61
141
2052
21130
98
304
1717
18394
Hematology
82 [38004501]
1.2e+00
1.8e+00
2.6e+00
—
2.7e+00
1.9e+00
1.5e+00
cases:3.00%
controls:0.92%
cases:3.68%
controls:0.61%
cases:2.90%
controls:0.21%
—
—
cases:2.82%
controls:0.20%
cases:3.69%
controls:0.58%
cases:4.57%
controls:1.06%
66
200
2136
21654
81
134
2123
21732
64
47
2140
21819
—
62
44
2138
21770
78
124
2035
21147
83
198
1732
18500
Arthritis, unspecified
M13.9 [45567463]
1.1e+00
1.5e+00
3.7e+00
1.0e+50
2.4e+00
2.0e+00
1.1e+00
cases:1.63%
controls:0.58%
cases:1.18%
controls:0.27%
cases:0.95%
controls:0.02%
cases:0.27%
controls:0.00%
cases:0.50%
controls:0.05%
cases:1.42%
controls:0.20%
cases:2.31%
controls:0.80%
36
126
2166
21728
26
60
2178
21806
21
5
2183
21861
6
0
2198
21866
11
10
2189
21804
30
43
2083
21228
42
149
1773
18549
cefalexin; oral
J01DB01 [21602870]
6.5e-01
1.1e+00
2.5e+00
3.8e+00
1.9e+00
9.4e-01
7.0e-01
cases:39.51%
controls:25.46%
cases:21.46%
controls:8.02%
cases:8.48%
controls:0.74%
cases:1.36%
controls:0.03%
cases:5.14%
controls:0.82%
cases:17.18%
controls:7.53%
cases:39.50%
controls:24.46%
870
5564
1332
16290
473
1753
1731
20113
187
161
2017
21705
30
7
2174
21859
113
179
2087
21635
363
1601
1750
19670
717
4573
1098
14125
Short blood count panel - Blood
55429-5 [40758558]
3.3e-01
8.8e-01
2.1e+00
4.5e+00
2.0e+00
1.1e+00
7.4e-01
cases:6.81%
controls:5.00%
cases:6.40%
controls:2.75%
cases:3.90%
controls:0.52%
cases:1.95%
controls:0.02%
cases:3.86%
controls:0.55%
cases:7.48%
controls:2.61%
cases:11.79%
controls:6.02%
150
1092
2052
20762
141
601
2063
21265
86
113
2118
21753
43
5
2161
21861
85
119
2115
21695
158
555
1955
20716
214
1125
1601
17573
Urticaria, unspecified
L50.9 [45562541]
1.2e+00
2.8e+00
—
—
3.6e+00
2.8e+00
1.2e+00
cases:0.91%
controls:0.28%
cases:1.32%
controls:0.08%
—
—
—
—
cases:0.82%
controls:0.02%
cases:1.14%
controls:0.07%
cases:0.88%
controls:0.27%
20
61
2182
21793
29
18
2175
21848
—
—
18
5
2182
21809
24
15
2089
21256
16
50
1799
18648
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
9.7e-01
1.7e+00
2.5e+00
—
3.0e+00
1.8e+00
1.5e+00
cases:0.82%
controls:0.31%
cases:0.86%
controls:0.16%
cases:0.41%
controls:0.03%
—
—
cases:0.64%
controls:0.03%
cases:0.66%
controls:0.11%
cases:1.54%
controls:0.34%
18
68
2184
21786
19
34
2185
21832
9
7
2195
21859
—
14
7
2186
21807
14
24
2099
21247
28
64
1787
18634
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
3.2e-01
1.0e+00
2.0e+00
4.5e+00
2.2e+00
8.9e-01
5.2e-01
cases:13.62%
controls:10.27%
cases:12.89%
controls:5.09%
cases:5.44%
controls:0.77%
cases:2.77%
controls:0.03%
cases:4.68%
controls:0.53%
cases:11.83%
controls:5.24%
cases:22.75%
controls:14.88%
300
2245
1902
19609
284
1113
1920
20753
120
168
2084
21698
61
7
2143
21859
103
115
2097
21699
250
1114
1863
20157
413
2782
1402
15916
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
1.3e+00
2.5e+00
—
—
3.3e+00
2.5e+00
1.8e+00
cases:2.04%
controls:0.58%
cases:2.40%
controls:0.21%
—
—
—
—
cases:0.64%
controls:0.02%
cases:2.41%
controls:0.20%
cases:3.42%
controls:0.57%
45
127
2157
21727
53
45
2151
21821
—
—
14
5
2186
21809
51
42
2062
21229
62
107
1753
18591
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
7.8e-01
1.7e+00
2.9e+00
—
2.9e+00
1.8e+00
1.3e+00
cases:3.04%
controls:1.41%
cases:4.49%
controls:0.81%
cases:2.36%
controls:0.13%
—
—
cases:2.68%
controls:0.15%
cases:4.50%
controls:0.81%
cases:6.94%
controls:2.06%
67
309
2135
21545
99
178
2105
21688
52
28
2152
21838
—
59
32
2141
21782
95
172
2018
21099
126
386
1689
18312
dexamethasone; oral, parenteral
H02AB02 [21602730]
6.9e-01
1.9e+00
3.2e+00
—
2.8e+00
1.8e+00
9.2e-01
cases:4.09%
controls:2.10%
cases:4.85%
controls:0.74%
cases:3.09%
controls:0.13%
—
—
cases:1.55%
controls:0.09%
cases:5.11%
controls:0.89%
cases:5.95%
controls:2.45%
90
458
2112
21396
107
161
2097
21705
68
29
2136
21837
—
34
20
2166
21794
108
190
2005
21081
108
459
1707
18239
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.6e-01
1.0e+00
2.0e+00
4.2e+00
2.0e+00
1.1e+00
5.5e-01
cases:8.27%
controls:5.93%
cases:7.35%
controls:2.84%
cases:3.13%
controls:0.42%
cases:1.81%
controls:0.03%
cases:2.59%
controls:0.34%
cases:8.05%
controls:2.78%
cases:13.99%
controls:8.57%
182
1295
2020
20559
162
620
2042
21246
69
92
2135
21774
40
6
2164
21860
57
75
2143
21739
170
591
1943
20680
254
1602
1561
17096
antibiotics in combination with corticosteroids
D01AA20 [21601918]
9.8e-01
1.7e+00
3.0e+00
—
2.7e+00
1.7e+00
1.2e+00
cases:3.13%
controls:1.20%
cases:1.86%
controls:0.36%
cases:0.82%
controls:0.04%
—
—
cases:0.77%
controls:0.05%
cases:1.75%
controls:0.31%
cases:3.47%
controls:1.07%
69
263
2133
21591
41
79
2163
21787
18
9
2186
21857
—
17
11
2183
21803
37
66
2076
21205
63
200
1752
18498
Neurology
13 [38004458]
4.8e-01
1.0e+00
1.9e+00
4.5e+00
1.6e+00
1.1e+00
6.9e-01
cases:13.62%
controls:8.87%
cases:9.62%
controls:3.64%
cases:4.63%
controls:0.74%
cases:2.40%
controls:0.03%
cases:3.64%
controls:0.73%
cases:9.84%
controls:3.66%
cases:17.19%
controls:9.40%
300
1939
1902
19915
212
796
1992
21070
102
161
2102
21705
53
6
2151
21860
80
160
2120
21654
208
779
1905
20492
312
1757
1503
16941
Bacteria identified in Isolate by Culture
43409-2 [3042936]
7.6e-01
1.7e+00
3.5e+00
1.0e+50
2.7e+00
1.6e+00
1.1e+00
cases:4.27%
controls:2.05%
cases:3.81%
controls:0.73%
cases:1.59%
controls:0.05%
cases:0.23%
controls:0.00%
cases:1.00%
controls:0.07%
cases:2.93%
controls:0.62%
cases:6.17%
controls:2.22%
94
448
2108
21406
84
159
2120
21707
35
11
2169
21855
5
0
2199
21866
22
15
2178
21799
62
132
2051
21139
112
415
1703
18283
Pulmonary Disease
29 [38004472]
6.4e-01
1.1e+00
1.9e+00
3.5e+00
1.9e+00
1.2e+00
9.2e-01
cases:12.72%
controls:7.14%
cases:9.71%
controls:3.47%
cases:3.86%
controls:0.63%
cases:1.45%
controls:0.05%
cases:3.82%
controls:0.57%
cases:11.50%
controls:3.59%
cases:16.91%
controls:7.52%
280
1560
1922
20294
214
758
1990
21108
85
137
2119
21729
32
10
2172
21856
84
124
2116
21690
243
764
1870
20507
307
1407
1508
17291
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
1.2e+00
1.5e+00
2.9e+00
—
3.0e+00
1.5e+00
9.5e-01
cases:2.63%
controls:0.77%
cases:2.99%
controls:0.65%
cases:1.95%
controls:0.11%
—
—
cases:2.82%
controls:0.14%
cases:3.27%
controls:0.74%
cases:4.74%
controls:1.89%
58
169
2144
21685
66
143
2138
21723
43
25
2161
21841
—
62
30
2138
21784
69
157
2044
21114
86
354
1729
18344
Normoblasts [#/volume] in Blood
715-3 [3021589]
3.9e-01
7.8e-01
1.9e+00
4.6e+00
2.0e+00
8.9e-01
6.0e-01
cases:10.67%
controls:7.45%
cases:11.75%
controls:5.77%
cases:7.99%
controls:1.29%
cases:4.58%
controls:0.05%
cases:8.68%
controls:1.24%
cases:13.72%
controls:6.11%
cases:20.11%
controls:12.16%
235
1628
1967
20226
259
1262
1945
20604
176
281
2028
21585
101
11
2103
21855
191
270
2009
21544
290
1299
1823
19972
365
2274
1450
16424
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.0e+00
1.6e+00
2.8e+00
—
3.2e+00
1.5e+00
9.0e-01
cases:5.00%
controls:1.81%
cases:2.54%
controls:0.50%
cases:0.95%
controls:0.06%
—
—
cases:1.27%
controls:0.05%
cases:2.41%
controls:0.54%
cases:5.29%
controls:2.21%
110
395
2092
21459
56
110
2148
21756
21
13
2183
21853
—
28
11
2172
21803
51
114
2062
21157
96
414
1719
18284
Abdominal ultrasound examination
JN3AE [2001305555]
1.0e+00
1.7e+00
2.8e+00
1.0e+50
2.8e+00
1.6e+00
1.2e+00
cases:3.77%
controls:1.40%
cases:2.18%
controls:0.40%
cases:0.59%
controls:0.04%
cases:0.73%
controls:0.00%
cases:0.73%
controls:0.05%
cases:1.85%
controls:0.37%
cases:3.58%
controls:1.16%
83
305
2119
21549
48
87
2156
21779
13
8
2191
21858
16
0
2188
21866
16
10
2184
21804
39
79
2074
21192
65
216
1750
18482
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
1.3e+00
2.0e+00
—
—
3.5e+00
2.6e+00
1.6e+00
cases:1.36%
controls:0.37%
cases:0.91%
controls:0.13%
—
—
—
—
cases:0.77%
controls:0.02%
cases:1.28%
controls:0.09%
cases:2.15%
controls:0.43%
30
81
2172
21773
20
28
2184
21838
—
—
17
5
2183
21809
27
20
2086
21251
39
80
1776
18618
Prick test
37968009 [4242723]
1.5e+00
2.7e+00
—
1.0e+50
1.0e+50
4.4e+00
2.4e+00
cases:1.95%
controls:0.43%
cases:1.00%
controls:0.07%
—
—
cases:3.72%
controls:0.00%
cases:1.77%
controls:0.00%
cases:4.40%
controls:0.06%
cases:2.81%
controls:0.25%
43
95
2159
21759
22
15
2182
21851
—
82
0
2122
21866
39
0
2161
21814
93
12
2020
21259
51
47
1764
18651
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.9e-01
8.5e-01
2.0e+00
4.4e+00
2.1e+00
9.0e-01
4.6e-01
cases:31.29%
controls:25.51%
cases:31.40%
controls:16.32%
cases:19.65%
controls:3.18%
cases:13.88%
controls:0.20%
cases:19.55%
controls:2.82%
cases:32.75%
controls:16.52%
cases:46.34%
controls:35.27%
689
5574
1513
16280
692
3569
1512
18297
433
695
1771
21171
306
43
1898
21823
430
615
1770
21199
692
3513
1421
17758
841
6594
974
12104
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
1.3e+00
2.0e+00
—
—
3.5e+00
2.7e+00
1.6e+00
cases:1.36%
controls:0.39%
cases:0.95%
controls:0.13%
—
—
—
—
cases:0.73%
controls:0.02%
cases:1.33%
controls:0.09%
cases:2.20%
controls:0.43%
30
86
2172
21768
21
28
2183
21838
—
—
16
5
2184
21809
28
20
2085
21251
40
81
1775
18617
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
9.9e-01
1.5e+00
3.1e+00
—
3.1e+00
1.4e+00
8.6e-01
cases:3.86%
controls:1.47%
cases:3.58%
controls:0.79%
cases:1.91%
controls:0.09%
—
—
cases:1.86%
controls:0.08%
cases:3.74%
controls:0.93%
cases:7.71%
controls:3.42%
85
322
2117
21532
79
173
2125
21693
42
20
2162
21846
—
41
18
2159
21796
79
197
2034
21074
140
639
1675
18059
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
8.8e-01
1.8e+00
2.5e+00
—
3.2e+00
1.6e+00
1.0e+00
cases:0.91%
controls:0.38%
cases:1.18%
controls:0.21%
cases:0.50%
controls:0.04%
—
—
cases:0.91%
controls:0.04%
cases:0.99%
controls:0.20%
cases:1.76%
controls:0.65%
20
83
2182
21771
26
45
2178
21821
11
9
2193
21857
—
20
8
2180
21806
21
43
2092
21228
32
121
1783
18577
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
5.6e-01
1.0e+00
2.0e+00
3.2e+00
2.2e+00
1.1e+00
7.5e-01
cases:11.76%
controls:7.11%
cases:10.48%
controls:3.94%
cases:4.63%
controls:0.64%
cases:0.77%
controls:0.03%
cases:5.41%
controls:0.60%
cases:11.45%
controls:4.02%
cases:20.00%
controls:10.54%
259
1553
1943
20301
231
861
1973
21005
102
141
2102
21725
17
7
2187
21859
119
131
2081
21683
242
855
1871
20416
363
1970
1452
16728
Extensive body CT
JN4BD [2001310899]
8.1e-01
1.9e+00
2.9e+00
—
2.1e+00
1.8e+00
1.4e+00
cases:2.77%
controls:1.25%
cases:2.81%
controls:0.44%
cases:0.59%
controls:0.03%
—
—
cases:0.41%
controls:0.05%
cases:1.51%
controls:0.26%
cases:2.42%
controls:0.59%
61
273
2141
21581
62
96
2142
21770
13
7
2191
21859
—
9
11
2191
21803
32
55
2081
21216
44
110
1771
18588
prednisone; oral
H02AB07 [21602735]
8.9e-01
1.3e+00
3.1e+00
1.0e+50
3.1e+00
1.5e+00
1.0e+00
cases:2.95%
controls:1.24%
cases:1.77%
controls:0.48%
cases:1.18%
controls:0.05%
cases:0.41%
controls:0.00%
cases:1.77%
controls:0.08%
cases:2.04%
controls:0.46%
cases:3.03%
controls:1.10%
65
270
2137
21584
39
105
2165
21761
26
12
2178
21854
9
0
2195
21866
39
18
2161
21796
43
97
2070
21174
55
205
1760
18493
prednisone
A07EA03 [21600655]
8.9e-01
1.3e+00
3.1e+00
1.0e+50
3.1e+00
1.5e+00
1.0e+00
cases:2.95%
controls:1.24%
cases:1.77%
controls:0.48%
cases:1.18%
controls:0.05%
cases:0.41%
controls:0.00%
cases:1.77%
controls:0.08%
cases:2.04%
controls:0.46%
cases:3.03%
controls:1.10%
65
270
2137
21584
39
105
2165
21761
26
12
2178
21854
9
0
2195
21866
39
18
2161
21796
43
97
2070
21174
55
205
1760
18493
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
8.8e-01
1.8e+00
2.5e+00
—
3.2e+00
1.6e+00
1.0e+00
cases:0.91%
controls:0.38%
cases:1.18%
controls:0.21%
cases:0.50%
controls:0.04%
—
—
cases:0.91%
controls:0.04%
cases:0.95%
controls:0.20%
cases:1.76%
controls:0.65%
20
83
2182
21771
26
45
2178
21821
11
9
2193
21857
—
20
8
2180
21806
20
43
2093
21228
32
121
1783
18577
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
1.2e+00
1.5e+00
2.7e+00
—
3.0e+00
1.5e+00
1.0e+00
cases:2.27%
controls:0.68%
cases:2.77%
controls:0.62%
cases:1.72%
controls:0.12%
—
—
cases:2.59%
controls:0.13%
cases:2.93%
controls:0.68%
cases:4.52%
controls:1.72%
50
149
2152
21705
61
135
2143
21731
38
26
2166
21840
—
57
29
2143
21785
62
144
2051
21127
82
321
1733
18377
Granulocytes [#/volume] in Blood
30394-1 [3035715]
7.8e-01
1.5e+00
3.0e+00
—
2.8e+00
2.0e+00
1.6e+00
cases:0.82%
controls:0.38%
cases:0.64%
controls:0.14%
cases:0.45%
controls:0.02%
—
—
cases:0.45%
controls:0.03%
cases:0.71%
controls:0.10%
cases:1.27%
controls:0.26%
18
82
2184
21772
14
30
2190
21836
10
5
2194
21861
—
10
6
2190
21808
15
21
2098
21250
23
49
1792
18649
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
1.2e+00
1.5e+00
2.8e+00
—
2.9e+00
1.5e+00
9.1e-01
cases:2.36%
controls:0.73%
cases:2.81%
controls:0.63%
cases:1.91%
controls:0.11%
—
—
cases:2.55%
controls:0.14%
cases:3.03%
controls:0.71%
cases:4.41%
controls:1.83%
52
160
2150
21694
62
137
2142
21729
42
25
2162
21841
—
56
30
2144
21784
64
152
2049
21119
80
342
1735
18356
Bacteria identified in Blood by Culture
600-7 [3023368]
6.6e-01
1.5e+00
3.1e+00
—
3.0e+00
1.7e+00
9.0e-01
cases:6.54%
controls:3.48%
cases:6.90%
controls:1.57%
cases:5.08%
controls:0.24%
—
—
cases:3.27%
controls:0.17%
cases:7.19%
controls:1.46%
cases:12.18%
controls:5.33%
144
761
2058
21093
152
343
2052
21523
112
52
2092
21814
—
72
38
2128
21776
152
311
1961
20960
221
997
1594
17701
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
8.8e-01
1.6e+00
2.9e+00
—
2.6e+00
1.7e+00
1.0e+00
cases:2.18%
controls:0.92%
cases:2.40%
controls:0.48%
cases:0.73%
controls:0.04%
—
—
cases:0.82%
controls:0.06%
cases:1.94%
controls:0.34%
cases:3.69%
controls:1.33%
48
200
2154
21654
53
104
2151
21762
16
9
2188
21857
—
18
13
2182
21801
41
73
2072
21198
67
249
1748
18449
Rheumatology
66 [38004491]
1.1e+00
1.6e+00
2.4e+00
—
2.3e+00
1.8e+00
1.5e+00
cases:7.81%
controls:2.71%
cases:7.40%
controls:1.64%
cases:3.68%
controls:0.33%
—
—
cases:3.23%
controls:0.32%
cases:8.90%
controls:1.56%
cases:11.52%
controls:2.76%
172
592
2030
21262
163
359
2041
21507
81
73
2123
21793
—
71
70
2129
21744
188
331
1925
20940
209
516
1606
18182
other preparations, combinations; ointment
C05AX03 [21601631]
1.1e+00
1.5e+00
2.8e+00
—
2.8e+00
1.4e+00
1.2e+00
cases:5.50%
controls:1.81%
cases:2.77%
controls:0.66%
cases:0.77%
controls:0.05%
—
—
cases:0.86%
controls:0.06%
cases:2.60%
controls:0.65%
cases:6.01%
controls:1.91%
121
396
2081
21458
61
144
2143
21722
17
10
2187
21856
—
19
12
2181
21802
55
139
2058
21132
109
357
1706
18341
pH of Capillary blood
2745-8 [3009343]
8.8e-01
1.6e+00
2.9e+00
—
2.6e+00
1.7e+00
1.1e+00
cases:2.18%
controls:0.92%
cases:2.27%
controls:0.46%
cases:0.73%
controls:0.04%
—
—
cases:0.77%
controls:0.06%
cases:1.80%
controls:0.32%
cases:3.69%
controls:1.28%
48
200
2154
21654
50
100
2154
21766
16
9
2188
21857
—
17
13
2183
21801
38
69
2075
21202
67
239
1748
18459
Blasts/Leukocytes in Blood
26446-5 [3025159]
1.2e+00
1.5e+00
2.7e+00
—
2.9e+00
1.4e+00
9.6e-01
cases:2.23%
controls:0.68%
cases:2.86%
controls:0.65%
cases:1.86%
controls:0.12%
—
—
cases:2.32%
controls:0.13%
cases:3.03%
controls:0.73%
cases:4.57%
controls:1.80%
49
148
2153
21706
63
142
2141
21724
41
27
2163
21839
—
51
29
2149
21785
64
155
2049
21116
83
336
1732
18362
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
8.9e-01
1.6e+00
2.8e+00
—
2.7e+00
1.7e+00
1.0e+00
cases:2.13%
controls:0.89%
cases:1.95%
controls:0.40%
cases:0.68%
controls:0.04%
—
—
cases:0.59%
controls:0.04%
cases:1.61%
controls:0.30%
cases:3.14%
controls:1.13%
47
194
2155
21660
43
88
2161
21778
15
9
2189
21857
—
13
9
2187
21805
34
63
2079
21208
57
212
1758
18486
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
7.6e-01
1.6e+00
3.3e+00
1.0e+50
2.7e+00
1.6e+00
6.6e-01
cases:3.09%
controls:1.47%
cases:2.22%
controls:0.46%
cases:0.77%
controls:0.03%
cases:0.36%
controls:0.00%
cases:0.55%
controls:0.04%
cases:2.08%
controls:0.42%
cases:3.25%
controls:1.71%
68
321
2134
21533
49
101
2155
21765
17
6
2187
21860
8
0
2196
21866
12
8
2188
21806
44
90
2069
21181
59
320
1756
18378
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
7.3e-01
1.3e+00
2.4e+00
1.0e+50
3.2e+00
1.7e+00
1.2e+00
cases:4.18%
controls:2.05%
cases:3.13%
controls:0.84%
cases:0.73%
controls:0.06%
cases:0.54%
controls:0.00%
cases:1.55%
controls:0.06%
cases:3.03%
controls:0.56%
cases:6.94%
controls:2.15%
92
449
2110
21405
69
183
2135
21683
16
14
2188
21852
12
0
2192
21866
34
14
2166
21800
64
119
2049
21152
126
402
1689
18296
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
5.3e-01
1.0e+00
2.0e+00
3.3e+00
2.0e+00
1.1e+00
6.5e-01
cases:13.44%
controls:8.39%
cases:11.89%
controls:4.70%
cases:5.22%
controls:0.76%
cases:1.27%
controls:0.05%
cases:5.68%
controls:0.79%
cases:12.97%
controls:4.83%
cases:22.04%
controls:12.84%
296
1834
1906
20020
262
1027
1942
20839
115
167
2089
21699
28
10
2176
21856
125
173
2075
21641
274
1027
1839
20244
400
2401
1415
16297
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
6.7e-01
1.5e+00
2.8e+00
—
2.9e+00
1.8e+00
9.6e-01
cases:4.45%
controls:2.34%
cases:5.08%
controls:1.13%
cases:2.50%
controls:0.16%
—
—
cases:2.41%
controls:0.14%
cases:5.30%
controls:0.93%
cases:7.11%
controls:2.86%
98
511
2104
21343
112
247
2092
21619
55
35
2149
21831
—
53
31
2147
21783
112
197
2001
21074
129
534
1686
18164
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
8.4e-01
1.6e+00
2.5e+00
—
2.5e+00
1.8e+00
1.4e+00
cases:1.59%
controls:0.70%
cases:1.50%
controls:0.31%
cases:0.45%
controls:0.04%
—
—
cases:0.32%
controls:0.03%
cases:1.14%
controls:0.19%
cases:2.48%
controls:0.62%
35
152
2167
21702
33
68
2171
21798
10
8
2194
21858
—
7
6
2193
21808
24
41
2089
21230
45
116
1770
18582
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.4e-01
1.0e+00
1.9e+00
3.1e+00
2.1e+00
1.1e+00
7.2e-01
cases:12.31%
controls:7.55%
cases:11.03%
controls:4.18%
cases:4.49%
controls:0.67%
cases:1.04%
controls:0.05%
cases:5.00%
controls:0.66%
cases:11.78%
controls:4.20%
cases:20.00%
controls:10.87%
271
1651
1931
20203
243
914
1961
20952
99
147
2105
21719
23
10
2181
21856
110
145
2090
21669
249
894
1864
20377
363
2032
1452
16666
mometasone
D07AC13 [21602132]
9.3e-01
1.3e+00
2.7e+00
—
2.8e+00
1.6e+00
1.1e+00
cases:6.95%
controls:2.85%
cases:3.36%
controls:0.90%
cases:1.54%
controls:0.11%
—
—
cases:1.68%
controls:0.10%
cases:4.31%
controls:0.88%
cases:8.04%
controls:2.77%
153
623
2049
21231
74
197
2130
21669
34
23
2170
21843
—
37
22
2163
21792
91
187
2022
21084
146
518
1669
18180
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
9.0e-01
1.7e+00
2.8e+00
—
3.0e+00
1.0e+00
1.1e+00
cases:1.27%
controls:0.52%
cases:1.27%
controls:0.24%
cases:0.36%
controls:0.02%
—
—
cases:0.55%
controls:0.03%
cases:0.71%
controls:0.25%
cases:2.42%
controls:0.79%
28
114
2174
21740
28
53
2176
21813
8
5
2196
21861
—
12
6
2188
21808
15
54
2098
21217
44
148
1771
18550
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
7.2e-01
1.4e+00
2.9e+00
—
2.7e+00
1.9e+00
1.6e+00
cases:0.86%
controls:0.42%
cases:0.64%
controls:0.16%
cases:0.50%
controls:0.03%
—
—
cases:0.55%
controls:0.04%
cases:0.76%
controls:0.12%
cases:1.49%
controls:0.29%
19
92
2183
21762
14
35
2190
21831
11
6
2193
21860
—
12
8
2188
21806
16
25
2097
21246
27
55
1788
18643
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
8.1e-01
1.4e+00
2.4e+00
—
3.0e+00
1.9e+00
1.1e+00
cases:2.63%
controls:1.19%
cases:2.22%
controls:0.58%
cases:0.95%
controls:0.09%
—
—
cases:1.18%
controls:0.06%
cases:3.31%
controls:0.52%
cases:4.90%
controls:1.75%
58
259
2144
21595
49
126
2155
21740
21
20
2183
21846
—
26
13
2174
21801
70
110
2043
21161
89
327
1726
18371
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
8.9e-01
1.7e+00
2.3e+00
—
2.9e+00
1.6e+00
1.1e+00
cases:0.91%
controls:0.38%
cases:1.04%
controls:0.20%
cases:0.41%
controls:0.04%
—
—
cases:0.68%
controls:0.04%
cases:0.90%
controls:0.19%
cases:1.65%
controls:0.56%
20
82
2182
21772
23
43
2181
21823
9
9
2195
21857
—
15
8
2185
21806
19
40
2094
21231
30
105
1785
18593
Epilepsy, unspecified
G40.9 [45562083]
4.8e-01
1.3e+00
2.7e+00
—
3.3e+00
1.8e+00
1.5e+00
cases:0.59%
controls:0.37%
cases:0.68%
controls:0.19%
cases:0.73%
controls:0.05%
—
—
cases:0.59%
controls:0.02%
cases:1.14%
controls:0.19%
cases:1.65%
controls:0.39%
13
80
2189
21774
15
42
2189
21824
16
11
2188
21855
—
13
5
2187
21809
24
41
2089
21230
30
72
1785
18626
Intravenous
ZX120 [2001311495]
8.1e-01
2.1e+00
2.2e+00
—
2.0e+00
1.8e+00
1.5e+00
cases:2.23%
controls:1.00%
cases:2.31%
controls:0.30%
cases:1.00%
controls:0.11%
—
—
cases:0.68%
controls:0.09%
cases:1.75%
controls:0.29%
cases:3.09%
controls:0.70%
49
218
2153
21636
51
66
2153
21800
22
24
2182
21842
—
15
20
2185
21794
37
61
2076
21210
56
131
1759
18567
clobetasol
D07AD01 [21602141]
1.1e+00
1.5e+00
2.0e+00
1.0e+50
2.9e+00
1.8e+00
1.2e+00
cases:4.31%
controls:1.46%
cases:2.72%
controls:0.64%
cases:0.77%
controls:0.10%
cases:0.54%
controls:0.00%
cases:1.18%
controls:0.07%
cases:3.50%
controls:0.61%
cases:5.84%
controls:1.90%
95
319
2107
21535
60
141
2144
21725
17
22
2187
21844
12
0
2192
21866
26
15
2174
21799
74
130
2039
21141
106
356
1709
18342
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.1e+00
1.7e+00
2.6e+00
—
2.5e+00
1.7e+00
8.1e-01
cases:2.82%
controls:0.96%
cases:2.81%
controls:0.52%
cases:1.00%
controls:0.08%
—
—
cases:1.05%
controls:0.09%
cases:2.65%
controls:0.49%
cases:3.86%
controls:1.75%
62
209
2140
21645
62
114
2142
21752
22
17
2182
21849
—
23
19
2177
21795
56
105
2057
21166
70
328
1745
18370
Nephrology
39 [38004479]
8.4e-01
1.1e+00
1.8e+00
2.5e+00
1.7e+00
1.4e+00
1.1e+00
cases:1.63%
controls:0.71%
cases:1.81%
controls:0.59%
cases:1.09%
controls:0.19%
cases:0.54%
controls:0.05%
cases:1.23%
controls:0.23%
cases:2.18%
controls:0.55%
cases:2.64%
controls:0.93%
36
155
2166
21699
40
129
2164
21737
24
41
2180
21825
12
10
2192
21856
27
51
2173
21763
46
116
2067
21155
48
173
1767
18525
imidazoles/triazoles in combination with corticosteroids
D01AC20 [21601936]
1.1e+00
1.5e+00
2.4e+00
—
2.7e+00
1.5e+00
1.2e+00
cases:7.40%
controls:2.70%
cases:4.45%
controls:0.99%
cases:1.32%
controls:0.12%
—
—
cases:1.50%
controls:0.11%
cases:4.02%
controls:0.94%
cases:9.31%
controls:3.03%
163
591
2039
21263
98
217
2106
21649
29
26
2175
21840
—
33
23
2167
21791
85
200
2028
21071
169
566
1646
18132
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
9.1e-01
1.4e+00
2.6e+00
—
2.7e+00
1.9e+00
8.4e-01
cases:1.82%
controls:0.74%
cases:1.54%
controls:0.38%
cases:0.59%
controls:0.05%
—
—
cases:0.77%
controls:0.05%
cases:2.04%
controls:0.31%
cases:3.09%
controls:1.35%
40
162
2162
21692
34
84
2170
21782
13
10
2191
21856
—
17
11
2183
21803
43
66
2070
21205
56
253
1759
18445
Skin Pathology biopsy report
65754-4 [40768443]
1.1e+00
2.1e+00
3.6e+00
1.0e+50
—
2.3e+00
1.2e+00
cases:1.18%
controls:0.41%
cases:1.32%
controls:0.16%
cases:0.86%
controls:0.02%
cases:1.91%
controls:0.00%
—
—
cases:1.47%
controls:0.15%
cases:1.76%
controls:0.54%
26
89
2176
21765
29
34
2175
21832
19
5
2185
21861
42
0
2162
21866
—
31
32
2082
21239
32
101
1783
18597
Systemic lupus erythematosus, unspecified
M32.9 [45553167]
2.1e+00
2.7e+00
—
—
—
2.5e+00
3.0e+00
cases:0.45%
controls:0.05%
cases:0.41%
controls:0.03%
—
—
—
—
—
—
cases:0.47%
controls:0.04%
cases:0.94%
controls:0.05%
10
12
2192
21842
9
6
2195
21860
—
—
—
10
8
2103
21263
17
9
1798
18689
Outpatient Visit
OP [9202]
5.1e-01
7.7e-01
1.3e+00
4.4e+00
1.7e+00
1.0e+00
6.7e-01
cases:76.75%
controls:66.51%
cases:64.79%
controls:45.99%
cases:28.63%
controls:9.83%
cases:26.00%
controls:0.45%
cases:37.55%
controls:10.01%
cases:70.89%
controls:46.55%
cases:84.96%
controls:74.24%
1690
14535
512
7319
1428
10056
776
11810
631
2149
1573
19717
573
98
1631
21768
826
2183
1374
19631
1498
9902
615
11369
1542
13882
273
4816
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
1.1e+00
2.2e+00
—
1.0e+50
3.7e+00
2.1e+00
1.3e+00
cases:2.50%
controls:0.84%
cases:2.22%
controls:0.26%
—
—
cases:0.59%
controls:0.00%
cases:1.09%
controls:0.03%
cases:1.99%
controls:0.25%
cases:3.20%
controls:0.93%
55
183
2147
21671
49
57
2155
21809
—
13
0
2191
21866
24
6
2176
21808
42
53
2071
21218
58
174
1757
18524
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4.0e-01
8.5e-01
1.8e+00
3.9e+00
1.8e+00
9.2e-01
5.8e-01
cases:22.16%
controls:15.97%
cases:17.24%
controls:8.17%
cases:6.13%
controls:1.11%
cases:1.63%
controls:0.03%
cases:6.27%
controls:1.05%
cases:17.94%
controls:8.05%
cases:32.62%
controls:21.33%
488
3490
1714
18364
380
1787
1824
20079
135
242
2069
21624
36
7
2168
21859
138
228
2062
21586
379
1712
1734
19559
592
3989
1223
14709
Gas panel - Capillary blood
24337-8 [3022313]
7.8e-01
1.6e+00
2.7e+00
—
2.3e+00
1.7e+00
1.2e+00
cases:1.59%
controls:0.74%
cases:1.72%
controls:0.36%
cases:0.54%
controls:0.04%
—
—
cases:0.41%
controls:0.04%
cases:1.23%
controls:0.23%
cases:2.70%
controls:0.86%
35
161
2167
21693
38
78
2166
21788
12
8
2192
21858
—
9
9
2191
21805
26
49
2087
21222
49
160
1766
18538
filgrastim; parenteral
L03AA02 [21603851]
1.3e+00
2.2e+00
2.8e+00
—
—
2.6e+00
1.3e+00
cases:0.68%
controls:0.18%
cases:0.77%
controls:0.09%
cases:0.50%
controls:0.03%
—
—
—
—
cases:1.23%
controls:0.09%
cases:0.66%
controls:0.18%
15
40
2187
21814
17
19
2187
21847
11
7
2193
21859
—
—
26
19
2087
21252
12
33
1803
18665
betamethasone
S03BA03 [21605203]
1.2e+00
1.6e+00
2.0e+00
—
2.7e+00
1.5e+00
1.2e+00
cases:4.81%
controls:1.48%
cases:2.54%
controls:0.50%
cases:0.64%
controls:0.09%
—
—
cases:0.95%
controls:0.06%
cases:2.37%
controls:0.56%
cases:4.63%
controls:1.48%
106
323
2096
21531
56
109
2148
21757
14
19
2190
21847
—
21
14
2179
21800
50
119
2063
21152
84
276
1731
18422
Treatment plan or consultation
WZC00 [2001310885]
3.6e-01
1.1e+00
2.3e+00
2.6e+00
1.7e+00
1.5e+00
6.5e-01
cases:6.81%
controls:4.83%
cases:5.58%
controls:1.86%
cases:1.50%
controls:0.16%
cases:0.36%
controls:0.03%
cases:1.14%
controls:0.21%
cases:6.72%
controls:1.65%
cases:10.14%
controls:5.58%
150
1056
2052
20798
123
406
2081
21460
33
34
2171
21832
8
6
2196
21860
25
45
2175
21769
142
350
1971
20921
184
1043
1631
17655
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.3e+00
1.8e+00
—
—
3.1e+00
2.4e+00
1.5e+00
cases:0.77%
controls:0.21%
cases:0.91%
controls:0.15%
—
—
—
—
cases:0.91%
controls:0.04%
cases:0.95%
controls:0.09%
cases:1.38%
controls:0.30%
17
45
2185
21809
20
32
2184
21834
—
—
20
9
2180
21805
20
19
2093
21252
25
56
1790
18642
Local dermatologic skincare
TQW80 [2001310149]
1.8e+00
3.1e+00
—
1.0e+50
—
3.6e+00
1.6e+00
cases:0.73%
controls:0.12%
cases:0.59%
controls:0.03%
—
—
cases:0.68%
controls:0.00%
—
—
cases:0.85%
controls:0.02%
cases:0.77%
controls:0.15%
16
26
2186
21828
13
6
2191
21860
—
15
0
2189
21866
—
18
5
2095
21266
14
28
1801
18670
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
9.5e-01
1.3e+00
3.0e+00
1.0e+50
2.9e+00
1.3e+00
7.6e-01
cases:2.50%
controls:0.98%
cases:2.04%
controls:0.59%
cases:1.41%
controls:0.07%
cases:0.68%
controls:0.00%
cases:1.23%
controls:0.07%
cases:2.37%
controls:0.66%
cases:5.12%
controls:2.45%
55
215
2147
21639
45
129
2159
21737
31
16
2173
21850
15
0
2189
21866
27
15
2173
21799
50
140
2063
21131
93
459
1722
18239
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
8.8e-01
1.3e+00
2.9e+00
—
2.9e+00
1.3e+00
7.8e-01
cases:2.32%
controls:0.97%
cases:2.22%
controls:0.59%
cases:1.41%
controls:0.08%
—
—
cases:1.23%
controls:0.07%
cases:2.56%
controls:0.70%
cases:5.34%
controls:2.54%
51
212
2151
21642
49
130
2155
21736
31
17
2173
21849
—
27
15
2173
21799
54
149
2059
21122
97
474
1718
18224
Allergic urticaria
L50.0 [45581945]
1.9e+00
3.2e+00
1.0e+50
1.0e+50
—
3.1e+00
2.0e+00
cases:0.73%
controls:0.11%
cases:1.09%
controls:0.05%
cases:1.50%
controls:0.00%
cases:1.32%
controls:0.00%
—
—
cases:0.62%
controls:0.03%
cases:1.16%
controls:0.17%
16
25
2186
21829
24
10
2180
21856
33
0
2171
21866
29
0
2175
21866
—
13
6
2100
21265
21
31
1794
18667
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
6.6e-01
1.5e+00
2.6e+00
—
2.8e+00
1.6e+00
9.0e-01
cases:2.54%
controls:1.34%
cases:2.77%
controls:0.65%
cases:0.77%
controls:0.05%
—
—
cases:1.23%
controls:0.08%
cases:2.65%
controls:0.55%
cases:3.64%
controls:1.51%
56
292
2146
21562
61
142
2143
21724
17
12
2187
21854
—
27
17
2173
21797
56
116
2057
21155
66
283
1749
18415
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
9.2e-01
1.9e+00
2.4e+00
—
2.6e+00
1.4e+00
9.3e-01
cases:2.18%
controls:0.88%
cases:2.04%
controls:0.32%
cases:0.73%
controls:0.07%
—
—
cases:0.95%
controls:0.07%
cases:1.51%
controls:0.39%
cases:3.03%
controls:1.22%
48
192
2154
21662
45
70
2159
21796
16
15
2188
21851
—
21
16
2179
21798
32
84
2081
21187
55
228
1760
18470
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
7.1e-01
1.8e+00
2.6e+00
—
2.5e+00
1.5e+00
9.8e-01
cases:2.23%
controls:1.11%
cases:2.31%
controls:0.41%
cases:0.59%
controls:0.05%
—
—
cases:0.32%
controls:0.03%
cases:1.70%
controls:0.37%
cases:3.14%
controls:1.20%
49
242
2153
21612
51
89
2153
21777
13
10
2191
21856
—
7
6
2193
21808
36
78
2077
21193
57
224
1758
18474
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
3.3e-01
7.7e-01
2.0e+00
4.0e+00
1.5e+00
8.4e-01
5.3e-01
cases:17.98%
controls:13.63%
cases:13.52%
controls:6.72%
cases:6.58%
controls:0.99%
cases:3.27%
controls:0.06%
cases:3.86%
controls:0.85%
cases:14.20%
controls:6.68%
cases:27.66%
controls:18.39%
396
2979
1806
18875
298
1470
1906
20396
145
216
2059
21650
72
13
2132
21853
85
186
2115
21628
300
1420
1813
19851
502
3438
1313
15260
tacrolimus
D11AH01 [21602338]
1.8e+00
2.1e+00
2.5e+00
—
—
2.0e+00
1.7e+00
cases:1.82%
controls:0.32%
cases:0.91%
controls:0.11%
cases:0.27%
controls:0.02%
—
—
—
—
cases:1.14%
controls:0.16%
cases:2.70%
controls:0.51%
40
69
2162
21785
20
25
2184
21841
6
5
2198
21861
—
—
24
34
2089
21237
49
96
1766
18602
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
4.2e-01
7.5e-01
1.9e+00
3.9e+00
1.5e+00
9.3e-01
5.5e-01
cases:7.54%
controls:5.09%
cases:5.58%
controls:2.71%
cases:2.68%
controls:0.40%
cases:1.32%
controls:0.03%
cases:1.73%
controls:0.39%
cases:7.00%
controls:2.87%
cases:13.55%
controls:8.26%
166
1112
2036
20742
123
593
2081
21273
59
88
2145
21778
29
6
2175
21860
38
84
2162
21730
148
611
1965
20660
246
1545
1569
17153
FEV1
20150-9 [3024653]
7.3e-01
1.1e+00
2.4e+00
—
2.4e+00
1.5e+00
1.7e+00
cases:3.32%
controls:1.62%
cases:1.72%
controls:0.56%
cases:0.36%
controls:0.03%
—
—
cases:0.45%
controls:0.04%
cases:2.13%
controls:0.47%
cases:4.79%
controls:0.94%
73
355
2129
21499
38
122
2166
21744
8
7
2196
21859
—
10
9
2190
21805
45
99
2068
21172
87
176
1728
18522
FEV1/FVC
19926-5 [3011505]
7.3e-01
1.1e+00
2.4e+00
—
2.4e+00
1.5e+00
1.7e+00
cases:3.32%
controls:1.62%
cases:1.72%
controls:0.56%
cases:0.36%
controls:0.03%
—
—
cases:0.45%
controls:0.04%
cases:2.13%
controls:0.47%
cases:4.79%
controls:0.94%
73
355
2129
21499
38
122
2166
21744
8
7
2196
21859
—
10
9
2190
21805
45
99
2068
21172
87
176
1728
18522
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
7.3e-01
1.1e+00
2.4e+00
—
2.4e+00
1.5e+00
1.7e+00
cases:3.32%
controls:1.62%
cases:1.72%
controls:0.56%
cases:0.36%
controls:0.03%
—
—
cases:0.45%
controls:0.04%
cases:2.13%
controls:0.47%
cases:4.79%
controls:0.94%
73
355
2129
21499
38
122
2166
21744
8
7
2196
21859
—
10
9
2190
21805
45
99
2068
21172
87
176
1728
18522
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
7.3e-01
1.3e+00
2.9e+00
—
2.7e+00
1.6e+00
7.1e-01
cases:2.36%
controls:1.15%
cases:2.31%
controls:0.64%
cases:1.32%
controls:0.07%
—
—
cases:1.27%
controls:0.09%
cases:2.41%
controls:0.52%
cases:3.36%
controls:1.68%
52
252
2150
21602
51
139
2153
21727
29
16
2175
21850
—
28
19
2172
21795
51
110
2062
21161
61
315
1754
18383
Secondary malignant neoplasm of liver and intrahepatic bile duct
C78.7 [45595688]
1.6e+00
2.0e+00
2.4e+00
—
2.3e+00
1.6e+00
7.2e-01
cases:0.41%
controls:0.08%
cases:0.68%
controls:0.09%
cases:0.50%
controls:0.05%
—
—
cases:0.36%
controls:0.04%
cases:0.57%
controls:0.12%
cases:0.33%
controls:0.16%
9
18
2193
21836
15
20
2189
21846
11
10
2193
21856
—
8
8
2192
21806
12
25
2101
21246
6
30
1809
18668
Metastasis to liver
OMOP5000224 [36770544]
1.6e+00
2.0e+00
2.4e+00
—
2.3e+00
1.6e+00
7.2e-01
cases:0.41%
controls:0.08%
cases:0.68%
controls:0.09%
cases:0.50%
controls:0.05%
—
—
cases:0.36%
controls:0.04%
cases:0.57%
controls:0.12%
cases:0.33%
controls:0.16%
9
18
2193
21836
15
20
2189
21846
11
10
2193
21856
—
8
8
2192
21806
12
25
2101
21246
6
30
1809
18668
Metastasis to intrahepatic bile ducts
OMOP5031661 [35226180]
1.6e+00
2.0e+00
2.4e+00
—
2.3e+00
1.6e+00
7.2e-01
cases:0.41%
controls:0.08%
cases:0.68%
controls:0.09%
cases:0.50%
controls:0.05%
—
—
cases:0.36%
controls:0.04%
cases:0.57%
controls:0.12%
cases:0.33%
controls:0.16%
9
18
2193
21836
15
20
2189
21846
11
10
2193
21856
—
8
8
2192
21806
12
25
2101
21246
6
30
1809
18668
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.2e-01
7.4e-01
1.8e+00
4.0e+00
1.7e+00
7.7e-01
5.4e-01
cases:18.85%
controls:14.40%
cases:14.43%
controls:7.42%
cases:5.99%
controls:1.07%
cases:2.68%
controls:0.05%
cases:4.91%
controls:0.95%
cases:14.81%
controls:7.44%
cases:28.87%
controls:19.18%
415
3146
1787
18708
318
1623
1886
20243
132
235
2072
21631
59
11
2145
21855
108
207
2092
21607
313
1582
1800
19689
524
3587
1291
15111
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
2.9e-01
7.2e-01
1.8e+00
4.2e+00
1.6e+00
7.3e-01
3.8e-01
cases:11.13%
controls:8.60%
cases:9.07%
controls:4.62%
cases:3.95%
controls:0.66%
cases:1.86%
controls:0.03%
cases:3.14%
controls:0.62%
cases:10.27%
controls:5.22%
cases:21.27%
controls:15.56%
245
1880
1957
19974
200
1010
2004
20856
87
144
2117
21722
41
6
2163
21860
69
135
2131
21679
217
1111
1896
20160
386
2909
1429
15789
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
6.2e-01
1.6e+00
2.7e+00
—
2.5e+00
1.6e+00
8.0e-01
cases:3.45%
controls:1.89%
cases:3.58%
controls:0.78%
cases:0.86%
controls:0.06%
—
—
cases:0.68%
controls:0.06%
cases:2.98%
controls:0.59%
cases:4.19%
controls:1.93%
76
413
2126
21441
79
170
2125
21696
19
13
2185
21853
—
15
12
2185
21802
63
125
2050
21146
76
361
1739
18337
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2.8e-01
7.1e-01
1.8e+00
4.2e+00
1.7e+00
7.4e-01
3.9e-01
cases:10.76%
controls:8.37%
cases:8.89%
controls:4.56%
cases:3.99%
controls:0.67%
cases:1.81%
controls:0.03%
cases:3.18%
controls:0.62%
cases:10.27%
controls:5.19%
cases:21.10%
controls:15.39%
237
1830
1965
20024
196
997
2008
20869
88
146
2116
21720
40
6
2164
21860
70
136
2130
21678
217
1104
1896
20167
383
2878
1432
15820
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
6.6e-01
1.7e+00
2.4e+00
—
2.5e+00
1.5e+00
9.7e-01
cases:2.09%
controls:1.09%
cases:2.50%
controls:0.46%
cases:0.86%
controls:0.08%
—
—
cases:1.27%
controls:0.10%
cases:2.27%
controls:0.52%
cases:4.13%
controls:1.60%
46
238
2156
21616
55
101
2149
21765
19
17
2185
21849
—
28
22
2172
21792
48
110
2065
21161
75
300
1740
18398
Thorax X-ray examination
GD1AA [2001303617]
8.6e-01
1.4e+00
2.7e+00
—
2.2e+00
1.6e+00
1.1e+00
cases:15.12%
controls:7.04%
cases:10.44%
controls:2.70%
cases:4.54%
controls:0.32%
—
—
cases:2.41%
controls:0.28%
cases:10.22%
controls:2.35%
cases:19.12%
controls:7.63%
333
1539
1869
20315
230
590
1974
21276
100
69
2104
21797
—
53
60
2147
21754
216
499
1897
20772
347
1426
1468
17272
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.0e-01
7.2e-01
1.8e+00
4.2e+00
1.6e+00
7.3e-01
3.9e-01
cases:10.76%
controls:8.24%
cases:8.76%
controls:4.48%
cases:3.81%
controls:0.64%
cases:1.81%
controls:0.03%
cases:3.09%
controls:0.61%
cases:10.08%
controls:5.11%
cases:20.83%
controls:15.17%
237
1800
1965
20054
193
980
2011
20886
84
140
2120
21726
40
6
2164
21860
68
134
2132
21680
213
1087
1900
20184
378
2836
1437
15862
palonosetron, combinations
A04AA55 [45893275]
1.2e-01
1.7e+00
2.2e+00
—
2.0e+00
2.1e+00
1.7e+00
cases:0.23%
controls:0.20%
cases:0.59%
controls:0.11%
cases:0.41%
controls:0.05%
—
—
cases:0.32%
controls:0.04%
cases:0.90%
controls:0.11%
cases:0.77%
controls:0.14%
5
44
2197
21810
13
24
2191
21842
9
10
2195
21856
—
7
9
2193
21805
19
23
2094
21248
14
26
1801
18672
leflunomide; oral
L04AK01 [955035]
1.7e+00
1.8e+00
2.3e+00
—
—
2.1e+00
1.9e+00
cases:1.09%
controls:0.21%
cases:0.77%
controls:0.12%
cases:0.27%
controls:0.03%
—
—
—
—
cases:0.90%
controls:0.11%
cases:1.21%
controls:0.19%
24
45
2178
21809
17
27
2187
21839
6
6
2198
21860
—
—
19
24
2094
21247
22
36
1793
18662
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
1.6e+00
2.6e+00
—
—
—
3.8e+00
1.7e+00
cases:0.82%
controls:0.16%
cases:1.09%
controls:0.08%
—
—
—
—
—
—
cases:0.99%
controls:0.02%
cases:1.38%
controls:0.25%
18
36
2184
21818
24
18
2180
21848
—
—
—
21
5
2092
21266
25
46
1790
18652
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
8.4e-01
1.7e+00
2.2e+00
—
2.9e+00
1.2e+00
7.3e-01
cases:1.18%
controls:0.51%
cases:1.18%
controls:0.22%
cases:0.41%
controls:0.05%
—
—
cases:0.68%
controls:0.04%
cases:0.90%
controls:0.26%
cases:1.76%
controls:0.86%
26
112
2176
21742
26
48
2178
21818
9
10
2195
21856
—
15
8
2185
21806
19
56
2094
21215
32
160
1783
18538
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
8.3e-01
1.7e+00
2.2e+00
—
2.9e+00
1.2e+00
7.3e-01
cases:1.18%
controls:0.52%
cases:1.18%
controls:0.22%
cases:0.41%
controls:0.05%
—
—
cases:0.68%
controls:0.04%
cases:0.90%
controls:0.26%
cases:1.76%
controls:0.86%
26
113
2176
21741
26
48
2178
21818
9
10
2195
21856
—
15
8
2185
21806
19
56
2094
21215
32
160
1783
18538
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
8.3e-01
1.7e+00
2.2e+00
—
2.9e+00
1.2e+00
7.3e-01
cases:1.18%
controls:0.52%
cases:1.18%
controls:0.22%
cases:0.41%
controls:0.05%
—
—
cases:0.68%
controls:0.04%
cases:0.90%
controls:0.26%
cases:1.76%
controls:0.86%
26
113
2176
21741
26
48
2178
21818
9
10
2195
21856
—
15
8
2185
21806
19
56
2094
21215
32
160
1783
18538
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
6.2e-01
1.6e+00
2.7e+00
1.0e+50
2.2e+00
1.5e+00
9.0e-01
cases:3.41%
controls:1.85%
cases:3.27%
controls:0.70%
cases:1.18%
controls:0.08%
cases:0.45%
controls:0.00%
cases:0.82%
controls:0.09%
cases:2.60%
controls:0.57%
cases:5.40%
controls:2.28%
75
405
2127
21449
72
153
2132
21713
26
17
2178
21849
10
0
2194
21866
18
19
2182
21795
55
121
2058
21150
98
426
1717
18272
CD19 cells [#/volume] in Blood
8116-6 [3010503]
1.6e+00
2.9e+00
—
—
—
3.0e+00
2.1e+00
cases:0.41%
controls:0.08%
cases:0.50%
controls:0.03%
—
—
—
—
—
—
cases:0.90%
controls:0.05%
cases:0.94%
controls:0.11%
9
18
2193
21836
11
6
2193
21860
—
—
—
19
10
2094
21261
17
21
1798
18677
cetirizine; oral
R06AE07 [21603497]
8.7e-01
1.3e+00
2.5e+00
—
2.7e+00
1.2e+00
1.0e+00
cases:14.94%
controls:6.85%
cases:10.80%
controls:3.29%
cases:5.67%
controls:0.48%
—
—
cases:7.82%
controls:0.56%
cases:10.03%
controls:3.20%
cases:17.30%
controls:7.11%
329
1497
1873
20357
238
720
1966
21146
125
104
2079
21762
—
172
123
2028
21691
212
681
1901
20590
314
1329
1501
17369
FEV1/FVC --post bronchodilation
69970-2 [42868459]
6.5e-01
1.0e+00
2.6e+00
—
2.1e+00
1.5e+00
1.6e+00
cases:2.63%
controls:1.40%
cases:1.27%
controls:0.46%
cases:0.32%
controls:0.02%
—
—
cases:0.27%
controls:0.03%
cases:1.75%
controls:0.39%
cases:4.08%
controls:0.85%
58
305
2144
21549
28
100
2176
21766
7
5
2197
21861
—
6
7
2194
21807
37
82
2076
21189
74
158
1741
18540
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
6.5e-01
1.0e+00
2.6e+00
—
2.1e+00
1.5e+00
1.6e+00
cases:2.63%
controls:1.40%
cases:1.27%
controls:0.46%
cases:0.32%
controls:0.02%
—
—
cases:0.27%
controls:0.03%
cases:1.75%
controls:0.39%
cases:4.08%
controls:0.85%
58
305
2144
21549
28
100
2176
21766
7
5
2197
21861
—
6
7
2194
21807
37
82
2076
21189
74
158
1741
18540
FEV1 --post bronchodilation
20155-8 [3023550]
6.5e-01
1.0e+00
2.6e+00
—
2.1e+00
1.5e+00
1.6e+00
cases:2.63%
controls:1.40%
cases:1.27%
controls:0.46%
cases:0.32%
controls:0.02%
—
—
cases:0.27%
controls:0.03%
cases:1.75%
controls:0.39%
cases:4.08%
controls:0.85%
58
305
2144
21549
28
100
2176
21766
7
5
2197
21861
—
6
7
2194
21807
37
82
2076
21189
74
158
1741
18540
FVC percent change Respiratory system
69982-7 [42868471]
6.5e-01
1.0e+00
2.6e+00
—
2.1e+00
1.5e+00
1.6e+00
cases:2.63%
controls:1.40%
cases:1.27%
controls:0.46%
cases:0.32%
controls:0.02%
—
—
cases:0.27%
controls:0.03%
cases:1.75%
controls:0.39%
cases:4.08%
controls:0.85%
58
305
2144
21549
28
100
2176
21766
7
5
2197
21861
—
6
7
2194
21807
37
82
2076
21189
74
158
1741
18540
FEV1 percent change
69983-5 [42868472]
6.5e-01
1.0e+00
2.6e+00
—
2.1e+00
1.5e+00
1.6e+00
cases:2.63%
controls:1.40%
cases:1.27%
controls:0.46%
cases:0.32%
controls:0.02%
—
—
cases:0.27%
controls:0.03%
cases:1.75%
controls:0.39%
cases:4.08%
controls:0.85%
58
305
2144
21549
28
100
2176
21766
7
5
2197
21861
—
6
7
2194
21807
37
82
2076
21189
74
158
1741
18540
hydrocortisone and antiinfectives
S02CA03 [21605175]
8.7e-01
1.5e+00
2.8e+00
—
2.1e+00
1.4e+00
8.8e-01
cases:3.45%
controls:1.47%
cases:2.00%
controls:0.45%
cases:0.68%
controls:0.04%
—
—
cases:0.55%
controls:0.07%
cases:1.89%
controls:0.47%
cases:4.63%
controls:1.98%
76
322
2126
21532
44
99
2160
21767
15
9
2189
21857
—
12
15
2188
21799
40
101
2073
21170
84
370
1731
18328
hydrocortisone and antiinfectives
S03CA04 [21605208]
8.7e-01
1.5e+00
2.8e+00
—
2.1e+00
1.4e+00
8.8e-01
cases:3.45%
controls:1.47%
cases:2.00%
controls:0.45%
cases:0.68%
controls:0.04%
—
—
cases:0.55%
controls:0.07%
cases:1.89%
controls:0.47%
cases:4.63%
controls:1.98%
76
322
2126
21532
44
99
2160
21767
15
9
2189
21857
—
12
15
2188
21799
40
101
2073
21170
84
370
1731
18328
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.5e+00
1.6e+00
1.5e+00
—
2.2e+00
2.2e+00
2.0e+00
cases:1.04%
controls:0.24%
cases:1.04%
controls:0.21%
cases:0.36%
controls:0.08%
—
—
cases:0.50%
controls:0.06%
cases:1.56%
controls:0.18%
cases:1.65%
controls:0.22%
23
53
2179
21801
23
45
2181
21821
8
18
2196
21848
—
11
12
2189
21802
33
38
2080
21233
30
41
1785
18657
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
3.1e-01
6.7e-01
1.8e+00
4.1e+00
1.6e+00
7.6e-01
3.4e-01
cases:9.72%
controls:7.29%
cases:6.85%
controls:3.63%
cases:3.18%
controls:0.54%
cases:1.36%
controls:0.02%
cases:2.09%
controls:0.45%
cases:8.09%
controls:3.94%
cases:15.43%
controls:11.53%
214
1593
1988
20261
151
793
2053
21073
70
119
2134
21747
30
5
2174
21861
46
98
2154
21716
171
839
1942
20432
280
2156
1535
16542
Predominantly allergic asthma
J45.0 [45557624]
1.1e+00
1.5e+00
2.1e+00
—
2.1e+00
1.6e+00
1.1e+00
cases:2.50%
controls:0.83%
cases:1.68%
controls:0.37%
cases:0.45%
controls:0.05%
—
—
cases:0.68%
controls:0.09%
cases:1.85%
controls:0.39%
cases:3.03%
controls:1.02%
55
182
2147
21672
37
80
2167
21786
10
12
2194
21854
—
15
19
2185
21795
39
84
2074
21187
55
191
1760
18507
INR in Blood by Coagulation assay
34714-6 [3032080]
4.6e-01
9.2e-01
1.1e+00
4.2e+00
1.2e+00
9.1e-01
6.1e-01
cases:12.44%
controls:8.20%
cases:11.12%
controls:4.74%
cases:4.72%
controls:1.59%
cases:2.18%
controls:0.03%
cases:4.95%
controls:1.53%
cases:10.74%
controls:4.62%
cases:18.35%
controls:10.85%
274
1792
1928
20062
245
1037
1959
20829
104
348
2100
21518
48
7
2156
21859
109
334
2091
21480
227
983
1886
20288
333
2029
1482
16669
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
1.6e+00
2.9e+00
—
—
—
3.1e+00
2.0e+00
cases:0.54%
controls:0.11%
cases:0.64%
controls:0.04%
—
—
—
—
—
—
cases:1.09%
controls:0.05%
cases:0.99%
controls:0.14%
12
25
2190
21829
14
8
2190
21858
—
—
—
23
11
2090
21260
18
26
1797
18672
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3.7e-01
1.5e+00
2.3e+00
—
3.0e+00
1.4e+00
1.2e+00
cases:0.68%
controls:0.47%
cases:0.86%
controls:0.20%
cases:0.27%
controls:0.03%
—
—
cases:0.45%
controls:0.02%
cases:0.80%
controls:0.19%
cases:1.60%
controls:0.47%
15
103
2187
21751
19
43
2185
21823
6
6
2198
21860
—
10
5
2190
21809
17
41
2096
21230
29
88
1786
18610
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
8.1e-01
1.4e+00
2.5e+00
1.0e+50
2.3e+00
1.6e+00
7.9e-01
cases:3.45%
controls:1.56%
cases:3.18%
controls:0.79%
cases:1.18%
controls:0.10%
cases:0.23%
controls:0.00%
cases:1.36%
controls:0.13%
cases:3.27%
controls:0.69%
cases:4.90%
controls:2.28%
76
342
2126
21512
70
173
2134
21693
26
22
2178
21844
5
0
2199
21866
30
29
2170
21785
69
146
2044
21125
89
426
1726
18272
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
5.2e-01
1.7e+00
3.0e+00
—
1.9e+00
1.4e+00
8.7e-01
cases:5.40%
controls:3.28%
cases:5.67%
controls:1.12%
cases:2.54%
controls:0.12%
—
—
cases:0.82%
controls:0.12%
cases:4.26%
controls:1.11%
cases:7.60%
controls:3.35%
119
717
2083
21137
125
244
2079
21622
56
27
2148
21839
—
18
26
2182
21788
90
237
2023
21034
138
626
1677
18072
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
8.3e-01
1.2e+00
2.6e+00
—
2.6e+00
1.3e+00
8.6e-01
cases:6.95%
controls:3.15%
cases:6.03%
controls:1.92%
cases:3.72%
controls:0.29%
—
—
cases:4.05%
controls:0.33%
cases:6.96%
controls:1.92%
cases:11.79%
controls:5.35%
153
689
2049
21165
133
419
2071
21447
82
63
2122
21803
—
89
71
2111
21743
147
409
1966
20862
214
1000
1601
17698
nystatin; oral
A07AA02 [21600604]
7.3e-01
1.7e+00
2.2e+00
—
2.4e+00
1.3e+00
1.1e+00
cases:1.59%
controls:0.77%
cases:1.13%
controls:0.22%
cases:0.36%
controls:0.04%
—
—
cases:0.36%
controls:0.03%
cases:0.95%
controls:0.26%
cases:2.15%
controls:0.73%
35
169
2167
21685
25
48
2179
21818
8
9
2196
21857
—
8
7
2192
21807
20
56
2093
21215
39
137
1776
18561
Adenocarcinoma of the endometrium
C54.11 [2000501064]
6.9e-01
2.0e+00
2.9e+00
1.0e+50
2.6e+00
1.9e+00
1.3e+00
cases:0.27%
controls:0.14%
cases:0.54%
controls:0.08%
cases:0.41%
controls:0.02%
cases:0.36%
controls:0.00%
cases:0.36%
controls:0.03%
cases:0.57%
controls:0.08%
cases:0.55%
controls:0.15%
6
30
2196
21824
12
17
2192
21849
9
5
2195
21861
8
0
2196
21866
8
6
2192
21808
12
18
2101
21253
10
28
1805
18670
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
5.4e-01
1.1e+00
2.4e+00
—
2.8e+00
1.4e+00
1.1e+00
cases:2.86%
controls:1.68%
cases:2.22%
controls:0.78%
cases:0.95%
controls:0.09%
—
—
cases:1.55%
controls:0.10%
cases:2.74%
controls:0.67%
cases:4.79%
controls:1.70%
63
368
2139
21486
49
171
2155
21695
21
19
2183
21847
—
34
21
2166
21793
58
142
2055
21129
87
317
1728
18381
pH of Urine
2756-5 [3015736]
3.0e-01
7.5e-01
1.7e+00
3.8e+00
1.7e+00
7.3e-01
3.6e-01
cases:8.95%
controls:6.77%
cases:6.85%
controls:3.36%
cases:2.72%
controls:0.50%
cases:1.18%
controls:0.03%
cases:2.27%
controls:0.44%
cases:7.48%
controls:3.75%
cases:15.70%
controls:11.49%
197
1480
2005
20374
151
735
2053
21131
60
110
2144
21756
26
6
2178
21860
50
96
2150
21718
158
797
1955
20474
285
2149
1530
16549
Otolaryngology
4 [38004449]
5.3e-01
8.3e-01
1.4e+00
3.6e+00
1.3e+00
9.2e-01
7.0e-01
cases:16.08%
controls:10.15%
cases:8.17%
controls:3.74%
cases:2.36%
controls:0.61%
cases:0.86%
controls:0.02%
cases:1.77%
controls:0.51%
cases:8.52%
controls:3.58%
cases:18.46%
controls:10.15%
354
2218
1848
19636
180
818
2024
21048
52
133
2152
21733
19
5
2185
21861
39
112
2161
21702
180
761
1933
20510
335
1897
1480
16801
hydrocortisone and antiinfectives
S01CA03 [21603654]
1.2e+00
1.9e+00
—
—
3.0e+00
1.9e+00
1.2e+00
cases:2.27%
controls:0.73%
cases:1.59%
controls:0.23%
—
—
—
—
cases:0.55%
controls:0.03%
cases:1.37%
controls:0.21%
cases:2.87%
controls:0.85%
50
159
2152
21695
35
51
2169
21815
—
—
12
6
2188
21808
29
45
2084
21226
52
158
1763
18540
Upper gastrointestinal surgery
106 [44777669]
5.8e-01
1.0e+00
1.5e+00
2.8e+00
1.6e+00
1.1e+00
6.4e-01
cases:13.22%
controls:7.83%
cases:7.71%
controls:2.86%
cases:2.00%
controls:0.45%
cases:0.36%
controls:0.02%
cases:1.86%
controls:0.39%
cases:7.24%
controls:2.59%
cases:14.55%
controls:8.26%
291
1712
1911
20142
170
625
2034
21241
44
98
2160
21768
8
5
2196
21861
41
85
2159
21729
153
550
1960
20721
264
1544
1551
17154
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
6.4e-01
1.3e+00
2.3e+00
—
2.9e+00
1.2e+00
8.1e-01
cases:5.77%
controls:3.11%
cases:3.95%
controls:1.09%
cases:1.09%
controls:0.11%
—
—
cases:1.68%
controls:0.10%
cases:3.27%
controls:1.01%
cases:8.21%
controls:3.81%
127
680
2075
21174
87
238
2117
21628
24
23
2180
21843
—
37
21
2163
21793
69
214
2044
21057
149
713
1666
17985
Office Visit
OMOP4822458 [581477]
5.6e-01
1.2e+00
2.5e+00
—
2.7e+00
1.4e+00
8.3e-01
cases:13.53%
controls:8.23%
cases:7.62%
controls:2.49%
cases:3.40%
controls:0.27%
—
—
cases:4.45%
controls:0.32%
cases:8.09%
controls:2.21%
cases:13.61%
controls:6.46%
298
1799
1904
20055
168
545
2036
21321
75
60
2129
21806
—
98
69
2102
21745
171
470
1942
20801
247
1207
1568
17491
combinations of corticosteroids
D07XB30 [21602188]
8.1e-01
1.4e+00
2.3e+00
—
2.4e+00
1.3e+00
1.0e+00
cases:17.08%
controls:8.38%
cases:10.21%
controls:2.71%
cases:3.86%
controls:0.40%
—
—
cases:3.36%
controls:0.33%
cases:10.13%
controls:3.01%
cases:21.27%
controls:9.08%
376
1831
1826
20023
225
593
1979
21273
85
88
2119
21778
—
74
72
2126
21742
214
641
1899
20630
386
1697
1429
17001
combinations of corticosteroids
D07AB30 [21602118]
8.1e-01
1.4e+00
2.3e+00
—
2.4e+00
1.3e+00
1.0e+00
cases:17.08%
controls:8.38%
cases:10.21%
controls:2.71%
cases:3.86%
controls:0.40%
—
—
cases:3.36%
controls:0.33%
cases:10.13%
controls:3.01%
cases:21.27%
controls:9.08%
376
1831
1826
20023
225
593
1979
21273
85
88
2119
21778
—
74
72
2126
21742
214
641
1899
20630
386
1697
1429
17001
hydrocortisone; oral, parenteral
H02AB09 [21602737]
1.2e+00
1.6e+00
1.4e+00
1.0e+50
3.0e+00
2.0e+00
1.3e+00
cases:3.32%
controls:1.01%
cases:2.09%
controls:0.43%
cases:0.36%
controls:0.09%
cases:0.68%
controls:0.00%
cases:1.23%
controls:0.06%
cases:2.56%
controls:0.36%
cases:3.86%
controls:1.09%
73
220
2129
21634
46
94
2158
21772
8
19
2196
21847
15
0
2189
21866
27
13
2173
21801
54
77
2059
21194
70
203
1745
18495
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.7e-01
4.8e-01
1.6e+00
4.3e+00
1.8e+00
4.9e-01
2.3e-01
cases:31.61%
controls:28.04%
cases:30.22%
controls:21.06%
cases:17.47%
controls:4.02%
cases:11.71%
controls:0.18%
cases:18.00%
controls:3.49%
cases:31.61%
controls:22.05%
cases:46.56%
controls:40.79%
696
6127
1506
15727
666
4606
1538
17260
385
880
1819
20986
258
39
1946
21827
396
761
1804
21053
668
4690
1445
16581
845
7626
970
11072
oxycodone; oral, parenteral
N02AA05 [21604260]
9.0e-01
1.5e+00
2.3e+00
—
1.8e+00
1.7e+00
9.4e-01
cases:2.63%
controls:1.08%
cases:2.81%
controls:0.65%
cases:1.72%
controls:0.17%
—
—
cases:1.14%
controls:0.20%
cases:4.59%
controls:0.88%
cases:5.62%
controls:2.27%
58
237
2144
21617
62
143
2142
21723
38
38
2166
21828
—
25
43
2175
21771
97
188
2016
21083
102
424
1713
18274
Allergy, unspecified
T78.4 [45580373]
1.6e+00
2.6e+00
1.0e+50
1.0e+50
—
2.9e+00
1.8e+00
cases:1.27%
controls:0.25%
cases:1.09%
controls:0.08%
cases:1.27%
controls:0.00%
cases:1.00%
controls:0.00%
—
—
cases:1.23%
controls:0.07%
cases:1.93%
controls:0.32%
28
55
2174
21799
24
18
2180
21848
28
0
2176
21866
22
0
2182
21866
—
26
14
2087
21257
35
59
1780
18639
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.6e-01
4.8e-01
1.6e+00
4.2e+00
1.8e+00
4.9e-01
2.2e-01
cases:31.65%
controls:28.23%
cases:30.44%
controls:21.39%
cases:17.56%
controls:4.09%
cases:11.71%
controls:0.20%
cases:18.14%
controls:3.56%
cases:31.85%
controls:22.29%
cases:46.45%
controls:41.00%
697
6170
1505
15684
671
4677
1533
17189
387
895
1817
20971
258
43
1946
21823
399
777
1801
21037
673
4741
1440
16530
843
7667
972
11031
Paranasal sinuses X-ray examination without contrast
DM1AA [2001301740]
1.7e+00
2.1e+00
—
—
—
3.3e+00
1.8e+00
cases:0.95%
controls:0.17%
cases:0.41%
controls:0.05%
—
—
—
—
—
—
cases:0.76%
controls:0.03%
cases:0.77%
controls:0.12%
21
38
2181
21816
9
11
2195
21855
—
—
—
16
6
2097
21265
14
23
1801
18675
Fungus identified in Specimen by Culture
580-1 [3000494]
5.2e-01
1.3e+00
2.6e+00
—
2.1e+00
1.6e+00
8.3e-01
cases:2.59%
controls:1.56%
cases:2.00%
controls:0.54%
cases:0.64%
controls:0.05%
—
—
cases:0.55%
controls:0.07%
cases:2.60%
controls:0.56%
cases:4.63%
controls:2.07%
57
341
2145
21513
44
119
2160
21747
14
10
2190
21856
—
12
15
2188
21799
55
119
2058
21152
84
387
1731
18311
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
1.6e+00
2.4e+00
—
—
—
3.2e+00
1.8e+00
cases:1.00%
controls:0.20%
cases:1.27%
controls:0.12%
—
—
—
—
—
—
cases:1.33%
controls:0.06%
cases:1.98%
controls:0.34%
22
44
2180
21810
28
26
2176
21840
—
—
—
28
12
2085
21259
36
64
1779
18634
Liver transplant status
Z94.4 [45566478]
1.7e+00
2.2e+00
—
—
2.8e+00
2.0e+00
2.0e+00
cases:0.27%
controls:0.05%
cases:0.36%
controls:0.04%
—
—
—
—
cases:0.36%
controls:0.02%
cases:0.38%
controls:0.05%
cases:0.39%
controls:0.05%
6
11
2196
21843
8
9
2196
21857
—
—
8
5
2192
21809
8
11
2105
21260
7
10
1808
18688
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
1.2e+00
1.5e+00
2.5e+00
—
—
2.0e+00
1.7e+00
cases:1.63%
controls:0.51%
cases:1.18%
controls:0.26%
cases:0.41%
controls:0.03%
—
—
—
—
cases:1.23%
controls:0.17%
cases:2.92%
controls:0.57%
36
111
2166
21743
26
56
2178
21810
9
7
2195
21859
—
—
26
36
2087
21235
53
107
1762
18591
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
1.6e+00
2.4e+00
—
—
—
3.2e+00
1.7e+00
cases:0.95%
controls:0.19%
cases:1.27%
controls:0.12%
—
—
—
—
—
—
cases:1.56%
controls:0.07%
cases:2.04%
controls:0.37%
21
42
2181
21812
28
26
2176
21840
—
—
—
33
14
2080
21257
37
69
1778
18629
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5.3e-01
1.2e+00
2.3e+00
1.0e+50
2.9e+00
1.4e+00
5.6e-01
cases:4.63%
controls:2.79%
cases:4.04%
controls:1.23%
cases:1.09%
controls:0.11%
cases:0.23%
controls:0.00%
cases:0.82%
controls:0.05%
cases:3.45%
controls:0.87%
cases:5.34%
controls:3.11%
102
610
2100
21244
89
269
2115
21597
24
25
2180
21841
5
0
2199
21866
18
10
2182
21804
73
185
2040
21086
97
582
1718
18116
Neutrophils [#/volume] in Blood
26499-4 [3017732]
5.9e-01
1.3e+00
2.8e+00
1.0e+50
2.5e+00
1.2e+00
4.9e-01
cases:1.86%
controls:1.04%
cases:2.18%
controls:0.59%
cases:1.13%
controls:0.07%
cases:0.54%
controls:0.00%
cases:1.27%
controls:0.11%
cases:2.51%
controls:0.78%
cases:4.24%
controls:2.65%
41
228
2161
21626
48
129
2156
21737
25
15
2179
21851
12
0
2192
21866
28
24
2172
21790
53
166
2060
21105
77
495
1738
18203
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
5.6e-01
1.7e+00
2.7e+00
1.0e+50
3.0e+00
1.5e+00
6.4e-01
cases:1.86%
controls:1.07%
cases:1.36%
controls:0.26%
cases:0.59%
controls:0.04%
cases:0.45%
controls:0.00%
cases:0.64%
controls:0.03%
cases:0.99%
controls:0.22%
cases:1.65%
controls:0.88%
41
234
2161
21620
30
57
2174
21809
13
9
2191
21857
10
0
2194
21866
14
7
2186
21807
21
46
2092
21225
30
165
1785
18533
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
6.6e-01
1.7e+00
2.0e+00
—
2.1e+00
1.4e+00
9.3e-01
cases:1.59%
controls:0.83%
cases:1.59%
controls:0.30%
cases:0.32%
controls:0.04%
—
—
cases:0.41%
controls:0.05%
cases:1.18%
controls:0.28%
cases:2.09%
controls:0.84%
35
181
2167
21673
35
66
2169
21800
7
9
2197
21857
—
9
11
2191
21803
25
60
2088
21211
38
157
1777
18541
hydrocortisone; local oral
A01AC03 [21600036]
1.3e+00
1.8e+00
2.6e+00
1.0e+50
—
2.0e+00
1.1e+00
cases:2.45%
controls:0.69%
cases:1.45%
controls:0.25%
cases:0.32%
controls:0.02%
cases:0.68%
controls:0.00%
—
—
cases:1.47%
controls:0.19%
cases:2.42%
controls:0.84%
54
150
2148
21704
32
54
2172
21812
7
5
2197
21861
15
0
2189
21866
—
31
41
2082
21230
44
157
1771
18541
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 [3020565]
1.9e+00
2.4e+00
—
—
—
3.0e+00
1.5e+00
cases:0.64%
controls:0.09%
cases:0.59%
controls:0.05%
—
—
—
—
—
—
cases:0.57%
controls:0.03%
cases:1.05%
controls:0.24%
14
20
2188
21834
13
12
2191
21854
—
—
—
12
6
2101
21265
19
45
1796
18653
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
8.4e-01
1.1e+00
3.2e+00
—
2.8e+00
9.7e-01
9.3e-02
cases:1.04%
controls:0.45%
cases:1.00%
controls:0.34%
cases:0.95%
controls:0.04%
—
—
cases:0.73%
controls:0.05%
cases:0.95%
controls:0.36%
cases:1.65%
controls:1.51%
23
99
2179
21755
22
75
2182
21791
21
9
2183
21857
—
16
10
2184
21804
20
77
2093
21194
30
282
1785
18416
Pneumonia, unspecified
J18.9 [45601123]
5.2e-01
1.3e+00
3.2e+00
—
1.7e+00
1.3e+00
7.5e-01
cases:4.18%
controls:2.53%
cases:3.04%
controls:0.84%
cases:2.13%
controls:0.09%
—
—
cases:0.50%
controls:0.09%
cases:3.74%
controls:1.00%
cases:7.22%
controls:3.56%
92
552
2110
21302
67
184
2137
21682
47
20
2157
21846
—
11
20
2189
21794
79
213
2034
21058
131
665
1684
18033
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.5e-01
5.4e-01
1.7e+00
3.9e+00
1.8e+00
5.7e-01
2.3e-01
cases:31.70%
controls:28.61%
cases:31.72%
controls:21.24%
cases:18.33%
controls:3.92%
cases:6.44%
controls:0.14%
cases:17.77%
controls:3.40%
cases:33.70%
controls:22.29%
cases:48.43%
controls:42.61%
698
6253
1504
15601
699
4644
1505
17222
404
857
1800
21009
142
30
2062
21836
391
742
1809
21072
712
4742
1401
16529
879
7968
936
10730
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.6e-01
4.7e-01
1.6e+00
4.1e+00
1.7e+00
5.1e-01
2.1e-01
cases:34.06%
controls:30.60%
cases:34.07%
controls:24.50%
cases:21.60%
controls:5.15%
cases:12.57%
controls:0.23%
cases:20.50%
controls:4.63%
cases:36.54%
controls:25.62%
cases:49.70%
controls:44.48%
750
6687
1452
15167
751
5358
1453
16508
476
1127
1728
20739
277
50
1927
21816
451
1010
1749
20804
772
5450
1341
15821
902
8316
913
10382
Serous epithelial malignant tumor of the ovary
C56.71 [2000501075]
1.3e+00
1.8e+00
2.7e+00
1.0e+50
2.6e+00
1.7e+00
1.5e+00
cases:0.36%
controls:0.10%
cases:0.59%
controls:0.10%
cases:0.54%
controls:0.04%
cases:0.41%
controls:0.00%
cases:0.55%
controls:0.04%
cases:0.52%
controls:0.10%
cases:0.44%
controls:0.10%
8
21
2194
21833
13
21
2191
21845
12
8
2192
21858
9
0
2195
21866
12
9
2188
21805
11
21
2102
21250
8
19
1807
18679
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
9.6e-01
1.2e+00
2.2e+00
1.0e+50
2.6e+00
1.9e+00
6.6e-01
cases:0.95%
controls:0.37%
cases:0.64%
controls:0.20%
cases:0.36%
controls:0.04%
cases:0.23%
controls:0.00%
cases:0.55%
controls:0.04%
cases:1.04%
controls:0.16%
cases:0.94%
controls:0.49%
21
80
2181
21774
14
43
2190
21823
8
9
2196
21857
5
0
2199
21866
12
9
2188
21805
22
35
2091
21236
17
91
1798
18607
Sacroiliitis, not elsewhere classified
M46.1 [45577263]
1.6e+00
2.5e+00
1.0e+50
—
—
2.4e+00
2.2e+00
cases:0.41%
controls:0.08%
cases:0.32%
controls:0.03%
cases:0.23%
controls:0.00%
—
—
—
—
cases:0.38%
controls:0.03%
cases:0.55%
controls:0.06%
9
18
2193
21836
7
6
2197
21860
5
0
2199
21866
—
—
8
7
2105
21264
10
11
1805
18687
Protein [Mass/volume] in Urine
2888-6 [3037121]
7.2e-01
1.6e+00
2.3e+00
—
2.6e+00
1.5e+00
8.2e-01
cases:1.04%
controls:0.51%
cases:1.09%
controls:0.23%
cases:0.36%
controls:0.04%
—
—
cases:0.36%
controls:0.03%
cases:1.09%
controls:0.25%
cases:1.21%
controls:0.54%
23
112
2179
21742
24
50
2180
21816
8
8
2196
21858
—
8
6
2192
21808
23
54
2090
21217
22
101
1793
18597
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
1.7e-01
4.5e-01
1.7e+00
3.9e+00
1.7e+00
6.2e-01
3.3e-01
cases:5.36%
controls:4.57%
cases:3.81%
controls:2.47%
cases:1.95%
controls:0.35%
cases:1.72%
controls:0.04%
cases:2.09%
controls:0.39%
cases:4.87%
controls:2.69%
cases:8.10%
controls:5.93%
118
999
2084
20855
84
541
2120
21325
43
77
2161
21789
38
8
2166
21858
46
84
2154
21730
103
573
2010
20698
147
1109
1668
17589
Teaching
WZC30 [2001310891]
6.2e-01
1.5e+00
2.1e+00
1.0e+50
2.3e+00
1.5e+00
6.9e-01
cases:2.86%
controls:1.56%
cases:2.72%
controls:0.65%
cases:0.95%
controls:0.11%
cases:0.45%
controls:0.00%
cases:0.95%
controls:0.10%
cases:2.41%
controls:0.55%
cases:4.24%
controls:2.17%
63
341
2139
21513
60
142
2144
21724
21
25
2183
21841
10
0
2194
21866
21
21
2179
21793
51
118
2062
21153
77
406
1738
18292
Psychiatry
26 [38004469]
6.5e-01
8.3e-01
1.3e+00
2.8e+00
1.3e+00
1.1e+00
7.6e-01
cases:8.40%
controls:4.59%
cases:5.35%
controls:2.40%
cases:3.09%
controls:0.89%
cases:0.54%
controls:0.03%
cases:3.23%
controls:0.94%
cases:6.58%
controls:2.33%
cases:10.08%
controls:5.00%
185
1003
2017
20851
118
524
2086
21342
68
195
2136
21671
12
7
2192
21859
71
204
2129
21610
139
495
1974
20776
183
934
1632
17764
Microorganisms panel - Urine sediment
58435-9 [40761536]
6.5e-01
1.0e+00
2.7e+00
—
2.0e+00
1.3e+00
9.7e-01
cases:2.86%
controls:1.52%
cases:2.09%
controls:0.75%
cases:1.45%
controls:0.10%
—
—
cases:0.77%
controls:0.10%
cases:2.51%
controls:0.73%
cases:4.57%
controls:1.79%
63
332
2139
21522
46
165
2158
21701
32
21
2172
21845
—
17
22
2183
21792
53
155
2060
21116
83
334
1732
18364
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.8e-01
4.4e-01
1.5e+00
4.1e+00
1.6e+00
4.7e-01
3.3e-01
cases:23.43%
controls:20.33%
cases:23.68%
controls:16.66%
cases:14.56%
controls:3.49%
cases:8.21%
controls:0.15%
cases:13.91%
controls:3.18%
cases:25.79%
controls:17.90%
cases:40.39%
controls:32.86%
516
4442
1686
17412
522
3642
1682
18224
321
764
1883
21102
181
32
2023
21834
306
693
1894
21121
545
3807
1568
17464
733
6144
1082
12554
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
8.6e-01
1.7e+00
2.3e+00
—
2.6e+00
1.2e+00
6.4e-01
cases:1.00%
controls:0.43%
cases:1.13%
controls:0.21%
cases:0.32%
controls:0.03%
—
—
cases:0.50%
controls:0.04%
cases:0.71%
controls:0.22%
cases:1.32%
controls:0.70%
22
93
2180
21761
25
45
2179
21821
7
7
2197
21859
—
11
8
2189
21806
15
47
2098
21224
24
131
1791
18567
X-ray examination of the lungs in one projection
GD1PA [2001303645]
6.4e-01
1.5e+00
2.8e+00
—
2.5e+00
1.1e+00
8.0e-01
cases:1.45%
controls:0.77%
cases:1.13%
controls:0.25%
cases:0.36%
controls:0.02%
—
—
cases:0.32%
controls:0.03%
cases:0.95%
controls:0.32%
cases:2.70%
controls:1.23%
32
168
2170
21686
25
54
2179
21812
8
5
2196
21861
—
7
6
2193
21808
20
68
2093
21203
49
230
1766
18468
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 [2001309601]
8.5e-01
3.5e+00
—
—
—
3.3e+00
1.9e+00
cases:0.50%
controls:0.22%
cases:1.18%
controls:0.04%
—
—
—
—
—
—
cases:0.62%
controls:0.02%
cases:0.66%
controls:0.10%
11
47
2191
21807
26
8
2178
21858
—
—
—
13
5
2100
21266
12
19
1803
18679
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
5.5e-01
1.3e+00
2.1e+00
—
2.2e+00
1.5e+00
9.1e-01
cases:2.23%
controls:1.29%
cases:2.77%
controls:0.79%
cases:1.41%
controls:0.17%
—
—
cases:1.41%
controls:0.15%
cases:3.22%
controls:0.71%
cases:4.41%
controls:1.82%
49
282
2153
21572
61
172
2143
21694
31
38
2173
21828
—
31
33
2169
21781
68
152
2045
21119
80
341
1735
18357
Supplier / Service Provider
OMOP5117446 [33004]
-7.4e-01
-1.7e-01
8.0e-02
—
3.5e+00
2.6e+00
3.2e+00
cases:14.35%
controls:25.99%
cases:7.85%
controls:9.17%
cases:1.09%
controls:1.01%
—
—
cases:1.41%
controls:0.04%
cases:5.96%
controls:0.47%
cases:18.51%
controls:0.94%
316
5679
1886
16175
173
2006
2031
19860
24
220
2180
21646
—
31
9
2169
21805
126
99
1987
21172
336
176
1479
18522
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
5.0e-01
1.4e+00
2.2e+00
—
2.3e+00
1.3e+00
8.0e-01
cases:3.50%
controls:2.14%
cases:3.54%
controls:0.88%
cases:0.91%
controls:0.10%
—
—
cases:1.05%
controls:0.11%
cases:3.03%
controls:0.81%
cases:5.84%
controls:2.70%
77
468
2125
21386
78
192
2126
21674
20
22
2184
21844
—
23
24
2177
21790
64
173
2049
21098
106
505
1709
18193
glycerol; rectal
A06AG04 [21600587]
1.8e+00
2.0e+00
—
—
—
2.5e+00
2.2e+00
cases:1.27%
controls:0.22%
cases:0.68%
controls:0.09%
—
—
—
—
—
—
cases:1.14%
controls:0.09%
cases:1.38%
controls:0.16%
28
48
2174
21806
15
20
2189
21846
—
—
—
24
20
2089
21251
25
29
1790
18669
glycerol
A06AX01 [21600597]
1.8e+00
2.0e+00
—
—
—
2.5e+00
2.2e+00
cases:1.27%
controls:0.22%
cases:0.68%
controls:0.09%
—
—
—
—
—
—
cases:1.14%
controls:0.09%
cases:1.38%
controls:0.16%
28
48
2174
21806
15
20
2189
21846
—
—
—
24
20
2089
21251
25
29
1790
18669
Other specified special examinations
Z01.8 [45581003]
7.1e-01
9.1e-01
1.9e+00
1.0e+50
2.3e+00
1.9e+00
7.9e-01
cases:4.45%
controls:2.23%
cases:1.95%
controls:0.79%
cases:0.36%
controls:0.05%
cases:0.23%
controls:0.00%
cases:1.00%
controls:0.11%
cases:4.69%
controls:0.75%
cases:6.34%
controls:2.97%
98
487
2104
21367
43
173
2161
21693
8
12
2196
21854
5
0
2199
21866
22
23
2178
21791
99
159
2014
21112
115
555
1700
18143
Cathetrisation of vein
TPH04 [2001309597]
5.2e-01
1.4e+00
2.2e+00
—
2.1e+00
1.5e+00
7.2e-01
cases:4.22%
controls:2.54%
cases:3.36%
controls:0.87%
cases:1.45%
controls:0.16%
—
—
cases:0.77%
controls:0.10%
cases:3.69%
controls:0.82%
cases:5.62%
controls:2.82%
93
556
2109
21298
74
191
2130
21675
32
36
2172
21830
—
17
21
2183
21793
78
174
2035
21097
102
527
1713
18171
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
8.5e-01
9.8e-01
1.6e+00
—
2.0e+00
1.6e+00
1.4e+00
cases:2.00%
controls:0.86%
cases:1.72%
controls:0.65%
cases:1.13%
controls:0.24%
—
—
cases:1.50%
controls:0.21%
cases:3.22%
controls:0.65%
cases:3.58%
controls:0.87%
44
188
2158
21666
38
143
2166
21723
25
53
2179
21813
—
33
46
2167
21768
68
139
2045
21132
65
163
1750
18535
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
8.3e-01
1.7e+00
1.9e+00
—
2.8e+00
1.2e+00
6.7e-01
cases:1.09%
controls:0.48%
cases:1.04%
controls:0.20%
cases:0.32%
controls:0.05%
—
—
cases:0.59%
controls:0.04%
cases:0.80%
controls:0.25%
cases:1.49%
controls:0.76%
24
105
2178
21749
23
44
2181
21822
7
10
2197
21856
—
13
8
2187
21806
17
53
2096
21218
27
143
1788
18555
Oxygen saturation in Arterial blood
2708-6 [3016502]
6.4e-01
1.2e+00
2.6e+00
—
2.2e+00
1.1e+00
6.2e-01
cases:2.00%
controls:1.07%
cases:1.68%
controls:0.53%
cases:0.64%
controls:0.05%
—
—
cases:0.36%
controls:0.04%
cases:1.56%
controls:0.52%
cases:3.58%
controls:1.96%
44
233
2158
21621
37
115
2167
21751
14
10
2190
21856
—
8
9
2192
21805
33
110
2080
21161
65
366
1750
18332
CBC panel - Blood by Automated count
58410-2 [40761511]
1.4e-01
5.3e-01
1.5e+00
3.9e+00
1.5e+00
5.4e-01
2.9e-01
cases:31.74%
controls:28.86%
cases:28.54%
controls:19.02%
cases:14.70%
controls:3.64%
cases:8.53%
controls:0.18%
cases:13.64%
controls:3.25%
cases:28.54%
controls:18.82%
cases:45.01%
controls:38.05%
699
6307
1503
15547
629
4158
1575
17708
324
796
1880
21070
188
40
2016
21826
300
708
1900
21106
603
4003
1510
17268
817
7114
998
11584
Multidisciplinary treatment meeting
WZC20 [2001310890]
1.1e+00
2.0e+00
—
—
2.3e+00
2.0e+00
9.4e-01
cases:1.32%
controls:0.43%
cases:1.23%
controls:0.17%
—
—
—
—
cases:0.27%
controls:0.03%
cases:0.95%
controls:0.13%
cases:1.27%
controls:0.50%
29
94
2173
21760
27
38
2177
21828
—
—
6
6
2194
21808
20
27
2093
21244
23
93
1792
18605
General Surgery
2 [38004447]
3.6e-01
9.2e-01
1.5e+00
3.2e+00
1.1e+00
7.4e-01
4.9e-01
cases:21.80%
controls:16.33%
cases:11.25%
controls:4.82%
cases:3.27%
controls:0.72%
cases:0.77%
controls:0.03%
cases:2.05%
controls:0.69%
cases:9.32%
controls:4.68%
cases:20.94%
controls:13.95%
480
3568
1722
18286
248
1053
1956
20813
72
158
2132
21708
17
7
2187
21859
45
150
2155
21664
197
996
1916
20275
380
2608
1435
16090
Spread to lymph node
OMOP4998263 [36768587]
9.6e-01
1.8e+00
2.0e+00
—
2.6e+00
1.8e+00
2.0e+00
cases:0.23%
controls:0.09%
cases:0.50%
controls:0.08%
cases:0.23%
controls:0.03%
—
—
cases:0.32%
controls:0.02%
cases:0.47%
controls:0.08%
cases:0.77%
controls:0.11%
5
19
2197
21835
11
18
2193
21848
5
7
2199
21859
—
7
5
2193
21809
10
16
2103
21255
14
20
1801
18678
Remote contact by phone
ZYC01 [2001311579]
7.3e-01
1.4e+00
1.6e+00
—
2.4e+00
1.6e+00
1.3e+00
cases:0.77%
controls:0.38%
cases:0.91%
controls:0.23%
cases:0.36%
controls:0.07%
—
—
cases:0.45%
controls:0.04%
cases:1.04%
controls:0.21%
cases:2.15%
controls:0.62%
17
82
2185
21772
20
50
2184
21816
8
16
2196
21850
—
10
9
2190
21805
22
45
2091
21226
39
116
1776
18582
methylprednisolone; oral, parenteral
H02AB04 [21602732]
7.4e-01
1.2e+00
2.0e+00
1.0e+50
1.9e+00
1.4e+00
1.1e+00
cases:3.36%
controls:1.64%
cases:2.22%
controls:0.70%
cases:0.95%
controls:0.13%
cases:0.36%
controls:0.00%
cases:0.91%
controls:0.14%
cases:2.13%
controls:0.55%
cases:4.02%
controls:1.36%
74
358
2128
21496
49
152
2155
21714
21
29
2183
21837
8
0
2196
21866
20
31
2180
21783
45
117
2068
21154
73
254
1742
18444
Immunohistochemistry procedure
117617002 [4035726]
6.9e-01
1.9e+00
—
—
3.1e+00
1.4e+00
1.2e+00
cases:2.41%
controls:1.22%
cases:2.90%
controls:0.46%
—
—
—
—
cases:0.50%
controls:0.02%
cases:1.04%
controls:0.25%
cases:3.03%
controls:0.97%
53
266
2149
21588
64
101
2140
21765
—
—
11
5
2189
21809
22
54
2091
21217
55
182
1760
18516
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
7.3e-02
1.9e+00
2.5e+00
1.0e+50
—
2.4e+00
1.5e+00
cases:0.59%
controls:0.55%
cases:1.00%
controls:0.15%
cases:0.32%
controls:0.03%
cases:0.23%
controls:0.00%
—
—
cases:1.09%
controls:0.10%
cases:1.43%
controls:0.34%
13
120
2189
21734
22
33
2182
21833
7
6
2197
21860
5
0
2199
21866
—
23
21
2090
21250
26
63
1789
18635
Measurement of expired nitric oxide
444642008 [40480257]
1.5e+00
2.1e+00
—
—
—
2.4e+00
2.1e+00
cases:0.77%
controls:0.18%
cases:0.27%
controls:0.03%
—
—
—
—
—
—
cases:0.38%
controls:0.03%
cases:0.77%
controls:0.09%
17
39
2185
21815
6
7
2198
21859
—
—
—
8
7
2105
21264
14
17
1801
18681
aciclovir; oral, parenteral
J05AB01 [21603131]
8.0e-01
1.1e+00
2.4e+00
—
1.6e+00
1.5e+00
7.9e-01
cases:5.50%
controls:2.55%
cases:2.59%
controls:0.90%
cases:1.50%
controls:0.13%
—
—
cases:0.73%
controls:0.14%
cases:3.74%
controls:0.88%
cases:6.12%
controls:2.88%
121
557
2081
21297
57
197
2147
21669
33
29
2171
21837
—
16
31
2184
21783
79
188
2034
21083
111
539
1704
18159
Essential (primary) hypertension
I10 [45591453]
3.2e-01
5.2e-01
1.4e+00
4.0e+00
1.4e+00
4.3e-01
2.3e-01
cases:18.53%
controls:14.15%
cases:11.89%
controls:7.41%
cases:4.45%
controls:1.18%
cases:3.77%
controls:0.07%
cases:4.18%
controls:1.12%
cases:11.64%
controls:7.87%
cases:23.58%
controls:19.73%
408
3093
1794
18761
262
1620
1942
20246
98
258
2106
21608
83
16
2121
21850
92
244
2108
21570
246
1673
1867
19598
428
3689
1387
15009
Bacteria identified in Stool by Culture
625-4 [3025941]
4.9e-01
1.3e+00
2.5e+00
—
2.4e+00
1.0e+00
9.1e-01
cases:1.50%
controls:0.92%
cases:0.91%
controls:0.24%
cases:0.27%
controls:0.02%
—
—
cases:0.36%
controls:0.03%
cases:0.76%
controls:0.28%
cases:2.15%
controls:0.88%
33
202
2169
21652
20
53
2184
21813
6
5
2198
21861
—
8
7
2192
21807
16
59
2097
21212
39
164
1776
18534
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
4.1e-01
1.1e+00
2.4e+00
—
3.0e+00
1.0e+00
5.0e-01
cases:2.18%
controls:1.45%
cases:2.27%
controls:0.75%
cases:1.23%
controls:0.11%
—
—
cases:1.23%
controls:0.06%
cases:2.13%
controls:0.76%
cases:4.63%
controls:2.86%
48
317
2154
21537
50
165
2154
21701
27
24
2177
21842
—
27
13
2173
21801
45
162
2068
21109
84
534
1731
18164
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
7.9e-01
1.7e+00
2.3e+00
—
1.8e+00
1.7e+00
1.7e+00
cases:1.45%
controls:0.66%
cases:1.23%
controls:0.23%
cases:0.45%
controls:0.05%
—
—
cases:0.27%
controls:0.05%
cases:1.28%
controls:0.24%
cases:2.92%
controls:0.57%
32
145
2170
21709
27
51
2177
21815
10
10
2194
21856
—
6
10
2194
21804
27
50
2086
21221
53
107
1762
18591
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 [3031478]
1.7e+00
2.4e+00
—
—
—
2.5e+00
1.5e+00
cases:0.59%
controls:0.11%
cases:0.82%
controls:0.07%
—
—
—
—
—
—
cases:0.66%
controls:0.06%
cases:1.27%
controls:0.29%
13
23
2189
21831
18
16
2186
21850
—
—
—
14
12
2099
21259
23
54
1792
18644
lenalidomide; oral
L04AX04 [21603930]
—
2.8e+00
—
—
—
3.0e+00
2.3e+00
—
—
cases:0.50%
controls:0.03%
—
—
—
—
—
—
cases:0.76%
controls:0.04%
cases:0.44%
controls:0.04%
—
11
7
2193
21859
—
—
—
16
8
2097
21263
8
8
1807
18690
CD3 cells [#/volume] in Blood
8122-4 [3011412]
1.2e+00
3.0e+00
—
—
—
2.9e+00
2.2e+00
cases:0.50%
controls:0.15%
cases:0.73%
controls:0.04%
—
—
—
—
—
—
cases:1.18%
controls:0.07%
cases:1.38%
controls:0.16%
11
32
2191
21822
16
8
2188
21858
—
—
—
25
14
2088
21257
25
29
1790
18669
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 [3025271]
8.6e-01
3.1e+00
—
—
1.0e+50
2.6e+00
2.4e+00
cases:0.23%
controls:0.10%
cases:0.59%
controls:0.03%
—
—
—
—
cases:0.23%
controls:0.00%
cases:0.57%
controls:0.04%
cases:0.94%
controls:0.09%
5
21
2197
21833
13
6
2191
21860
—
—
5
0
2195
21814
12
9
2101
21262
17
16
1798
18682
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
9.9e-02
3.8e-01
1.5e+00
4.1e+00
1.6e+00
4.4e-01
1.5e-01
cases:22.71%
controls:21.02%
cases:22.82%
controls:16.85%
cases:15.29%
controls:3.77%
cases:9.57%
controls:0.17%
cases:14.91%
controls:3.42%
cases:24.99%
controls:17.70%
cases:35.10%
controls:31.86%
500
4594
1702
17260
503
3684
1701
18182
337
824
1867
21042
211
37
1993
21829
328
747
1872
21067
528
3765
1585
17506
637
5958
1178
12740
Gas panel - Arterial blood
24336-0 [3019060]
6.5e-01
1.1e+00
2.5e+00
—
2.5e+00
1.3e+00
5.5e-01
cases:1.50%
controls:0.79%
cases:1.09%
controls:0.36%
cases:0.50%
controls:0.04%
—
—
cases:0.27%
controls:0.02%
cases:1.04%
controls:0.29%
cases:1.93%
controls:1.12%
33
172
2169
21682
24
79
2180
21787
11
9
2193
21857
—
6
5
2194
21809
22
61
2091
21210
35
209
1780
18489
Platelets [#/volume] in Blood
26515-7 [3007461]
9.9e-02
4.2e-01
1.5e+00
4.0e+00
1.6e+00
4.4e-01
1.4e-01
cases:36.06%
controls:33.80%
cases:36.93%
controls:27.71%
cases:23.46%
controls:6.11%
cases:14.56%
controls:0.30%
cases:22.41%
controls:5.66%
cases:38.57%
controls:28.78%
cases:52.01%
controls:48.44%
794
7387
1408
14467
814
6059
1390
15807
517
1337
1687
20529
321
65
1883
21801
493
1234
1707
20580
815
6121
1298
15150
944
9058
871
9640
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
9.6e-02
4.2e-01
1.5e+00
4.0e+00
1.6e+00
4.4e-01
1.4e-01
cases:36.10%
controls:33.92%
cases:36.98%
controls:27.78%
cases:23.46%
controls:6.12%
cases:14.56%
controls:0.30%
cases:22.41%
controls:5.66%
cases:38.71%
controls:28.85%
cases:52.01%
controls:48.54%
795
7412
1407
14442
815
6075
1389
15791
517
1338
1687
20528
321
65
1883
21801
493
1235
1707
20579
818
6136
1295
15135
944
9076
871
9622
MCH [Entitic mass]
28539-5 [3035941]
9.8e-02
4.2e-01
1.5e+00
4.0e+00
1.6e+00
4.4e-01
1.4e-01
cases:36.10%
controls:33.87%
cases:36.93%
controls:27.77%
cases:23.46%
controls:6.12%
cases:14.56%
controls:0.30%
cases:22.41%
controls:5.66%
cases:38.67%
controls:28.83%
cases:51.96%
controls:48.55%
795
7401
1407
14453
814
6072
1390
15794
517
1338
1687
20528
321
65
1883
21801
493
1235
1707
20579
817
6132
1296
15139
943
9077
872
9621
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
9.6e-02
4.2e-01
1.5e+00
4.0e+00
1.6e+00
4.4e-01
1.4e-01
cases:36.10%
controls:33.92%
cases:36.98%
controls:27.78%
cases:23.46%
controls:6.13%
cases:14.56%
controls:0.30%
cases:22.41%
controls:5.66%
cases:38.71%
controls:28.87%
cases:52.01%
controls:48.56%
795
7413
1407
14441
815
6075
1389
15791
517
1341
1687
20525
321
65
1883
21801
493
1235
1707
20579
818
6140
1295
15131
944
9079
871
9619
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
9.6e-02
4.2e-01
1.5e+00
4.0e+00
1.6e+00
4.4e-01
1.4e-01
cases:36.10%
controls:33.93%
cases:36.93%
controls:27.78%
cases:23.46%
controls:6.13%
cases:14.56%
controls:0.30%
cases:22.45%
controls:5.67%
cases:38.67%
controls:28.87%
cases:52.01%
controls:48.56%
795
7415
1407
14439
814
6074
1390
15792
517
1341
1687
20525
321
65
1883
21801
494
1237
1706
20577
817
6142
1296
15129
944
9079
871
9619
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
9.2e-02
4.2e-01
1.5e+00
4.0e+00
1.6e+00
4.4e-01
1.4e-01
cases:36.06%
controls:33.98%
cases:37.02%
controls:27.82%
cases:23.50%
controls:6.16%
cases:14.56%
controls:0.30%
cases:22.45%
controls:5.68%
cases:38.67%
controls:28.89%
cases:52.07%
controls:48.62%
794
7425
1408
14429
816
6083
1388
15783
518
1347
1686
20519
321
65
1883
21801
494
1239
1706
20575
817
6146
1296
15125
945
9091
870
9607
Pharmacy visit
OMOP4822462 [581458]
3.0e-01
7.4e-01
1.5e+00
2.5e+00
1.2e+00
7.7e-01
9.5e-01
cases:91.42%
controls:88.74%
cases:89.25%
controls:79.84%
cases:76.95%
controls:42.56%
cases:22.50%
controls:2.26%
cases:71.55%
controls:42.33%
cases:89.97%
controls:80.65%
cases:97.52%
controls:93.85%
2013
19393
189
2461
1967
17457
237
4409
1696
9306
508
12560
496
495
1708
21371
1574
9233
626
12581
1901
17155
212
4116
1770
17548
45
1150
carbamide
D02AE01 [21601975]
1.0e+00
1.2e+00
—
—
2.2e+00
1.8e+00
1.8e+00
cases:0.86%
controls:0.31%
cases:0.59%
controls:0.18%
—
—
—
—
cases:0.32%
controls:0.04%
cases:0.90%
controls:0.15%
cases:1.49%
controls:0.24%
19
68
2183
21786
13
39
2191
21827
—
—
7
8
2193
21806
19
32
2094
21239
27
45
1788
18653
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
6.2e-01
1.0e+00
3.0e+00
—
2.1e+00
1.1e+00
8.0e-01
cases:1.50%
controls:0.81%
cases:1.18%
controls:0.42%
cases:0.45%
controls:0.02%
—
—
cases:0.45%
controls:0.06%
cases:1.04%
controls:0.37%
cases:2.59%
controls:1.18%
33
177
2169
21677
26
91
2178
21775
10
5
2194
21861
—
10
12
2190
21802
22
78
2091
21193
47
220
1768
18478
Leukocytes [#/volume] in Blood
26464-8 [3010813]
9.4e-02
4.2e-01
1.5e+00
4.0e+00
1.6e+00
4.4e-01
1.4e-01
cases:36.10%
controls:33.97%
cases:36.98%
controls:27.84%
cases:23.46%
controls:6.16%
cases:14.52%
controls:0.30%
cases:22.50%
controls:5.68%
cases:38.67%
controls:28.90%
cases:52.12%
controls:48.60%
795
7423
1407
14431
815
6088
1389
15778
517
1346
1687
20520
320
66
1884
21800
495
1238
1705
20576
817
6148
1296
15123
946
9087
869
9611
Emergency Room and Inpatient Visit
ERIP [262]
4.8e-01
1.3e+00
2.3e+00
—
2.2e+00
1.1e+00
5.8e-01
cases:5.63%
controls:3.55%
cases:7.12%
controls:2.11%
cases:2.99%
controls:0.31%
—
—
cases:2.68%
controls:0.30%
cases:7.15%
controls:2.42%
cases:13.39%
controls:7.99%
124
776
2078
21078
157
462
2047
21404
66
67
2138
21799
—
59
65
2141
21749
151
514
1962
20757
243
1494
1572
17204
Supine thorax X-ray examination
GD1QA [2001303648]
7.9e-01
1.2e+00
2.4e+00
—
1.8e+00
1.1e+00
5.6e-01
cases:3.13%
controls:1.44%
cases:1.95%
controls:0.58%
cases:0.77%
controls:0.07%
—
—
cases:0.55%
controls:0.09%
cases:2.13%
controls:0.69%
cases:4.30%
controls:2.49%
69
315
2133
21539
43
127
2161
21739
17
15
2187
21851
—
12
19
2188
21795
45
147
2068
21124
78
466
1737
18232
moxifloxacin; oral, parenteral
J01MA14 [21603021]
8.1e-01
1.6e+00
—
—
2.6e+00
1.6e+00
1.4e+00
cases:1.82%
controls:0.81%
cases:0.77%
controls:0.16%
—
—
—
—
cases:0.32%
controls:0.02%
cases:0.95%
controls:0.20%
cases:2.42%
controls:0.63%
40
178
2162
21676
17
36
2187
21830
—
—
7
5
2193
21809
20
42
2093
21229
44
117
1771
18581
Infection and inflammatory reaction due to internal joint prosthesis
T84.5 [45556287]
1.2e+00
2.9e+00
—
1.0e+50
—
3.1e+00
1.9e+00
cases:0.32%
controls:0.09%
cases:0.64%
controls:0.04%
—
—
cases:0.32%
controls:0.00%
—
—
cases:0.76%
controls:0.03%
cases:0.66%
controls:0.10%
7
20
2195
21834
14
8
2190
21858
—
7
0
2197
21866
—
16
7
2097
21264
12
18
1803
18680
desloratadine; oral
R06AX27 [21603526]
7.3e-01
1.0e+00
2.2e+00
—
1.9e+00
1.2e+00
9.1e-01
cases:8.13%
controls:4.10%
cases:4.95%
controls:1.86%
cases:2.90%
controls:0.32%
—
—
cases:2.14%
controls:0.33%
cases:6.01%
controls:1.97%
cases:10.69%
controls:4.62%
179
895
2023
20959
109
407
2095
21459
64
70
2140
21796
—
47
72
2153
21742
127
418
1986
20853
194
863
1621
17835
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
1.7e+00
2.3e+00
—
—
—
2.5e+00
1.5e+00
cases:0.68%
controls:0.13%
cases:0.86%
controls:0.09%
—
—
—
—
—
—
cases:0.80%
controls:0.07%
cases:1.49%
controls:0.34%
15
28
2187
21826
19
20
2185
21846
—
—
—
17
14
2096
21257
27
64
1788
18634
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
5.5e-01
1.1e+00
2.1e+00
—
2.6e+00
1.1e+00
5.5e-01
cases:8.45%
controls:5.07%
cases:6.17%
controls:2.20%
cases:2.36%
controls:0.31%
—
—
cases:2.55%
controls:0.20%
cases:6.11%
controls:2.13%
cases:12.01%
controls:7.29%
186
1108
2016
20746
136
482
2068
21384
52
67
2152
21799
—
56
43
2144
21771
129
453
1984
20818
218
1363
1597
17335
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
4.0e-01
1.0e+00
2.2e+00
1.0e+50
2.5e+00
1.2e+00
5.5e-01
cases:5.36%
controls:3.66%
cases:4.08%
controls:1.49%
cases:1.32%
controls:0.15%
cases:0.41%
controls:0.00%
cases:1.05%
controls:0.08%
cases:3.74%
controls:1.20%
cases:6.67%
controls:3.95%
118
799
2084
21055
90
325
2114
21541
29
32
2175
21834
9
0
2195
21866
23
18
2177
21796
79
256
2034
21015
121
739
1694
17959
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
1.0e+00
2.1e+00
3.0e+00
—
—
1.7e+00
1.1e+00
cases:0.54%
controls:0.19%
cases:0.86%
controls:0.11%
cases:0.45%
controls:0.02%
—
—
—
—
cases:0.71%
controls:0.13%
cases:0.94%
controls:0.31%
12
42
2190
21812
19
24
2185
21842
10
5
2194
21861
—
—
15
27
2098
21244
17
58
1798
18640
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
5.4e-01
1.3e+00
2.5e+00
—
1.9e+00
1.1e+00
6.0e-01
cases:2.18%
controls:1.28%
cases:2.13%
controls:0.62%
cases:0.68%
controls:0.05%
—
—
cases:0.36%
controls:0.06%
cases:1.70%
controls:0.58%
cases:3.97%
controls:2.22%
48
280
2154
21574
47
135
2157
21731
15
12
2189
21854
—
8
12
2192
21802
36
124
2077
21147
72
415
1743
18283
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
5.4e-01
1.3e+00
2.5e+00
—
1.9e+00
1.1e+00
6.0e-01
cases:2.18%
controls:1.28%
cases:2.13%
controls:0.62%
cases:0.68%
controls:0.05%
—
—
cases:0.36%
controls:0.06%
cases:1.70%
controls:0.58%
cases:3.97%
controls:2.22%
48
280
2154
21574
47
135
2157
21731
15
12
2189
21854
—
8
12
2192
21802
36
124
2077
21147
72
416
1743
18282
Sleep apnoea
G47.3 [45562094]
5.6e-01
6.5e-01
1.1e+00
3.1e+00
1.1e+00
7.7e-01
5.9e-01
cases:5.59%
controls:3.27%
cases:3.86%
controls:2.04%
cases:1.18%
controls:0.39%
cases:0.73%
controls:0.03%
cases:1.18%
controls:0.41%
cases:4.40%
controls:2.10%
cases:7.49%
controls:4.28%
123
715
2079
21139
85
447
2119
21419
26
85
2178
21781
16
7
2188
21859
26
89
2174
21725
93
446
2020
20825
136
800
1679
17898
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.5e-01
6.9e-01
1.2e+00
3.2e+00
1.7e+00
5.8e-01
2.8e-01
cases:15.62%
controls:12.62%
cases:11.07%
controls:5.90%
cases:2.81%
controls:0.83%
cases:0.95%
controls:0.04%
cases:3.27%
controls:0.63%
cases:9.89%
controls:5.81%
cases:22.09%
controls:17.66%
344
2757
1858
19097
244
1291
1960
20575
62
181
2142
21685
21
9
2183
21857
72
137
2128
21677
209
1236
1904
20035
401
3302
1414
15396
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
6.8e-01
1.1e+00
2.4e+00
1.0e+50
2.5e+00
1.1e+00
4.7e-01
cases:1.68%
controls:0.86%
cases:1.32%
controls:0.45%
cases:0.50%
controls:0.05%
cases:0.23%
controls:0.00%
cases:0.64%
controls:0.05%
cases:1.56%
controls:0.51%
cases:2.87%
controls:1.81%
37
187
2165
21667
29
99
2175
21767
11
10
2193
21856
5
0
2199
21866
14
11
2186
21803
33
108
2080
21163
52
338
1763
18360
Acute tubulo-interstitial nephritis
N10 [45543856]
7.5e-01
1.0e+00
2.7e+00
1.0e+50
1.8e+00
8.7e-01
6.4e-01
cases:2.32%
controls:1.11%
cases:1.23%
controls:0.45%
cases:1.04%
controls:0.07%
cases:0.59%
controls:0.00%
cases:0.36%
controls:0.06%
cases:1.14%
controls:0.48%
cases:3.31%
controls:1.77%
51
242
2151
21612
27
98
2177
21768
23
15
2181
21851
13
0
2191
21866
8
13
2192
21801
24
102
2089
21169
60
331
1755
18367
Osmolality of Urine
2695-5 [3026782]
4.2e-01
1.0e+00
2.4e+00
1.0e+50
2.1e+00
1.2e+00
6.3e-01
cases:5.45%
controls:3.64%
cases:3.86%
controls:1.46%
cases:1.95%
controls:0.17%
cases:1.09%
controls:0.00%
cases:1.41%
controls:0.18%
cases:4.07%
controls:1.22%
cases:7.16%
controls:3.94%
120
796
2082
21058
85
319
2119
21547
43
38
2161
21828
24
0
2180
21866
31
39
2169
21775
86
260
2027
21011
130
737
1685
17961
pH of Arterial blood
2744-1 [3019977]
5.4e-01
1.2e+00
2.5e+00
—
1.9e+00
9.9e-01
6.3e-01
cases:2.18%
controls:1.29%
cases:2.09%
controls:0.63%
cases:0.68%
controls:0.05%
—
—
cases:0.36%
controls:0.06%
cases:1.61%
controls:0.61%
cases:4.08%
controls:2.20%
48
281
2154
21573
46
138
2158
21728
15
12
2189
21854
—
8
12
2192
21802
34
129
2079
21142
74
412
1741
18286
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
4.2e-01
1.2e+00
2.4e+00
—
2.0e+00
1.1e+00
6.9e-01
cases:5.31%
controls:3.56%
cases:5.04%
controls:1.55%
cases:1.72%
controls:0.16%
—
—
cases:1.18%
controls:0.16%
cases:3.88%
controls:1.36%
cases:8.60%
controls:4.49%
117
777
2085
21077
111
338
2093
21528
38
36
2166
21830
—
26
35
2174
21779
82
290
2031
20981
156
840
1659
17858
Left sided colitis
K51.5 [45533604]
8.1e-01
1.4e+00
1.6e+00
1.0e+50
2.3e+00
1.2e+00
1.2e+00
cases:0.82%
controls:0.37%
cases:1.00%
controls:0.24%
cases:0.50%
controls:0.10%
cases:0.45%
controls:0.00%
cases:0.50%
controls:0.05%
cases:0.76%
controls:0.22%
cases:1.10%
controls:0.33%
18
80
2184
21774
22
53
2182
21813
11
22
2193
21844
10
0
2194
21866
11
11
2189
21803
16
47
2097
21224
20
62
1795
18636
Arthropathic psoriasis
L40.5 [45557703]
1.5e+00
2.0e+00
—
—
—
2.1e+00
2.1e+00
cases:0.91%
controls:0.20%
cases:0.77%
controls:0.11%
—
—
—
—
—
—
cases:0.71%
controls:0.08%
cases:1.27%
controls:0.15%
20
43
2182
21811
17
24
2187
21842
—
—
—
15
18
2098
21253
23
28
1792
18670
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 [3012477]
2.0e+00
2.2e+00
—
—
—
2.3e+00
1.3e+00
cases:0.68%
controls:0.10%
cases:0.59%
controls:0.07%
—
—
—
—
—
—
cases:0.62%
controls:0.06%
cases:1.10%
controls:0.29%
15
21
2187
21833
13
15
2191
21851
—
—
—
13
13
2100
21258
20
55
1795
18643
Dermatological photography
XQ848 [2001310110]
1.5e+00
2.6e+00
—
—
—
2.4e+00
1.2e+00
cases:0.59%
controls:0.13%
cases:0.54%
controls:0.04%
—
—
—
—
—
—
cases:0.47%
controls:0.04%
cases:0.77%
controls:0.23%
13
28
2189
21826
12
9
2192
21857
—
—
—
10
9
2103
21262
14
43
1801
18655
Unspecified adverse effect of drug or medicament
T88.7 [45556308]
1.8e+00
—
—
1.0e+50
1.0e+50
3.8e+00
2.1e+00
cases:0.59%
controls:0.10%
—
—
—
—
cases:0.77%
controls:0.00%
cases:0.27%
controls:0.00%
cases:1.04%
controls:0.02%
cases:1.10%
controls:0.13%
13
21
2189
21833
—
—
17
0
2187
21866
6
0
2194
21814
22
5
2091
21266
20
25
1795
18673
Cardiology
6 [38004451]
3.8e-01
6.0e-01
1.1e+00
3.3e+00
1.1e+00
7.0e-01
5.5e-01
cases:11.72%
controls:8.34%
cases:7.62%
controls:4.31%
cases:2.00%
controls:0.68%
cases:0.64%
controls:0.02%
cases:1.95%
controls:0.67%
cases:7.43%
controls:3.84%
cases:15.21%
controls:9.38%
258
1822
1944
20032
168
943
2036
20923
44
149
2160
21717
14
5
2190
21861
43
146
2157
21668
157
816
1956
20455
276
1754
1539
16944
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
313 [2001600274]
1.4e+00
2.0e+00
—
—
—
2.2e+00
2.1e+00
cases:1.09%
controls:0.27%
cases:0.50%
controls:0.07%
—
—
—
—
—
—
cases:0.47%
controls:0.05%
cases:1.54%
controls:0.19%
24
59
2178
21795
11
15
2193
21851
—
—
—
10
11
2103
21260
28
35
1787
18663
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
5.4e-01
1.2e+00
1.8e+00
—
2.2e+00
1.1e+00
7.8e-01
cases:2.86%
controls:1.69%
cases:2.40%
controls:0.75%
cases:0.68%
controls:0.11%
—
—
cases:0.77%
controls:0.08%
cases:2.37%
controls:0.77%
cases:4.46%
controls:2.10%
63
370
2139
21484
53
163
2151
21703
15
24
2189
21842
—
17
18
2183
21796
50
164
2063
21107
81
392
1734
18306
Bone marrow biopsy
XW000 [2001310618]
1.2e+00
2.6e+00
—
—
—
2.7e+00
1.2e+00
cases:0.86%
controls:0.27%
cases:1.27%
controls:0.10%
—
—
—
—
—
—
cases:1.09%
controls:0.07%
cases:0.83%
controls:0.25%
19
60
2183
21794
28
21
2176
21845
—
—
—
23
15
2090
21256
15
46
1800
18652
Obstetrics / Gynecology
16 [38004461]
3.1e-01
4.9e-01
1.2e+00
3.7e+00
9.2e-01
5.3e-01
4.8e-01
cases:18.12%
controls:13.95%
cases:8.53%
controls:5.41%
cases:3.27%
controls:0.96%
cases:1.86%
controls:0.05%
cases:2.41%
controls:0.97%
cases:8.52%
controls:5.22%
cases:20.44%
controls:13.66%
399
3049
1803
18805
188
1182
2016
20684
72
210
2132
21656
41
10
2163
21856
53
212
2147
21602
180
1110
1933
20161
371
2554
1444
16144
sulfadiazine and trimethoprim
J01EE02 [21602962]
3.5e-01
1.2e+00
3.0e+00
—
1.8e+00
1.0e+00
6.8e-01
cases:4.63%
controls:3.31%
cases:2.63%
controls:0.85%
cases:2.36%
controls:0.11%
—
—
cases:0.64%
controls:0.11%
cases:2.22%
controls:0.79%
cases:4.79%
controls:2.48%
102
724
2100
21130
58
185
2146
21681
52
25
2152
21841
—
14
24
2186
21790
47
169
2066
21102
87
463
1728
18235
valaciclovir; oral
J05AB11 [21603137]
7.9e-01
1.2e+00
1.8e+00
—
1.9e+00
1.2e+00
8.9e-01
cases:3.50%
controls:1.61%
cases:2.04%
controls:0.64%
cases:1.00%
controls:0.17%
—
—
cases:0.73%
controls:0.11%
cases:2.46%
controls:0.77%
cases:4.46%
controls:1.88%
77
352
2125
21502
45
139
2159
21727
22
38
2182
21828
—
16
25
2184
21789
52
164
2061
21107
81
351
1734
18347

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
280
628
4.91
117.71
1.4
1.2
—
—
—
0
0
68
23
30.40
103.07
1.0
1.1
0.07
0.02
u/ml
0.65
68
23
1588
10415
2.55
100.20
11.8
6.3
0.58
0.57
e9/l
1.08
1473
8907
1194
6904
2.45
99.25
11.6
6.4
—
—
—
0
0
1587
10435
2.53
99.09
11.8
6.3
0.04
0.04
e9/l
0.46
1470
8920
388
1258
3.49
97.74
1.7
1.3
438.06
137.55
u/ml
3.69
364
1161
994
5323
2.48
97.48
6.4
4.2
—
—
—
0
0
1614
10770
2.52
96.36
12.3
6.5
0.21
0.18
e9/l
4.66
1508
9373
1606
10708
2.51
95.79
12.0
6.3
1.90
1.95
e9/l
0.21
1516
9410
1688
11721
2.48
88.69
17.2
9.5
4.21
4.06
e9/l
1.97
1565
10130
89
82
11.23
83.70
1.3
1.6
6.30
10.17
ug/l
0.74
84
72
1454
9648
2.28
81.91
12.6
6.5
8.66
8.72
%
0.35
1387
9061
1446
9634
2.26
79.78
12.6
6.5
3.08
2.76
%
4.25
1382
9040
1442
9633
2.24
78.53
12.7
6.5
0.67
0.67
%
0.08
1377
9033
415
1587
2.95
78.13
4.4
2.8
10.27
10.63
g/l
0.77
387
1467
1471
9955
2.23
76.88
12.5
6.4
26.68
28.35
%
6.93
1420
9461
1450
9759
2.22
76.80
12.1
6.3
58.05
57.01
%
2.56
1401
9334
208
540
4.12
71.70
2.8
1.8
1.15
1.19
g/l
0.79
201
514
1352
9013
2.14
71.19
10.1
6.4
1.21
1.21
mmol/l
1.87
1266
8340
1507
10484
2.17
70.89
10.6
6.4
10.63
11.38
umol/l
1.20
1444
9970
203
522
4.16
70.87
2.8
1.8
0.22
0.23
g/l
0.68
193
497
506
2256
2.57
70.11
2.1
1.6
—
—
—
0
0
591
2876
2.40
67.46
1.6
1.4
681.58
506.10
titre
1.21
152
607
1451
10060
2.12
67.35
11.6
7.0
1.21
1.21
mmol/l
1.00
1252
8706
332
1235
2.96
65.03
2.5
1.9
1.14
1.34
g/l
0.97
305
1143
241
780
3.32
59.70
3.2
1.8
14.29
7.80
iu/ml
1.06
68
181
1289
8829
1.99
58.50
8.4
5.0
34.96
35.88
g/l
6.68
1211
8297
1294
8916
1.98
57.26
14.8
14.0
1.19
1.23
inr
2.54
1104
7397
100
170
6.09
56.54
2.9
2.7
1188.26
1113.91
e6/l
0.34
92
147
1915
15306
2.24
54.61
15.4
7.8
81.14
78.44
u/l
1.41
1849
14521
402
1812
2.46
53.22
7.2
4.4
0.94
0.97
%
0.09
205
518
225
754
3.19
52.46
2.6
1.9
1.42
1.71
ug/l
0.24
199
663
384
1721
2.47
51.35
7.0
4.1
0.75
0.71
%
0.14
191
491
535
2795
2.18
49.77
2.6
2.0
—
—
—
0
0
600
3303
2.09
48.55
5.9
3.7
0.81
0.82
mmol/l
1.06
577
3115
964
6263
1.90
48.27
3.9
2.6
57.06
71.38
u/l
0.57
893
5792
416
1992
2.32
47.66
3.2
2.1
332.68
383.19
nmol/l
5.92
389
1841
769
4668
1.95
47.01
8.2
4.4
—
—
—
0
0
574
3176
2.06
45.43
3.2
2.5
2.32
2.35
g/l
0.57
535
2938
606
3421
2.03
45.37
3.2
2.5
12.38
13.39
umol/l
3.12
577
3195
373
1739
2.36
45.31
7.5
4.5
0.10
0.11
%
0.25
176
445
376
1760
2.35
45.25
7.7
4.7
0.63
0.10
%
0.56
179
423
122
303
4.19
44.39
3.7
3.9
2.18
1.59
%
0.59
109
272
488
2578
2.12
43.50
4.3
3.0
5.25
4.52
e9/l
0.64
417
2255
196
677
3.06
43.22
1.4
1.3
—
—
—
0
0
496
2644
2.10
43.14
9.0
5.8
1.07
1.05
mmol/l
0.63
464
2453
364
1714
2.32
43.07
11.2
7.3
9.53
9.33
mmol/l
0.22
342
1648
719
4374
1.92
42.96
2.1
1.5
2.33
2.33
g/l
0.00
511
2727
337
1541
2.38
42.63
4.6
2.9
65.59
66.40
g/l
1.05
312
1424
305
1350
2.44
41.42
5.5
3.9
5.10
5.16
kpa
0.71
290
1308
527
2920
2.03
41.05
3.3
2.5
21.59
23.02
%
1.62
497
2725
298
1313
2.45
40.86
5.5
3.9
7.42
7.42
ph
0.10
254
1098
1697
13564
1.85
40.16
6.5
4.6
62.22
1899.25
e6/l
3.55
18
192
1055
7374
1.77
39.24
4.9
3.6
42.20
58.95
ng/l
0.69
777
4924
1526
11883
1.78
38.58
7.7
4.9
6.60
6.62
mmol/l
0.14
1472
11166
897
6018
1.78
38.14
6.3
4.1
7.40
7.40
ph
0.85
682
4314
432
2287
2.08
37.81
1.9
1.4
—
—
—
0
0
1824
15032
1.89
37.68
7.9
4.2
14.52
11.50
mm/h
12.52
1733
14052
1442
11096
1.75
37.49
5.4
3.8
0.00
3.46
estimate
1.58
336
2392
898
6055
1.77
37.33
2.8
2.2
151.92
218.19
u/l
2.23
854
5741
273
1207
2.42
37.00
3.8
2.7
—
—
—
0
0
351
1732
2.20
36.76
3.7
2.8
70.04
69.83
e9/l
0.04
274
1264
1425
10968
1.74
36.62
5.4
3.8
0.00
0.00
estimate
0.80
334
2341
70
129
5.56
36.37
3.3
3.0
240.48
205.32
e6/l
0.46
62
108
49
63
7.92
35.79
2.3
1.8
33.37
28.86
%
0.97
49
63
838
5593
1.77
35.72
3.7
3.2
1434.49
1284.28
ng/l
0.43
720
4774
199
768
2.73
35.69
1.4
1.2
2.88
1.02
u/ml
0.47
19
55
423
2267
2.05
35.64
3.7
3.0
1.81
1.79
%
0.14
382
2026
1440
11167
1.72
35.50
5.5
3.8
0.01
0.14
estimate
0.50
322
2262
135
419
3.35
35.49
1.5
1.2
15.81
4.04
u/ml
0.43
14
37
1262
9479
1.70
34.68
3.1
2.5
75.39
76.64
nmol/l
0.85
1171
8647
707
4551
1.78
33.76
2.0
1.8
1.16
1.25
mg/l
0.37
561
3488
118
347
3.52
33.74
3.8
3.2
4.51
3.94
e9/l
1.52
118
347
1190
8842
1.69
33.69
4.6
3.4
6.25
6.25
ph
0.03
642
4949
764
5032
1.76
33.69
3.9
2.7
336.69
335.25
umol/l
0.14
683
4467
472
2684
1.94
33.40
2.0
1.6
—
—
—
0
0
368
1950
2.05
31.71
3.2
2.4
0.21
0.21
g/l
0.39
336
1825
152
541
2.93
31.67
1.6
1.2
18.42
7.25
u/ml
0.84
39
90
151
540
2.92
31.19
1.5
1.2
12.22
2.72
u/ml
0.58
27
60
509
3032
1.86
31.00
2.4
2.3
29.37
29.39
s
0.03
497
2958
687
4497
1.74
30.37
3.9
2.6
5.85
6.43
e6/l
0.56
644
4081
823
5665
1.69
30.22
4.4
3.2
0.44
0.43
e6/l
0.05
657
4091
79
191
4.24
29.78
3.5
3.4
59.60
57.43
%
0.35
67
169
337
1768
2.05
29.73
1.6
1.5
—
—
—
0
0
154
573
2.80
29.55
1.6
1.2
54.55
47.25
u/ml
0.11
19
34
117
373
3.25
29.45
2.2
1.7
—
—
—
0
0
37
10
37.56
29.32
1.1
1.1
0.03
0.06
u/ml
—
37
10
867
6092
1.66
29.19
5.7
3.8
0.00
0.00
estimate
1.54
310
2197
63
129
4.99
29.13
3.2
2.9
608.53
459.49
e6/l
1.23
53
104
132
455
3.01
29.10
4.0
3.0
59.97
57.90
%
0.86
132
455
97
277
3.61
28.99
1.9
1.6
—
—
—
0
0
97
277
3.61
28.99
1.9
1.6
—
—
—
0
0
97
277
3.61
28.99
1.9
1.6
—
—
—
0
0
97
277
3.61
28.99
1.9
1.6
—
—
—
0
0
803
5547
1.67
28.78
3.1
2.3
3.01
2.77
mg/l
2.18
699
4813
78
196
4.08
27.95
4.4
4.8
—
—
—
0
0
889
6368
1.63
27.26
4.2
3.1
—
—
—
0
0
114
375
3.14
27.24
5.6
4.2
—
—
—
0
0
907
6552
1.62
26.74
4.7
3.3
31.63
75.86
e6/l
2.13
745
4925
34
40
8.61
26.66
1.1
1.1
1.66
2.23
u/ml
0.10
24
23
152
596
2.66
26.34
5.2
4.0
74.17
61.88
mg/l
0.18
124
524
596
3882
1.71
26.21
1.4
1.3
32.56
31.65
iu/ml
0.06
190
1172
152
598
2.65
26.16
5.2
4.0
39.43
77.87
mg/l
0.76
125
525
602
3937
1.71
26.06
2.0
1.7
—
—
—
0
0
463
2818
1.80
25.79
3.6
2.5
124.35
121.67
ug/g
0.08
367
2253
1027
7702
1.58
25.52
5.4
3.8
95.81
91.13
e6/l
0.06
778
5230
592
3886
1.69
25.15
4.2
2.9
499.76
532.01
mosm/kgh2o
3.18
535
3403
1188
9242
1.56
24.95
21.2
11.0
0.00
0.00
e9/l
0.31
1030
7518
772
5433
1.62
24.93
4.4
3.1
0.00
0.00
estimate
—
5
22
136
520
2.71
24.76
5.2
3.9
16.61
3.99
ratio
0.79
78
305
134
511
2.72
24.52
2.4
2.2
12.81
11.52
mg/l
0.61
125
470
1087
8314
1.56
24.44
5.4
3.7
0.37
0.09
estimate
0.36
283
1917
507
3214
1.73
24.37
1.9
1.7
1246.11
1172.31
nmol/l
0.95
386
2468
123
451
2.82
24.25
1.7
1.4
—
—
—
0
0
99
322
3.16
24.12
2.1
1.3
9.68
11.32
u/ml
—
6
5
1304
10413
1.55
23.99
4.1
3.1
147.22
107.31
ug/l
2.25
1226
9776
923
6823
1.57
23.98
3.3
2.4
—
—
—
0
0
174
761
2.39
23.93
6.6
4.2
24.70
24.79
mmol/l
0.15
162
711
71
187
3.88
23.87
1.5
1.5
2.40
2.95
g/l
1.53
46
139
71
187
3.88
23.87
1.5
1.5
0.39
0.40
g/l
0.07
48
139
71
187
3.88
23.87
1.5
1.5
6.26
6.93
g/l
0.41
47
137
98
319
3.16
23.85
1.6
1.7
0.58
0.78
g/l
0.89
67
251
380
2231
1.84
23.67
9.5
7.9
1.28
0.95
mmol/l
0.83
307
1827
381
2240
1.83
23.62
9.7
7.9
7.42
7.42
ph
1.23
232
1198
70
184
3.89
23.61
1.6
1.5
—
—
—
0
0
200
935
2.24
23.55
6.6
4.0
—
—
—
0
0
794
5704
1.59
23.15
1.9
1.7
19.56
20.21
nmol/l
0.58
698
4853
549
3602
1.68
23.10
1.4
1.3
16.21
11.39
u/ml
0.26
213
1407
222
1098
2.13
22.69
5.2
4.6
—
—
—
0
0
180
819
2.29
22.60
1.5
1.3
—
—
—
0
0
944
7083
1.55
22.58
4.8
3.4
2.33
2.35
mmol/l
5.65
877
6475
1231
9785
1.53
22.55
3.6
2.8
—
—
estimate
—
0
0
187
870
2.25
22.26
2.0
1.8
1.67
1.50
g/l
1.33
164
765
376
2247
1.80
21.98
9.8
7.9
5.02
5.11
kpa
1.02
358
2152
376
2248
1.80
21.95
9.8
7.9
12.17
12.46
kpa
0.50
356
2152
727
5184
1.58
21.57
5.7
4.2
91.39
90.57
%
0.39
704
5080
720
5126
1.58
21.50
1.4
1.3
1.12
1.59
u/ml
0.88
195
1384
340
1986
1.83
21.40
9.9
8.3
95.36
95.70
%
0.41
324
1918
226
1161
2.04
20.84
8.0
6.4
24.69
24.49
mmol/l
0.33
217
1103
666
4687
1.58
20.77
2.3
2.0
—
—
—
0
0
71
209
3.47
20.32
1.7
1.5
62.65
60.75
%
0.15
49
131
110
418
2.71
20.28
1.8
1.5
166.21
148.84
au/ml
0.67
29
132
2192
20171
1.99
20.25
31.1
14.6
21.89
23.34
mg/l
1.63
1992
16437
300
1717
1.85
20.10
1.6
1.4
—
—
—
0
0
35
60
5.90
19.64
1.2
1.4
—
—
—
0
0
340
2038
1.78
19.53
5.1
4.1
7.38
7.38
ph
0.06
207
1164
339
2035
1.78
19.37
5.4
4.1
5.73
5.80
kpa
0.65
329
1976
1112
8829
1.48
19.35
2.4
2.1
96.31
96.58
pmol/l
0.06
671
4657
117
471
2.56
19.23
1.6
1.3
315.46
254.91
u/ml
0.97
76
292
30
18
16.87
19.16
1.4
1.0
21.66
0.02
u/ml
0.68
30
18
593
4137
1.58
18.93
1.8
1.7
73631281.78
27087363.12
pmol/l
0.66
493
3474
315
1863
1.80
18.90
11.0
8.7
119.16
121.37
g/l
1.15
308
1818
327
1973
1.76
18.30
5.5
4.2
1.74
1.81
mmol/l
0.14
291
1680
155
726
2.21
18.13
4.2
2.6
3.51
3.65
g/l
0.67
145
668
155
727
2.21
18.07
4.2
2.6
7.39
7.43
g/l
0.10
145
668
155
727
2.21
18.07
4.2
2.6
4.26
4.23
g/l
0.19
145
668
826
6243
1.49
18.02
11.5
6.2
—
—
—
0
0
57
158
3.67
17.87
1.6
1.2
3.22
0.70
u/ml
0.77
40
77
108
434
2.56
17.83
5.0
3.6
—
—
—
0
0
308
1842
1.77
17.75
6.6
4.0
7.36
7.35
ph
0.47
232
1327
26
38
6.91
16.98
2.0
2.0
—
—
—
0
0
145
682
2.20
16.79
3.8
2.7
2.87
2.99
g/l
0.73
135
623
186
968
2.00
16.49
2.7
2.1
0.43
0.80
estimate
0.17
47
318
138
641
2.22
16.48
2.7
3.3
3.77
3.56
g/l
0.88
130
614
265
1555
1.79
16.24
5.2
3.8
98.54
82.59
ng/l
1.59
228
1357
359
2292
1.67
16.24
4.2
3.1
8.15
7.52
umol/l
0.21
314
2011
209
1142
1.91
16.07
1.4
1.2
—
—
—
0
0
294
1789
1.73
15.87
11.6
9.2
—
—
—
0
0
314
1946
1.71
15.86
2.5
2.1
0.00
0.02
estimate
1.06
64
418
299
1829
1.72
15.84
9.4
8.0
1.48
1.32
mmol/l
1.21
291
1791
46
120
3.89
15.75
2.7
2.7
35.44
41.15
%
1.05
25
62
66
219
3.07
15.63
1.6
1.3
—
—
—
0
0
895
7018
1.44
15.55
5.3
3.3
32.17
31.15
u/l
0.29
841
6647
23
12
19.34
15.54
1.1
1.1
0.22
0.02
u/ml
—
10
6
146
714
2.11
15.32
4.2
3.4
1337.66
300.03
mg/l
0.53
76
309
54
162
3.39
15.07
1.3
1.2
—
—
—
0
0
242
1416
1.79
14.94
2.5
2.4
25.07
19.47
au/ml
0.39
24
156
69
244
2.88
14.63
3.6
2.8
—
—
—
0
0
96
402
2.45
14.57
5.2
4.0
2.22
2.52
mmol/l
0.58
68
267
31
63
4.97
14.52
2.0
2.9
1.49
0.16
e9/l
0.51
15
29
1807
16177
1.47
14.46
5.6
4.4
14.83
14.70
pmol/l
1.35
1671
14917
45
123
3.71
14.45
1.2
1.0
9.86
0.46
u/ml
2.20
26
24
342
2235
1.62
13.98
1.5
1.4
—
—
—
0
0
222
1299
1.78
13.69
1.3
1.3
29.45
45.35
au/ml
0.71
11
92
276
1721
1.68
13.55
5.5
3.6
4.62
4.56
kpa
0.18
267
1671
102
454
2.30
13.52
1.6
1.2
41.33
48.31
u/ml
—
9
45
67
244
2.80
13.48
5.3
2.6
—
—
—
0
0
776
6058
1.41
13.32
4.6
3.2
1.06
0.20
estimate
0.44
269
1856
488
3501
1.49
13.07
3.6
2.8
1.02
1.31
e6/l
0.69
294
1794
2160
20211
1.68
13.07
31.7
17.1
139.37
139.68
mmol/l
7.33
2130
19787
2163
20252
1.68
12.98
32.0
17.2
3.96
3.96
mmol/l
0.42
2134
19793
126
624
2.08
12.82
4.2
2.8
10.48
10.23
g/l
0.18
114
562
1576
13887
1.39
12.77
5.0
3.3
54.11
43.77
u/l
3.67
1498
13143
86
366
2.40
12.63
1.2
1.1
—
—
—
0
0
645
4923
1.42
12.40
5.3
3.9
1.02
1.33
kg/l
0.50
425
3249
34
85
4.04
12.38
28.0
31.2
106.31
124.25
ug/l
0.82
29
71
49
157
3.17
12.36
1.1
1.1
—
—
—
0
0
134
689
2.00
12.31
2.4
2.4
188.35
434.99
ug/l
2.24
123
650
84
358
2.40
12.31
1.3
1.4
65.55
65.40
mmol/l
0.01
66
294
22
19
11.67
12.30
1.2
1.0
2.39
0.44
u/ml
0.55
17
14
41
118
3.52
12.24
1.3
1.0
15.90
0.97
u/ml
1.02
26
33
248
1544
1.68
12.22
3.1
2.4
0.67
0.55
e6/l
0.20
234
1480
64
240
2.71
12.21
1.7
1.3
0.66
84.68
u/ml
—
5
12
252
1581
1.66
12.05
6.8
3.6
1.22
1.23
mmol/l
0.93
221
1357
84
364
2.36
11.87
1.1
1.1
—
—
—
0
0
390
2722
1.52
11.83
1.3
1.2
—
—
—
0
0
191
1116
1.77
11.82
13.6
10.3
15.76
15.98
%
0.54
182
1068
115
570
2.07
11.69
6.6
5.5
1.21
1.28
mmol/l
0.47
102
495
76
318
2.44
11.61
1.4
1.4
28.59
25.10
u/l
0.36
67
262
57
209
2.77
11.37
2.2
2.1
-0.43
0.67
mmol/l
1.29
52
203
52
182
2.90
11.30
2.6
2.2
—
—
—
0
0
119
606
2.01
11.25
1.3
1.3
—
1019.41
—
0
17
267
1730
1.61
11.22
6.6
3.7
—
—
—
0
0
37
107
3.50
10.99
1.1
1.2
1.57
16.00
u/ml
—
7
8
100
482
2.12
10.96
2.0
1.6
22712.24
12673.11
e6/l
0.71
74
344
511
3814
1.43
10.94
4.9
3.7
220.40
456.81
ng/l
2.06
364
2857
111
557
2.04
10.94
1.3
1.3
—
—
—
0
0
975
8091
1.35
10.91
2.3
2.1
—
—
—
0
0
88
405
2.22
10.83
1.1
1.1
10.08
4.76
u/ml
1.46
60
215
58
222
2.65
10.67
1.5
1.4
—
—
—
0
0
117
605
1.98
10.61
1.3
1.3
79.00
91.94
titre
—
10
62
35
100
3.54
10.60
1.4
1.6
—
—
—
0
0
98
475
2.11
10.60
1.1
1.1
2.06
2.00
u/ml
0.03
66
249
65
265
2.49
10.53
1.6
1.5
27.34
29.05
ng/l
0.07
65
265
42
136
3.13
10.45
1.0
1.0
—
—
—
0
0
836
6841
1.34
10.05
4.0
3.5
7.13
7.61
mmol/l
2.49
699
5853
140
783
1.84
10.03
1.1
1.1
—
—
—
0
0
83
388
2.18
9.86
4.1
3.2
8.71
8.16
pmol/l
0.24
83
388
198
1232
1.66
9.76
12.9
10.4
0.70
0.65
%
1.05
192
1226
120
646
1.90
9.69
5.6
5.6
1.58
1.44
mg/l
0.93
112
599
138
780
1.82
9.57
7.0
4.8
0.96
0.89
%
0.71
132
729
262
1753
1.56
9.57
1.2
1.2
—
—
—
0
0
72
322
2.27
9.53
1.3
1.2
—
—
—
0
0
746
6042
1.34
9.49
3.6
2.9
0.00
0.03
—
10
132
520
3983
1.39
9.44
4.1
2.9
2.44
2.45
mmol/l
0.30
481
3575
62
261
2.41
9.41
2.5
2.5
18.16
36.16
iu/ml
—
8
28
125
689
1.86
9.40
1.6
1.5
11.86
9.43
u/l
1.12
105
546
195
1221
1.65
9.39
4.2
3.3
125.21
129.44
g/l
1.76
188
1188
65
281
2.35
9.30
2.5
2.0
0.97
0.93
%
0.18
51
184
212
1359
1.61
9.29
3.1
3.4
4.51
4.55
pmol/l
0.22
191
1218
57
233
2.48
9.22
2.8
2.4
1.24
1.20
g/24h
0.04
42
132
146
850
1.76
9.18
6.8
4.6
1.76
1.58
%
0.55
139
797
202
1284
1.63
9.16
12.6
10.1
1.33
1.29
%
0.28
196
1275
754
6142
1.33
9.16
4.1
3.5
55.24
45.03
mg/l
0.58
475
3888
80
380
2.14
9.15
1.1
1.1
4.40
0.82
u/ml
1.30
56
179
59
247
2.42
9.07
1.3
1.3
—
—
—
0
0
36
116
3.14
9.07
1.2
1.0
1.12
0.24
u/ml
0.88
23
20
43
154
2.82
9.02
1.8
1.4
30.36
34.01
%
0.25
31
91
72
330
2.22
9.00
1.1
1.1
8.18
1.75
u/ml
2.03
50
150
82
396
2.11
9.00
1.1
1.1
2.31
0.99
u/ml
0.90
55
163
763
6241
1.33
8.97
4.9
4.2
9.99
7.83
mg/mmol
0.64
472
3867
112
607
1.89
8.89
4.6
3.7
1.35
1.38
mmol/l
0.12
107
598
80
385
2.12
8.86
7.6
6.4
11.24
11.28
mmol/l
0.03
74
344
19
39
4.90
8.83
1.5
1.4
29.25
21.80
%
0.37
12
25
434
3258
1.41
8.81
3.8
3.0
3.88
2.70
e6/l
1.18
229
1548
80
386
2.11
8.81
7.7
6.4
104.42
105.27
mmol/l
0.80
74
345
84
415
2.06
8.69
2.8
3.2
28.16
34.74
umol/l
2.65
79
384
14
10
14.07
8.68
1.0
1.0
0.17
0.01
u/ml
—
9
10
2220
21265
1.58
8.03
35.5
18.7
80.15
74.86
umol/l
5.96
2205
21008
283
1996
1.47
8.03
3.1
2.3
36.56
62.00
u/l
0.52
242
1685
66
308
2.18
7.94
1.0
1.1
8.06
4.12
u/ml
0.74
39
120
102
560
1.86
7.81
1.2
1.1
—
—
—
0
0
105
582
1.84
7.80
1.4
1.4
271.21
284.88
ug/g
0.25
54
324
2007
18882
1.38
7.79
6.9
5.3
1.87
1.90
mu/l
0.40
1881
17598
18
26
6.97
7.76
1.3
1.0
—
—
u/ml
—
0
0
64
300
2.16
7.63
5.8
5.6
368.74
365.52
umol/l
0.06
54
268
24
67
3.61
7.57
5.5
4.2
—
—
—
0
0
146
901
1.66
7.47
2.2
1.7
0.35
0.31
mg/l
0.29
66
403
77
392
2.00
7.39
4.3
3.5
104.70
1037.48
u/ml
0.82
70
366
318
2332
1.42
7.31
5.0
4.7
32.00
32.39
%
0.24
232
1573
85
451
1.92
7.25
1.7
1.6
—
—
—
0
0
225
1547
1.50
7.24
2.3
2.3
5.48
7.46
ug/l
1.41
193
1368
23
65
3.56
7.14
2.2
1.7
—
—
—
0
0
43
176
2.47
7.01
1.2
1.1
—
—
—
0
0
1961
18475
1.33
6.81
7.1
5.9
39.15
38.82
mmol/mol
0.84
1832
17364
209
1434
1.50
6.80
3.9
2.8
173.39
197.28
ng/l
0.40
189
1306
229
1606
1.47
6.68
1.3
1.2
117.82
149.79
u/ml
0.50
88
588
133
827
1.64
6.64
2.5
2.7
20.52
21.15
s
0.94
117
732
2200
21145
1.48
6.57
21.6
11.3
26.25
25.52
u/l
1.16
2161
20570
22
64
3.46
6.56
1.0
1.0
—
—
—
0
0
272
1981
1.42
6.49
5.0
4.3
16.13
18.89
ug/l
0.16
221
1610
41
171
2.42
6.45
1.3
1.3
—
—
—
0
0
40
165
2.45
6.44
1.4
1.3
251694.76
102893.31
e6/l
0.40
25
109
32
119
2.71
6.34
1.1
1.0
—
—
—
0
0
52
247
2.13
6.06
1.7
1.6
—
—
—
0
0
16
29
5.55
5.99
1.1
1.1
—
—
—
0
0
94
548
1.74
5.98
1.1
1.1
2.53
5.07
eliau/ml
—
8
75
33
129
2.58
5.96
1.2
1.2
—
—
—
0
0
19
54
3.54
5.88
1.6
1.7
—
—
—
0
0
59
298
2.00
5.86
1.0
1.0
0.89
0.05
u/ml
0.92
31
81
25
85
2.96
5.84
1.6
1.3
1.43
2.31
%
—
7
16
86
493
1.77
5.81
1.7
1.6
2728.51
1256.21
e6/l
0.23
73
382
85
488
1.77
5.72
1.6
1.6
32.31
24.82
e6/l
0.18
67
357
48
228
2.13
5.62
1.7
1.4
275.82
279.74
mosm/kgh2o
0.62
40
172
26
93
2.82
5.57
3.1
1.7
—
—
—
0
0
22
72
3.07
5.49
4.4
2.7
19.76
16.72
ug/l
0.40
22
63
99
601
1.68
5.47
12.3
10.2
—
—
—
0
0
22
73
3.03
5.37
1.1
1.1
29.71
257.28
ng/l
—
7
18
24
84
2.88
5.35
3.7
2.8
—
—
—
0
0
92
552
1.69
5.32
3.2
3.3
1.62
2.21
index
0.59
50
279
65
356
1.85
5.13
2.2
1.9
4.92
5.09
mmol/24h
0.16
56
314
23
81
2.86
5.08
3.4
4.3
8.12
9.22
mg/l
0.47
16
73
26
100
2.62
4.89
2.9
2.3
1.93
1.87
umol/l
0.14
26
89
16
46
3.49
4.89
3.3
2.1
—
—
—
0
0
81
481
1.71
4.89
2.7
2.3
127.88
130.37
g/l
0.41
67
387
15
33
4.57
4.86
1.3
1.5
—
—
—
0
0
35
156
2.26
4.82
1.8
1.6
—
—
—
0
0
117
767
1.55
4.77
1.6
1.7
10.64
12.94
u/ml
0.37
33
178
18
58
3.12
4.64
1.4
1.2
42.34
39.55
g/l
0.35
11
30
39
186
2.11
4.58
1.3
1.1
111.67
110.36
pmol/l
0.06
39
186
24
92
2.62
4.56
1.2
4.0
61.58
75.02
mg/l
0.36
19
65
40
193
2.09
4.56
1.1
1.1
—
—
—
0
0
19
64
2.98
4.55
1.2
1.1
—
—
—
0
0
22
81
2.73
4.51
3.7
2.5
9.01
9.52
mg/l
0.14
17
68
40
194
2.08
4.50
1.4
1.2
—
—
—
0
0
95
607
1.59
4.35
2.2
2.0
5.60
13.04
iu/l
0.38
35
256
22
83
2.67
4.32
2.5
1.7
15.90
34.71
umol/l
—
5
8
44
225
1.97
4.31
2.1
2.3
—
—
—
0
0
27
114
2.38
4.23
1.2
1.2
—
—
—
0
0
88
556
1.60
4.23
1.1
1.1
—
—
—
0
0
67
395
1.72
4.20
1.3
1.1
—
—
—
0
0
67
396
1.71
4.16
1.3
1.1
—
—
—
0
0
34
161
2.13
4.10
1.2
1.1
—
—
—
0
0
51
280
1.84
4.07
1.7
1.5
454.19
358.79
mu/l
0.49
43
215
23
92
2.51
4.05
1.4
1.3
150.65
165.04
mmol/24h
0.44
23
92
14
42
3.35
4.04
1.4
2.5
13.29
5.07
ug/l
0.45
14
42
59
341
1.75
3.98
1.3
1.3
49.58
38.06
u/l
0.22
49
287
18
64
2.83
3.95
3.3
2.7
0.60
0.62
mmol/l
0.40
18
64
10
19
5.28
3.82
1.6
1.1
—
—
—
0
0
22
89
2.49
3.80
1.6
2.0
117.63
124.32
umol/l
—
8
53
37
187
1.99
3.78
1.3
1.1
—
—
—
0
0
33
160
2.08
3.77
1.1
1.0
238.84
253.92
mg/l
0.15
25
139
34
169
2.03
3.64
1.2
1.1
38.36
41.02
mg/l
0.12
26
139
106
725
1.48
3.62
4.2
3.4
4504.58
856.77
u/ml
0.44
90
626
55
322
1.72
3.58
1.3
1.3
4.00
4.86
u/ml
0.25
25
145
197
1507
1.33
3.54
2.2
2.3
11.41
12.42
nmol/l
0.93
180
1358
51
296
1.74
3.44
2.3
2.9
3.85
152.76
u/ml
0.58
51
291
12
32
3.76
3.38
5.5
3.8
—
—
—
0
0
129
931
1.41
3.34
2.1
1.9
—
—
—
0
0
132
957
1.40
3.33
2.4
2.3
—
—
—
0
0
1971
18986
1.21
3.25
5.8
4.8
5.91
5.86
mmol/l
0.85
1816
17522
9
19
4.75
3.23
1.3
1.3
—
—
—
0
0
9
19
4.75
3.23
1.3
1.2
—
—
—
0
0
1922
18485
1.20
3.14
4.7
4.0
1.33
1.26
mmol/l
4.36
1779
17123
22
98
2.26
3.13
2.9
2.3
32.08
28.63
umol/l
0.79
22
88
33
173
1.92
3.09
1.2
1.3
134.00
257.19
titre
—
5
32
22
99
2.23
3.06
1.2
1.2
988.89
1033.33
titre
—
9
18
16
62
2.59
3.04
1.1
1.1
—
—
—
0
0
1796
17191
1.18
3.02
33.2
18.2
13.83
13.54
%
16.27
1785
16956
144
1083
1.35
2.94
3.1
2.3
1566.75
5913.99
u/l
3.35
53
442
7
13
5.40
2.87
1.4
1.0
—
—
—
0
0
12
38
3.17
2.85
2.0
1.9
—
—
—
0
0
91
639
1.44
2.79
2.1
2.6
—
—
—
0
0
2252
22079
1.32
2.76
43.2
22.4
6.99
6.68
e9/l
4.31
2222
21585
25
124
2.03
2.76
1.3
1.1
1731.68
1424.05
miu/ml
0.55
25
124
2251
22068
1.32
2.76
43.2
22.4
256.17
253.55
e9/l
0.99
2225
21641
5
6
8.35
2.75
1.0
1.0
0.03
0.02
u/ml
—
5
6
2251
22074
1.31
2.70
42.9
22.3
91.18
90.73
fl
4.58
2235
21861
2251
22076
1.31
2.68
43.9
22.8
39.71
40.41
%
2.70
2235
21851
2251
22076
1.31
2.68
42.9
22.3
30.27
30.22
pg
0.69
2236
21862
2251
22077
1.31
2.67
43.0
22.4
4.38
4.49
e12/l
18.68
2224
21588
16
67
2.40
2.63
1.1
1.0
22.28
11.21
u/ml
—
7
48
27
141
1.93
2.60
3.2
2.3
646.25
618.89
ml
0.14
20
96
26
134
1.95
2.60
1.3
1.2
0.60
0.60
ratio
0.00
12
77
2251
22086
1.30
2.59
43.4
22.6
131.67
134.68
g/l
18.49
2237
21872
31
170
1.83
2.59
2.1
1.4
0.64
1.31
promille
1.79
24
135
19
87
2.19
2.57
1.1
1.1
185.75
208.29
iu/ml
0.17
19
87
706
6372
1.15
2.57
1.6
1.5
—
—
—
0
0
5
7
7.15
2.55
1.0
1.0
—
—
—
0
0
5
7
7.15
2.55
1.8
5.6
—
—
—
0
0
151
1180
1.30
2.41
1.6
1.4
25.12
25.09
iu/l
0.00
133
990
5
8
6.26
2.37
1.2
1.0
—
—
—
0
0
24
125
1.93
2.35
1.2
1.2
1.06
1.06
ratio
0.13
17
105
11
39
2.83
2.34
1.4
1.3
—
—
—
0
0
174
1393
1.27
2.31
1.2
1.3
—
—
—
0
0
13
53
2.46
2.27
1.1
1.1
—
—
—
0
0
13
53
2.46
2.27
1.1
1.1
—
—
—
0
0
13
53
2.46
2.27
1.1
1.1
—
—
—
0
0
16
72
2.23
2.27
1.8
1.5
16.03
14.46
pmol/l
0.47
11
58
47
302
1.57
2.25
1.3
1.2
—
—
—
0
0
326
2797
1.19
2.23
2.0
1.8
—
—
—
0
0
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
61
417
1.47
2.21
3.5
2.4
88.54
97.26
ug/min
0.08
37
256
23
121
1.91
2.20
1.7
1.5
1.52
1.31
nmol/l
0.26
18
89
21
107
1.97
2.20
1.1
1.3
—
—
—
0
0
39
241
1.63
2.19
1.5
1.3
1182.09
1665.35
e6/l
0.63
33
171
309
2645
1.19
2.18
1.6
1.5
—
—
—
0
0
15
67
2.25
2.17
1.2
1.2
—
—
—
0
0
9
30
3.01
2.14
1.2
1.1
—
—
—
0
0
41
260
1.59
2.09
1.5
1.3
0.16
0.25
nmol/l
0.64
32
199
8
25
3.21
2.09
3.9
2.6
—
—
—
0
0
111
850
1.32
2.09
1.5
1.3
236.55
232.64
miu/ml
0.03
45
416
27
153
1.77
2.08
1.3
1.1
—
—
—
0
0
116
898
1.31
2.03
2.0
1.7
360.42
299.30
mu/l
0.98
110
816
533
4793
1.14
2.00
5.7
5.4
2.31
2.99
ug/l
0.93
470
4313
314
2713
1.18
2.00
1.3
1.3
—
—
—
0
0
33
201
1.65
1.99
1.5
1.3
—
—
—
0
0
7
22
3.19
1.88
1.0
1.0
2.77
7.42
u/ml
—
7
22
58
409
1.43
1.84
1.1
1.1
9.05
18.38
au/ml
0.80
15
111
64
460
1.40
1.83
2.3
3.0
—
—
—
0
0
162
1965
0.81
1.82
1.4
1.3
—
—
—
0
0
2008
19593
1.15
1.81
5.5
4.8
4.58
4.64
mmol/l
2.27
1881
18433
19
101
1.89
1.80
3.0
2.8
—
—
—
0
0
15
74
2.03
1.75
3.5
1.9
42.51
40.17
g/l
1.06
15
74
9
36
2.51
1.74
2.1
1.8
—
—
—
0
0
49
339
1.45
1.73
2.1
2.7
6.90
5.91
umol/l
0.13
30
243
30
186
1.62
1.72
3.6
3.5
12.67
12.55
index
0.02
21
106
32
202
1.59
1.71
1.6
1.3
17898.76
83063.75
e6/l
0.97
21
111
97
753
1.30
1.71
2.0
1.9
—
—
—
0
0
7
25
2.81
1.65
3.0
4.9
—
—
—
0
0
16
83
1.93
1.64
1.1
1.1
—
—
—
0
0
11
50
2.21
1.57
1.6
2.8
31.09
47.90
%
1.78
11
50
11
50
2.21
1.57
3.3
5.5
11.91
8.02
%
0.61
11
50
13
64
2.04
1.54
1.2
1.5
—
—
—
0
0
21
123
1.71
1.50
7.6
7.9
680.20
164.11
ug/l
0.34
14
81
6
21
2.86
1.50
1.0
1.0
—
50.75
—
0
8
47
334
1.42
1.48
1.1
1.2
—
—
—
0
0
1990
19473
1.13
1.45
5.4
4.7
1.43
1.47
mmol/l
4.40
1852
18210
6
22
2.73
1.43
4.5
9.6
5.82
5.82
mmol/l
—
6
22
2025
19844
1.13
1.41
6.0
5.4
2.68
2.72
mmol/l
1.26
1890
18581
56
415
1.36
1.40
3.6
2.4
1.10
0.83
nmol/l
1.41
41
354
58
769
0.75
1.39
1.1
1.1
0.75
0.65
ratio
—
9
88
70
538
1.31
1.37
2.9
3.6
59.03
61.21
%
0.30
65
525
9
41
2.20
1.37
6.4
6.0
7.06
5.42
kpa
—
9
41
37
258
1.44
1.31
1.6
1.3
—
—
nmol/l
—
0
0
6
24
2.50
1.30
1.0
1.1
—
—
—
0
0
63
816
0.77
1.30
1.1
1.1
1.49
1.54
g/l
1.06
63
816
48
352
1.37
1.29
1.3
1.1
60.15
1631.10
iu/ml
0.52
13
82
882
8341
1.09
1.27
2.1
1.9
1.42
1.34
mmol/l
1.92
723
7109
34
235
1.45
1.27
2.2
1.9
—
—
—
0
0
29
194
1.50
1.27
1.6
1.4
—
—
—
0
0
41
294
1.40
1.26
1.1
1.1
1.33
2.65
eliau/ml
1.72
15
135
122
1016
1.21
1.24
2.4
2.3
—
—
—
0
0
18
108
1.67
1.22
2.4
2.6
14.84
16.13
%
0.62
18
108
16
93
1.73
1.21
3.4
2.9
—
—
—
0
0
130
1096
1.20
1.18
2.3
2.2
—
—
—
0
0
47
351
1.35
1.16
1.1
1.2
—
—
—
0
0
5
20
2.50
1.15
2.2
1.4
63.80
48.60
umol/l
—
5
20
121
1018
1.20
1.13
4.6
3.3
1.02
1.02
ratio
0.56
111
920
130
1101
1.19
1.13
2.3
2.2
—
—
—
0
0
26
175
1.49
1.12
1.0
1.1
20.63
15.31
u/ml
—
8
74
17
103
1.66
1.12
1.7
2.4
51.57
52.20
umol/l
0.01
12
93
122
1438
0.84
1.10
1.6
1.6
992.30
1007.51
mu/l
0.07
101
1223
5
21
2.38
1.09
1.0
1.2
—
—
—
0
0
31
218
1.43
1.09
1.7
2.1
—
—
—
0
0
18
112
1.61
1.08
1.3
1.2
14.22
8.79
mm/h
0.88
18
112
50
382
1.32
1.07
1.4
1.4
5.48
4.22
ug/l
0.24
44
350
194
1707
1.15
1.06
2.3
2.6
6.06
6.11
ph
0.26
122
1153
128
1090
1.18
1.06
2.4
2.2
—
—
—
0
0
155
1783
0.86
1.05
1.5
1.6
3.41
3.48
mmol/l
0.27
93
1198
30
212
1.42
1.04
6.1
5.4
42.90
67.27
u/ml
0.28
11
71
27
187
1.45
1.03
1.8
1.6
—
—
—
0
0
9
46
1.96
1.03
1.6
1.1
47.27
56.66
%
—
9
39
29
204
1.43
1.03
2.4
2.6
—
—
—
0
0
104
874
1.20
1.01
2.3
2.2
—
—
—
0
0
56
442
1.27
0.97
5.7
4.2
—
—
—
0
0
126
1086
1.17
0.93
2.4
2.1
—
—
—
0
0
25
175
1.43
0.93
1.0
1.1
10.61
9.87
iu/ml
—
10
42
48
374
1.29
0.92
4.0
3.6
0.78
0.80
nmol/l
0.14
35
306
17
254
0.67
0.89
1.4
1.6
—
—
—
0
0
6
30
2.00
0.87
1.5
1.3
—
—
—
0
0
260
2369
1.11
0.85
1.7
1.8
—
—
—
0
0
6
31
1.94
0.84
1.2
1.4
—
—
—
0
0
21
146
1.44
0.82
4.0
1.6
5.80
6.61
mmol/l
0.76
16
95
14
89
1.58
0.81
1.6
1.6
—
—
—
0
0
31
234
1.33
0.77
3.2
2.3
—
—
—
0
0
71
840
0.84
0.73
1.4
1.2
0.88
0.89
g/l
0.06
71
840
215
2356
0.90
0.73
1.7
1.9
3.34
3.46
ratio
0.75
149
1760
11
68
1.62
0.71
1.9
2.6
146.83
122.10
ng/l
—
6
44
16
110
1.46
0.68
2.3
1.9
104.25
113.86
ng/l
0.24
16
110
23
170
1.36
0.67
1.1
1.2
—
—
—
0
0
5
28
1.79
0.66
2.2
1.6
—
—
—
0
0
307
2862
1.08
0.65
3.3
3.2
0.72
0.78
ug/l
0.44
215
1804
15
103
1.46
0.65
1.9
2.1
—
—
—
0
0
5
30
1.67
0.61
3.4
1.6
1.22
1.31
umol/l
—
5
18
5
30
1.67
0.61
1.6
1.4
—
—
—
0
0
62
527
1.18
0.60
1.4
1.4
—
—
—
0
0
0
20
0.00
0.60
0.0
3.5
—
0.20
—
0
20
8
52
1.54
0.59
1.0
1.0
19.79
37.04
iu/ml
—
8
52
11
72
1.53
0.59
1.3
1.5
41.09
169.14
nmol/24h
0.83
11
72
20
149
1.35
0.57
1.5
2.3
1.13
1.96
u/field
0.84
15
80
16
115
1.39
0.56
1.3
1.3
139.69
138.18
nmol/l
0.04
16
115
8
125
0.64
0.54
1.1
1.5
5.16
5.76
mmol/l
—
8
119
50
588
0.85
0.53
1.5
1.5
1.20
1.29
mm
0.86
33
415
47
397
1.19
0.51
1.5
1.5
0.23
0.39
nmol/l
2.56
37
315
25
198
1.27
0.49
1.4
1.3
6.92
6.47
mmol/l
0.30
25
188
52
601
0.86
0.46
1.5
1.5
—
—
—
0
0
53
611
0.86
0.46
1.5
1.6
—
—
—
0
0
8
58
1.38
0.41
1.4
1.9
—
—
—
0
0
14
105
1.34
0.41
1.3
1.3
168.49
161.65
pmol/l
0.06
14
105
62
553
1.12
0.37
1.4
1.3
—
—
—
0
0
6
42
1.43
0.35
1.2
1.4
2.80
4.79
nmol/l
—
6
42
6
45
1.33
0.33
2.3
1.1
—
—
—
0
0
38
435
0.87
0.33
4.3
3.4
19.77
25.35
mg/l
0.91
28
296
6
47
1.28
0.32
1.0
1.0
5.55
6.57
mg/g
—
6
47
24
282
0.85
0.30
1.2
1.4
6.61
7.22
mmol/l
0.84
24
251
8
62
1.29
0.28
1.3
1.3
26.75
28.11
s
—
8
62
8
63
1.27
0.27
2.4
1.6
6.76
7.95
mmol/l
—
8
63
105
981
1.07
0.27
1.1
1.1
—
—
—
0
0
9
116
0.77
0.27
1.9
1.5
0.73
0.47
e9/l
—
9
116
73
790
0.92
0.26
1.5
1.5
72.64
59.53
ug/l
0.98
61
665
1714
17273
0.97
0.24
33.7
18.7
331.67
332.34
g/l
2.22
1701
17171
26
228
1.14
0.22
1.2
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
0.14
—
0
11
14
118
1.19
0.19
2.5
2.3
7.56
8.65
mmol/l
0.81
14
118
7
58
1.21
0.18
2.3
3.3
—
—
—
0
0
35
383
0.91
0.18
1.7
1.9
—
—
—
0
0
11
94
1.17
0.13
1.0
1.0
—
—
—
0
0
791
7989
0.99
0.12
3.4
2.9
—
—
—
0
0
15
134
1.12
0.11
1.1
1.0
729.70
727.16
ng/l
—
10
88
116
1129
1.03
0.09
1.8
1.7
—
—
—
0
0
5
61
0.82
0.08
1.2
1.4
0.60
3.27
%
—
5
53
14
129
1.09
0.05
1.2
1.5
77.57
79.97
umol/l
0.17
14
129
31
316
0.98
0.00
1.0
1.2
—
—
—
0
0
20
205
0.98
0.00
1.3
1.6
7.42
7.63
mmol/l
0.18
20
199
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
231.86
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
72
0.97
-0.00
1.1
1.7
0.00
0.00
estimate
—
7
72
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
71.74
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
2800.00
—
0
5
0
7
0.00
-0.00
0.0
6.4
—
—
—
0
0
8
86
0.93
-0.00
2.6
2.0
143.63
152.20
nmol/l
—
8
79
0
5
0.00
-0.00
0.0
1.0
—
36.46
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: L12_INTERNALSUBSTANCEDERM – Dermatitis due to substances taken internally

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).